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Abstract
The uterus of a mature female mammal undergoes hormonally initiated 
morphological and transcriptional changes during early pregnancy, preparing it for 
the implantation and subsequent nurturing of the developing embryo. Implantation 
involves a global change in gene expression that has not been fully elucidated. The 
uterus consists of layers of different types of tissue: the luminal epithelium confronts 
the uterine lumen and acts as a transducer between the blastocyst and the 
underlying uterine stroma. The stroma contains areas of glandular epithelium and is 
surrounded by two myometriai layers: one circular and one longitudinal. Each layer 
of the uterus is undergoing different transcriptional changes and these changes 
often involve communicating with the other uterine layers and the embryo.
The aim of this work was to identify and characterise molecular markers for 
the luminal epithelial, glandular epithelial and stromal layers of the uterus. Samples 
of uterine luminal epithelium and stroma/glands were obtained from mice on day 4 
of pseudopregnancy using an enzyme treatment and mechanical extraction 
technique. Maternally controlled molecular markers of peri-implantation receptivity 
in the luminal epithelium (EP2), glandular epithelium (LIF) and stroma (EP3 and Tn-c) 
were characterised using real-time RT-PCR with Taqman® fluorogenic probes. Pure 
samples of each tissue were then obtained using laser microdissection, and were 
used first to verify the specificity of the markers, then to run a microarray study to 
identify more putative markers. Finally, the enzyme treatment and mechanical 
extraction technique with subsequent real-time RT-PCR using Taqman® was used to 
investigate the expression of canonical circadian genes (Bmal, Clock, Perl, Per2 and 
Cryl) in the luminal epithelium and stroma of the uterus. All genes were found to be 
expressed in the luminal epithelium and the stroma, but did not appear to have a 
circadian rhythm.
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Chapter 1: Introduction
Summary
1.1: Structure of the uterus 
1.2: Temporal changes of the uterus 
1.2.1: The oestrous cycle 
1.2.2: The peri-implantation period 
1.3: Studying changes in transcription in the uterus
1.3.1 Techniques used in studying gene expression 
1.3.2: Previous studies investigating the mouse luminal epithelium 
1.4: Overview of thesis
The uterus is a hollow muscular organ located in the pelvic cavity and posterior 
abdominal wall of female mammals in which the fertilized egg implants and 
develops. In rodents the uterus is split into two horns that join at the cervix to enter 
the vaginal vault, but in humans the two horns have become completely united 
into a single hollow structure with a single cervical communication to the vagina. 
The uterus is a complex organ both anatomically and temporally. It consists of 
layers of different tissue types, ail morphologically and biochemically distinct. When 
mature, the uterus of a mature female mammal undergoes hormonally initiated 
morphological and transcriptional changes called the oestrous cycle that prepare 
it first for sperm transport and capacitation. The uterus then becomes prepared for 
the implantation and subsequent nurturing of the developing embryo, should 
fertilisation occur. These many layers of complexity have made the uterus difficult 
to study in the past. This dissertation will focus on the transcriptional changes that 
take place around the time of implantation.
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Implantation is the most important time in early pregnancy. If a fertilised 
embryo arrives in a uterus that is not prepared for implantation then the pregnancy 
will fail. This preparation involves a global change in gene expression that has not 
been fully elucidated. To further complicate matters, each layer of the uterus is 
undergoing different transcriptional changes and these changes often involve 
communicating with the other uterine layers and the embryo, as discussed in 
section 1.2.2. The ultimate aim of this research is to characterise maternally 
controlled molecular markers of peri-implantation receptivity in the different tissue 
types in the uterus of the mouse. Ethical and technical problems with experiments 
into human implantation mean that animal models are generally preferred.
The mouse is a useful model organism in reproductive biology. It is easy to 
keep in large numbers due to its relatively small size and short reproductive life 
cycle, yet it is mammalian so resembles human anatomy and physiology 
sufficiently. It also has an almost completely sequenced genome, which makes it 
very useful for molecular genetics. Its high fecundity permits large numbers of mice 
with the same traits to be bred relatively quickly and easily. Inbred strains are also 
readily available. There are quite large physiological and gross anatomical 
differences (discussed in section 1.2) between human and mouse uteri. However 
the genetic control of reproduction seems well conserved in mammals and both 
species have a similar invasive implantation mechanism. Mouse genetic studies are 
a powerful tool as its genome is well-characterised and large scale studies are 
relatively easy to do. This gives the mouse its advantage as a model organism in 
reproductive biology (Lee and Demayo, 2004).
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1.1: Structure of the uterus
The mouse uterus is bicornuate, having two uterine horns and a short stem where the 
two horns join. The stem leads to the cervix and vagina, the other ends of the horns are 
continuous with the two oviducts. Spatially the uterus is composed of different tissue 
types in radial layers (see Figure 1.1). The layers of the uterus can be seen clearly v/hen 
a transverse section is viewed under the microscope. Each layer has distinct roles but 
they work together to contribute to the function of the uterus as a whole organ. The 
circular and longitudinal muscles of the myometrium allow the changes in size, shape 
and motility of the uterus that occur during the cycle, pregnancy and subsequent 
parturition. The stroma is the tissue that forms the main decidual interface between the 
mother and the embryo during pregnancy in mice and humans (but not in the early 
stages of ungulate development in which the luminal epithelium remains intact). The 
glandular epithelium secretes fluid into the uterine cavity during the oestrous cycle and 
pregnancy. This fluid may contain proteins, lymphatic cells, hormones and signalling 
molecules depending on the endocrine state of the uterus. The luminal epithelium is at 
the heart of the complexity of the uterus as it confronts the uterine lumen, through 
which both spermatozoa and embryo must pass before implantation. The cells of the 
endometrium (mainly the stromal cells) become the decidual cells of the placenta 
during the early stages of pregnancy.
5
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Figure 1.1: Transverse H&E stained section through the murine uterus. The outer 
m esenchym al layer (A) interposes be tw een  the uterus a nd  the peritonea l ca v ity  a nd  is 
th ickened  into a m esom etria l layer a tta ch in g  the uterus to the posterior abdom ina l 
wall a nd  through w hich b lo od  vessels pass. The m yom etrium  (B), s ituated inside the 
m esenchym e, is com posed  first o f a layer o f long itud ina l sm ooth muscle, then a layer 
o f c ircu la r sm ooth muscle. The endom etrium , w hich lies inside the musculature, consists 
o f a m esenchym al stroma (C) con ta in ing  g landu la r invaginations (D) o f the innermost I 
layer, the uterine lum inal epithe lium  (E), which confronts the uterine lum en (F).
1.2: Temporal changes of the uterus
1.2.1: The oestrous cycle
Over time, the uterus changes under the influence of hormones. The oestrous cycles of 
mammals are based around changing levels of the hormones luteinising hormone (LH), 
follicle stimulating hormone (FSH), oestradiol (E2, an oestrogen) and progesterone (P4), 
as illustrated in Figure 1.2.
LH
FSH
14 21 280 7
Follicular phase Luteal phase
Figure 1.2: Levels of progesterone (P4), oestradiol (E2) follicle-stimulating hormone 
(FSH) and luteinising hormone (LH) during the human menstrual cycle.
Humans have a 28-day menstrual cycle (Wang and Dey, 2006). Just before 
menstruation (day 1), E2 and P4 levels are low. Moderate levels of E2 and P4 inhibit LH 
and FSH so levels of these two gonadotrophins begin to rise. The increasing 
concentrations of FSH and LH lead to growth of ovarian follicles tha t are nearing 
maturity (antral follicles). Maturing antral follicles secrete E2, which has a negative 
feedback effect on FSH and LH and prevents further rise. Contrary to the inhibitory
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effects of small rises in E2 on FSH, a large increase in E2 causes positive feedback and 
an increase of FSH and LH levels. When a dominant follicle is selected for ovulation a 
large rise in oestrogen causes a rapid rise in LH and FSH and ovulation occurs. After 
ovulation, oestrogen levels begin to fall and the corpus luteum ('CL', the post­
ovulatory follicle) secretes progesterone. This again represses FSH and LH levels. The CL 
starts to secrete some oestrogen and levels rise slightly. The combined effect of E2 and 
P4 stops LH and FSH levels from rising and antral growth from resuming, until the corpus 
luteum ceases to be functional and secrete these two hormones. Menstruation occurs 
and the cycle begins again (Johnson and Everitt, 2000).
The mouse has a 4-5 day oestrous cycle where both the follicular and luteal 
phases are abbreviated if mating does not occur. In the mouse, maturation of ovarian 
follicles takes place over the course of several cycles because FSH and LH levels do 
not fall to negligible levels during the luteal phase. The length of luteal phase depends 
on mating occurring during oestrus. If mating does not occur, the luteal phase is only 
two to three days long and the corpora lutea secretes a small amount of progesterone 
only. If a female mates with a vasectomised male she will enter a phase called 
‘pseudopregnancy' which lasts for approximatelyJ 2 days under the duration of the 
functional corpora lutea. The maternal hormonal changes in early pregnancy and 
pseudopregnancy are induced by mechanical stimulation of the cervix inducing the 
release of prolactin by the pituitary gland, which causes maturation of the corpora 
lutea. The short cycle time maximises the number of opportunities for pregnancy 
during the short reproductive life of the mouse.
There are four stages of the mouse oestrous cycle: dioestrus, pro-oestrous, 
oestrus and metoestrus. Each stage lasts for approximately one day. Although the 
oestrous cycle of rodents is much shorter than that of humans, the temporal 
relationships of oestradiol, LH and FSH secretion are very similar. The difference is in
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the secretion of progesterone, which is rises and falls more rapidly after the LH/FSH 
surge, then begins to rise again if the animal enters an extended luteal phase. 
During dioestrus, the uterine epithelial cells are in a quiescent 'Go' phase as levels 
of oestrogen begin to increase. The luminal epithelium is not receptive to embryo 
implantation in this phase. As the level of oestrogen rises, epithelial cells re-enter the 
cell cycle and begins to replicate their DNA. During this proliferative phase (pro­
oestrus), the luminal epithelium increases in surface area and metabolic activity, 
and secretes proteins into the uterine lumen. The proliferation continues into oestrus 
(during which ovulation occurs), and results in the uterus becoming distended with 
fluid; this can be observed macroscopicaily. These changes prepare the uterus to 
receive, transport and capacitate spermatozoa (Johnson and Everitt, 2000). The 
rising oestrogen levels also affect the female's behaviour, making her receptive to 
males. The surge of LH and FSH takes place between 5 and 7 hours before darkness 
to ensure that ovulation and the receptive period begin at around midnight, in the 
middle of the mouse active period. If mating does not occur, after ovulation, the 
oestrogen level falls, mitosis stops and the uterine wall together with the luminal 
and glandular epithelia begin to degenerate (metoestrus). The proliferative cycle 
then begins again. The oestrous cycle can be followed in mice by analysis of the 
cells lining the vagina (section 2.2.2).
1.2.2: The peri-implantation period
Mating in mice usually takes place during the early hours of the morning. Mating 
can be confirmed by the presence of a plug of coagulated semen at the 
entrance to the vagina (see section 2.2.3). The day the plug is seen can be 
designated day 0, 0.5 or 1 of pregnancy, the notation used depending 
conventionally (and confusingly!) on the type of study being undertaken. Uterine 
studies usually designate the day of plug as day 1 and this will be the notation used
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in this Thesis. After mating takes place, sperm move through the uterus and meet 
the egg in the ampulla of the oviduct where fertilisation occurs. The fertilised 
embryo then begins to divide and moves down the oviduct to enter the uterus on 
day 3. There, it becomes a blastocyst and, in preparation for implantation, loses its 
zona pellucida due to the action of uterine proteases, (Johnson and Everitt, 2000). 
The hormonal synchronisation of the movement of the embryo and receptivity of 
the uterus coincides in a 'window of implantation'. In the mouse this begins around 
2200-2300 h on day 4 of pregnancy and lasts for around 24 hours. Prior to this 
window, the uterus is pre-receptive and after it, the uterus loses its receptivity and 
enters a refractory period where implantation cannot occur (Dey et al., 2004). This 
restricted period of receptivity has led the uterus to be described as a relatively 
hostile site for the embryo when it is not receptive. It is thought that this is to protect 
the mother from the potentially dangerous invasive characteristics of trophoblast, 
which behaves much like a malignant tumour during implantation (Soundararajan 
and Jagannadha Rao, 2004).
Implantation in the mouse involves three stages: apposition, adhesion and 
penetration (Carson et al., 2000). During apposition the trophectoderm of the 
developing blastocyst becomes closely apposed to the luminal epithelium. 
Adhesion involves an attachment reaction that results in the inability to dislodge 
the blastocyst from the luminal epithelium by flushing the uterus. At this stage the 
luminal epithelium (LE) acts as a transducer signalling the embryo's presence 
locally to the underlying stroma to initiate the decidual response and increase the 
local vascularisation. During subsequent penetration, the trophectoderm invades 
through the LE into the decidualising stroma, which contains and nourishes the 
embryo. The residuum of the epithelium and the underlying decidualised stroma 
form the maternal component of the placenta.
The steroid hormones progesterone (P4) and oestrogen work in a spatio- 
temporal manner to establish the window of implantation (DeMayo et al., 2002).
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The major ovarian oestrogen is oestradiol (E2). Steroid hormone receptors are 
present in the cytoplasm of the cells that express them. The hormone/receptor 
complex translocates to the nucleus and can regulate transcription of genes by 
binding to response elements in their promoter regions. There are two different 
types of oestrogen receptor (ER), oestrogen receptor alpha (ERa) and oestrogen 
receptor beta (ERp). ERa is the predominant ER expressed in the uterus. In early 
pregnancy, ERa is primarily expressed in the luminal epithelium. During the peri- 
implantation period, expression generally increases in the uterine stroma but levels 
decrease in the stroma at the site of implantation. The progesterone receptor (PR) 
exists in two isoforms known as PRA and PRB. Levels of both are low in early 
pregnancy but increase in both epithelium and stroma during the implantation 
period. Expression of ER and PR is self-regulated as well as being regulated by the 
steroid hormones themselves. Both ER and PR null mutant mice are infertile and 
exhibit pleiotropic reproductive abnormalities (DeMayo et al., 2002).
The pre-ovulatory oestrogen rise causes epithelial cells to proliferate, as 
described in section 1.2.1. Mating induces the corpus luteum to secrete 
progesterone via the action of prolactin (Johnson and Everitt, 2000). Rising 
progesterone levels initiate stromal cell proliferation around day 3 of pregnancy. 
On day 4 a small amount of oestrogen secreted from the murine ovary (nidatory 
oestrogen), further stimulates stromal cell proliferation. This secondary release of 
oestrogen is vital for the timing of the window of implantation, having effects on 
both the endometrium and the blastocyst. Delayed implantation will occur (and 
the blastocyst will stop dividing and become dormant) if the ovaries are removed 
before the morning of day 4 and the uterus is kept primed with systemic injections 
of progesterone. Implantation can then be re-started with a single injection of 
oestrogen (Dey et al., 2004). The full effects of progesterone and nidatory 
oestrogen are not clear but genes affected by ovarian steroids have been 
identified by: observing reproductive phenotypes of mutant mice, library screening
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and (more recently) microarray studies. These studies are discussed in 1.3.2. There is 
also evidence that catechoioestrogen (CE), a metabolite of nidatory oestrogen, 
may act directly on the blastocyst itself (Paria et a!., 1998b).
The variety of genes involved in implantation includes the genes encoding 
cytokines, adhesion molecules, growth factors, developmental genes and 
vasoactive factors. Genes expressed around the time of implantation are either 
maternally controlled (transcriptionally regulated by oestrogen and progesterone) 
or controlled by the cross-talk between the blastocyst and the epithelium from the 
time of blastocyst apposition at the luminal epithelium.
Maternally controlled gene expression:
LIF and its downstream effects
The cytokine Leukaemia Inhibitory Factor (LIF) is vital for the initiation of 
implantation. Blastocysts cannot implant in the uteri of Z./F null mutant mice, nor do 
their uteri undergo decidualisation (Chen et al., 2000). LIF is induced by nidatory 
oestrogen. It is produced by the glandular epithelium on day 4 of pregnancy and 
secreted into the uterine lumen (Bhatt et al., 1991). It binds to the heterodimeric LIF 
receptor present on the apical luminal epithelium. Binding of LIF to the 
transmembrane protein LIF receptor alpha (LIFRa) causes dimerisation of the 
receptor with gp!30 and activation of a number of downstream pathways 
including the mitogen-activated protein kinase (MAPK) pathway, the protein 
kinase C (PKC) pathway and the JAK/STAT signalling pathway. The JAK/STAT 
pathway in the luminal epithelium is thought to be the primary mediator of LIF 
signalling in implantation. Deletion of the cytoplasmic domain in gpl30 selectively 
abolishes the activation of the JAK/STAT pathway and results in failure of 
implantation, and luminai epithelium incubated with LIF in vitro selectively activates
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the JAK/STAT pathway and not the MAPK pathway. This evidence does not rule out 
the contribution of the other pathways or tissues to the transmission of LIF signalling 
during implantation, Binding of interleukin-11 (IL-11) to its receptor also causes its 
dimerisation with gpl30 and activation of the MAPK and JAK/STAT pathways. 
Binding of the appropriate ligand ,phosphorylates the signal transducer Stat3 which 
then enters the epithelial cell nucleus and acts as a transcription factor (Cheng et 
al., 2001). This signalling cascade induces the expression of many genes involved in 
early pregnancy, including vitally important ones, as inhibition of Stat3 activation in 
the endometrium has been shown to prevent implantation (Catalano et al., 2005). 
LIF null mutant mice show absent or aberrant expression of several genes known to 
be involved in implantation (Song et al., 2000) (Fouladi-Nashta et al., 2005), 
including Heparin-binding epidermal growth factor-like growth factor (HB-EGF), 
Amphiregulin, Cyclo-oxygenase-2 (Cox-2), Homeobox gene A10 (Hoxa-10) and 
Tenascin (Tn-c) (molecules discussed below). LIF null mutant mice also show 
aberrant uterine physiology: animals fail to develop apical pinopods and have an 
increased glycocalyx (Fouladi-Nashta et al., 2005). An injection of LIF has been 
shown to restart delayed implantation as a substitute for oestrogen, implying that 
the actions of nidatory oestrogen that are vital to implantation are mediated 
through the LIF signalling pathway (Chen et al., 2000).
Hoxa- 7 0 and its downstream effects
Another uterine gene up-regulated by ovarian steroids is Hoxa-10. Hoxa-10 is a 
member of the Homeobox family of transcription factors, which are important in 
segmentation patterning in early development; Hoxa-10 null mutant mice have a 
transformation of the proximal 25% of the uterus into oviduct (Benson et al., 1996). 
Hoxa-10 levels are up-regulated in the stroma by progesterone on late day 3 of 
pregnancy (Ma et al., 1998) and Hoxa-10 mutant mice show reduced stromal cell 
proliferation in response to progesterone, leading to decidualisation defects (Lim et
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al., 1999b). This evidence implies that Hoxa-10 is involved in the regulation of cell 
cycle gene expression, backed up by studies that showed aberrant expression of 
cyclins (Vue et al., 2005) (Das et al., 1999) and cyclin dependent kinases (Rahman 
et al., 2006) in the stroma cells of Hoxa-10 null mutant mice. Other genes aberrantly 
expressed in Hoxa-10 null mutant uteri include Cox-2 and Prostaglandin receptor E2 
subtypes EP3 and EP4 (Urn et al., 1999b), implying that Hoxa-10 has an effect on lipid 
signalling pathways during implantation, though this has not been fully 
investigated. Hoxa-10 is also known to induce the expression of uterine epithelial 
b3 integrin subunit (of which more is discussed below) in human cells in vitro 
(Daftary et al., 2005).
Adhesion factors and glycoproteins on the luminal epithelium:
There are numerous molecules present on both the apical membrane of epithelial 
cells and the trophoblast of the blastocyst that may mediate the attachment of 
the embryo to the uterine luminal epithelium. These complex patterns of expression 
are reviewed in two comprehensive reviews (Aplin, 1997) (Kimber and Spanswick, 
2000). Some molecules mediate adhesion, others block it until the uterus is ready. 
One of the more numerous types of adhesion molecules in implantation is the 
integrin family. Integrins are heterodimeric transmembrane glycoproteins, consisting 
of an alpha and a beta subunit, found in both the receptive luminal epithelium 
and the hatched blastocyst (Bowen and Hunt, 2000). Integrins can bind other 
integrins and to a wide variety of extra-cellular matrix proteins found on both 
blastocyst and LE, including Laminin, Heparan sulphate proteoglycan (HSPG) and 
Oncofetal fibronectin on the trophoblast (Kimber and Spanswick, 2000). The uterine 
integrin best characterised in implantation is av{33, found in the apical membrane 
of epithelial cells. avj83 integrin is up-regulated by Hoxa-10 (Daftary et al., 2005), 
and injection of an antibody to block avp3 integrin resulted in reduced 
implantation (lllera et al., 2000).
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Other glycoprotein molecules present on the luminal epithelium have a 
restrictive role in implantation. Muc-1 is a large glycoprotein found in the apical 
luminal epithelium during the oestrous cycle and early pregnancy. It prevents 
embryo apposition at the luminal epithelium due to its large, highly branched 
structure. Muc-1 is up-regulated by oestrogen but down-regulated by 
progesterone, so it is present during the oestrous cycle and early pregnancy when 
the uterus is not ready for implantation, but is repressed at the beginning of the 
implantation window to allow apposition to proceed (Surveyor et al., 1995).
Other genes have been found to be regulated by maternal oestrogen and 
progesterone during the pre-implantation period, but they are often not as well 
characterised as those discussed above. These genes are discussed more 
thoroughly in two excellent reviews (Dey et al., 2004) (Lee and Demayo, 2004) and 
the pathways above are illustrated in Figure 1.3.
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Signalling between blastocyst and uterus during implantation
The interaction of the blastocyst with the luminal epithelium during attachment 
initiates further molecular signalling between the blastocyst and the epithelium and 
thereby the stroma. This signalling initiates the invasive procedure of implantation 
and the massive signalling cascade that is involved in decidualisation of the stroma 
and the increase in vascular permeability to prepare the uterus for the invasion of 
the implanting blastocyst.
Heparin-binding epidermal growth factor-like growth factor (HB-EGF)
HB-EGF is thought to be the earliest uterine gene regulated directly by the 
presence of the blastocyst. It has been found to be expressed in the luminal 
epithelium surrounding the blastocyst 6-7 hours before the onset of the attachment 
reaction, but is not expressed in a progesterone-maintained model of delayed 
implantation, nor in a pseudo-pregnant uterus (Das et al., 1994b). The embryo is still 
contained within the zona pellucida at the onset of HB-EGF expression, ruling out 
direct interaction as the trigger for expression. These observations led to the 
conclusion that expression of HB-EGF is induced by a factor secreted in the 
presence of an activated embryo in the luminal epithelium before attachment. The 
nature of this factor has not been discovered. HB-EGF is known to bind to a 
receptor called EGF-R, a member of the ErbB family of growth factor receptors 
(Raab et al., 1996) found on the surface of the blastocyst (Paria et al., 1993). 
Binding to the EGF-R receptor causes its phosphorylation and induces blastocyst 
hatching and trophoblast outgrowth (Mishra and Seshagiri, 2000). Ovariectomy on 
the morning of day 4 of pregnancy down regulates the expression of EGF-R on the 
blastocyst surface (Paria et al., 1993), and HB-EGF in the uterus (Wang et al., 1994). 
Both are restored with an injection of oestrogen to resume implantation. This 
evidence implies that HB-EGF binds to blastocyst cells to promote the preparation 
of the embryo for implantation, but only when the uterus is hormonally prepared.
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HB-EGF is found in both a membrane bound precursor form and a mature 
soluble form, as described in the references above. HB-EGF is present in the luminal 
epithelium in a membrane bound form around the time of implantation, and 
blastocysts adhere to cells expressing the membrane bound form, implying that the 
interaction is important for juxtacrine signalling during apposition. But the mature 
form must also play a part in paracrine signalling between the embryo and the 
uterus before apposition, as downstream effects become apparent before the 
hatching of the blastocyst. The interaction between embryo and uterus via the 
EGF-R signalling pathway is a good example of peri-implantation cross talk. EGF-R is 
also found in the stroma of the hormonally prepared uterus (Das et al., 1994a), 
implying another role for secreted HB-EGF, though this has not been fully 
investigated. HB-EGF is also found in human endometrium during the window of 
implantation. Other growth factors such as Beta-regulin, Epiregulin and Neuregulin 
are induced in the uterus around the time of attachment, slightly later than HB-EGF.
Vasoactive factors
One of the first signs of implantation is an increase in vascular permeability at 
implantation sites (reviewed in (Dey et al., 2004). Molecules involved in 
angiogenesis play an important role in forming the placenta during deciduaiisation 
of the stroma. Two well-characterised molecules involved in angiogenesis are 
cyclo-oxygenase (Cox) and vascular endothelial growth factor (VEGF).
Cox is an enzyme that converts arachidonic acid into prostaglandin H2 
(PGH2). Individual prostaglandin synthases then act on PGH2 to form several 
structurally similar yet biologically diverse prostaglandins, which have many 
functions in female reproduction, including angiogenesis in the deciduaiising 
stroma. Cox exists in two forms, both present in the peri-implantation uterus. Cox-1 is 
a constitutively expressed enzyme, found in epithelial cells pre-implantation but 
disappearing from the uterus around implantation (Chakraborty et al., 1996). Cox-1
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null mutant mice are fertile, but have problems with parturition (Urn et al., 1997). 
Cox-2 is inducible, its expression triggered by the actions of both maternally 
regulated genes (such as LIF), and the presence of the activated blastocyst. It is 
up-regulated in hormonally activated luminal epithelium and subepithelial stromal 
cells at the anti-mesometrial pole exclusively surrounding the blastocyst at the time 
of attachment reaction on day 4 and the morning of day 5 (Chakraborty et al., 
1996). Cox-2 null mutants are infertile, exhibiting pleiotropic reproductive anomalies 
(including failure of implantation and decidualisation), which have led it to be 
implicated as an important factor in implantation. These abnormalities are due to 
the lack of the prostaglandins produced by Cox-2, as fertility was restored with their 
injection into the uterus (Lim et al., 1997). Prostacyclin (PGb) is the most abundant 
prostaglandin expressed at the implantation site. It exerts its effects through the 
Peroxisome proliferater-activated receptor-8 (PPAR-5). Both PPAR-delta and 
Prostacyclin synthase are co-expressed with PGh at the implantation site, implying 
an important role for this signalling pathway in implantation (Lim et al., 1999a).
Cox-2 derived prostaglandins are thought to influence the signalling 
pathway of vascular endothelial growth factor (VEGF) (Matsumoto et al., 2002). 
VEGF was known to be a growth factor involved in angiogenesis, so its expression 
during implantation was investigated. There are low levels of VEGF present in the 
uterus before implantation, but the attachment of the blastocyst induces strong 
up-regulation of this signal in the luminal epithelium and peri-epithelial stroma. 
Expression of the VEGF receptor is also induced with the presence of the implanting 
blastocyst (Chakraborty et al., 1995).
Histidine decarboxylase (HDC) is an enzyme that produces Histamine (H2) 
from L-histidine. Histamine is a ubiquitous cell-cell mediator found in a diverse range 
of biological processes including inflammation, angiogenesis and smooth muscle 
contraction. Rising levels of progesterone during early pregnancy cause up- 
regulation of HDC expression in the luminal and glandular epithelia of the uterus.
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Levels peak at day 4 and then start to fall during decidualisation. Pseudo-pregnant 
mice exhibit a similar pattern, proving that the presence of a blastocyst is not 
needed for expression (Paria et al., 1998a). Despite this, histamine H2 receptors are 
present on the surface of embryos, and H2 antagonists or an HDC inhibitor inhibit 
hatching and implantation. H2 receptors are not present on the blastocyst surface 
during delayed implantation. This suggests that histamine is involved in 
communication with the blastocyst and induces it to mature in preparation for 
implantation (Zhao et al., 2000).
The pathways discussed above are just a few of the signalling pathways 
initiated by cross-talk between the uterus and the blastocyst and are illustrated in 
Figure 1.4.
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As described above, the transcriptional changes in the uterus around the time of 
implantation may be controlled by the hormonal response to mating, initiated by 
the presence of the embryo at attachment, or in many cases result from a complex 
interplay between maternal gene expression and interaction with the activated 
blastocyst. Activation pathways of genes involved in decidualisation are often 
complex, for example Cox-2 expression is affected in LIF and Hoxa-10 null mice, as 
well as being induced by the presence of an activated blastocyst as discussed 
above. Moreover, both direct and down-stream indirect changes occur in rapid 
succession, making fine-grained temporo-spatial analysis difficult. To reduce 
complexity and separate these two responses, pseudo-pregnant mice were used 
in my studies. Pseudo-pregnant mice are female mice mated with a vasectomised 
male. The mechanical stimulus of mating causes the mouse to undergo the 
hormonal changes detailed above, but the absence of fertilised embryos means 
maternal gene expression pathways initiated by and down-stream of the embryo 
will not occur. Pseudo-pregnancy can continue for up to 10 days before a normal 
oestrous cycle is resumed; it is the equivalent of the human luteal phase. The 
techniques, results and conclusions of some of the previous studies into gene 
expression in the uterus are discussed below in section 1.3.2.
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1.3: Studying changes in transcription in the uterus
When studying gene expression in an organ as complex as the uterus, three broad 
questions can be asked initially. Where and when are the genes expressed, and at 
what levels are they expressed in these tissues? Answers to these questions are 
important for the conduct of experimental studies to address function and 
regulation.
One of the more traditional methods of investigating both the level and 
location of expression of a gene of interest is in situ hybridisation. Other methods of 
looking at gene expression involve either homogenising the whole tissue, or 
dissecting certain parts of the tissue out, before extracting the RNA population of 
the tissue (either total RNA or just mRNA), then using this RNA in downstream 
applications described below. These applications are mostly directed towards one 
or two genes of interest, but if the aim of the study is to identify new genes of 
interest when none are known already, then microarrays can be used. The 
methods used can either be semi-quantitative, where an idea of the levels of gene 
expression can be obtained (even if it is on a scale of absent or present i.e. below 
or above the detection threshold of the technique) or quantitative, where levels of 
gene expression in one tissue can be accurately compared to another tissue or 
even measured absolutely. The range of technical approaches is discussed below, 
then summarised in Table 1.1. Other studies looking at gene expression in the uterus 
in a variety of states are also discussed. The techniques, results and conclusions of 
some of the previous studies into gene expression in the uterus are discussed below 
in section 1.3.2.
Although looking at transcriptional control in gene expression is 
fundamental to unravelling the processes of implantation, the control of translation 
and post-translational modification of the proteins is an important yet relatively 
neglected area in the research. A gene can be constitutively expressed at the
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mRNA level but be translated only under certain conditions, or can be 
constitutively translated but its activity modified by phosphorylation or cleavage 
activation under certain conditions. Although this dissertation will not directly 
address these circumstances, it is important that they are considered when 
analysing results.
1.3.1 Techniques used in studying gene expression 
In whole tissues
In-situ hybridisation
The traditional method of localising gene expression in an organ is in situ 
hybridisation. This involves using radioactive or dye labelled probes for the RNA of 
interest and hybridising the probe to thin sections of tissue so that specific sites of 
expression can be identified, even down to the location of transcripts in individual 
cells. The advantage of this method is that it is very useful when looking at a 
heterogeneous tissue where the site of expression of your gene of interest is 
unknown. The disadvantage of this method is that it is often of low sensitivity and 
probes can bind non-specifically giving false positive results, making in situ 
hybridisation difficult to set up and optimise. The size of the transcript being 
localised (and thus its processing state and/or actual identity) is also not deducible 
from the results.
RNA obtained from tissues: known transcript of interest
Northern blotting
Northern blots are used to show whether an RNA species of interest is present in a 
tissue. RNA is run on a denaturing agarose gel, blotted onto a nitrocellulose 
membrane, cross-linked, then probed with a labelled hybridisation probe
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complementary to the gene of interest. This can be used to show whether a 
transcript is present in the tissue and the size of the RNA of interest (when 
compared against size standards run simultaneously). Northern blots can also be 
used to quantify the relative amount of the transcript present by relating the 
intensity of the band to the intensity of a normaliser gene such as p-actin. 
Photographs of the gel can be scanned into software that will quantify the 
brightness of the bands. The values generated can be normalised to brightness of a 
marker gene run in parallel, which can be difficult if the expression of the gene 
chosen as a normaliser is highly expressed. Another disadvantage of Northern Blots 
is that they can give misleading results if the RNA used is even slightly degraded 
and are less sensitive than many other techniques.
RNase protection assay
The RNase protection assay is another method that relies on the hybridisation of a 
labelled complementary probe to the RNA of interest. After hybridisation, the 
remaining, unhybridised, RNA is degraded using an RNase, leaving the double 
stranded nucleic acids intact. The RNA is then separated using an acrylamide gel. 
RNase protection assays are more efficient than Northern blots and can tolerate 
partially degraded RNA. Their disadvantage is their lack of flexibility - the probe 
must be labelled RNA that is exactly complementary to the region of interest, if not 
then the region will be degraded along with the non-hybridised RNA.
Reverse-Transcript PCR (RT-PCR)
RT-PCR is a technique based on conventional PCR, but with an added step at the 
start where mRNA is reverse transcribed into cDNA using a Reverse Transcriptase 
isolated from a retrovirus. Complementary oligonucleotide primers are then used to 
designate a region amplified by a thermostable DNA polymerase. This results in 
exponential amplification of the region of interest. The resulting PCR product is run
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on an agarose gel with size standards, stained with ethidium bromide and 
visualised under UV light. This confirms that the amplification was specific to the 
region of interest (the size of the band and absence of other bands). The 
exponential amplification means that the method is very sensitive and can 
theoretically detect one copy of a transcript, and is ideal for small samples or very 
low copy transcripts. This advantage can also work as a disadvantage as small 
amounts of contaminating DNA can also be amplified. Because of this a negative 
control must always be run simultaneously. RT-PCR also requires a lot of pre­
reaction optimisation: the annealing temperature of the primers, the concentration 
of MgCb and the cycle length are only a few of the many variables.
Quantification of RT-PCR results is difficult. Reactions are generally run for a 
number of cycles that give a saturated (or plateaued) end-point for all samples 
despite differences in the initial amount of template. For quantitation, ideally the 
number of cycles should be optimised to give an end point during the exponential 
phase of amplification (see the section on Quantitative RT-PCR below) so that the 
brightness of the product when visualised on an agarose gel with ethidium bromide 
is proportional to the amount of starting template. Analysis of the results is similar to 
that of a quantitative northern blot. Photographs of the gel can be scanned into 
software that will quantify the brightness of the bands. The values generated can 
be normalised to the brightness of a marker gene run in parallel. There are many 
disadvantages with this method of quantification; primarily the many sources of 
potential error when running the PCR and gel electrophoresis, photographing the 
gel and the computer analysis of the image; as well as normalising the results. 
Quantifying standard PCR in this way has become obsolete with the invention of 
QRT-PCR, described below.
Real-time RT-PCR
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Real-Time RT-PCR (also known as QRT-PCR or quantitative RT-PCR) involves following 
the exponential amplification of DNA with respect to time, in contrast to other 
methods, which involve only analysis at the end-point of the reaction (such as 
running the PCR products on an agarose gel and visualising the bands with 
ethidium bromide).
Initial amplifications in a PCR reaction will be exponential because reagents 
are in excess, and template and product are in low enough concentrations that 
product renaturation does not compete with primer binding. When primer binding 
begins to occur, the reaction enters the 'plateau' phase where the amplification 
rate becomes linear with each subsequent cycle. Because the plateau point and 
the subsequent linear rate of amplification is highly variable, even in duplicate 
reactions from the same sample, data must be taken from the exponential phase 
at the beginning of amplification where the level of fluorescence corresponds to 
initial copy number. Real-time PCR allows the rate of amplification to be viewed 
after each cycle of replication has finished. There are several technologies that 
allow the amplification rate to be visualised, all of which are based on the 
generation of a fluorescent signal. A threshold fluorescence level is set in the 
exponential amplification phase and the cycle number that corresponds to this 
threshold is recorded by software running in tandem with the machine. The two 
most used methods of quantification in Real-Time PCR are SYBR green dye and 
Taqman® fluorogenic probes.
SYBR green is a dye that selectively fluoresces when bound to double­
stranded DNA molecules. As amplicon copies accumulate during the PCR 
reaction, the level of fluorescence detected by the machine also increases and 
can be recorded affer each cycle. Because SYBR green does not distinguish 
between the amplicon and any non-specific amplification or primer-dimers, a 
melting curve must be run at the end of every experiment to ensure that the size of 
the product(s) formed are as expected. It is often found that there is some non­
27
specific fluorescence occurring, and this is a major disadvantage of using SYBR 
green. Sometimes this problem can be overcome if the melt temperature of the 
contaminant double stranded DNA is higher than that of the desired amplicon by 
inserting a controlled melt step before each cycle fluorescent reading.
Taqman® is a technology invented and developed by Applied Biosystems. 
It is like conventional PCR but includes in addition to the primers a 'probe' that 
binds between the two primers. The probe contains both a fluorescent dye and a 
quencher. When the intervening length of DNA is short, the quencher quenches the 
dye's fluorescence by FRET (fluorescence resonance energy transfer). During the 
PCR reaction, the DNA polymerase cleaves the probe and releases the dye and 
quencher into solution. The dye can now fluoresce, and fluorescence is 
proportional to the amplification of the target sequence. The probe has a Tm value 
of 10°C higher than the primer pair and has a fluorescent dye conjugated at the 5' 
end and a quencher conjugated at the 3' end. There are differing opinions on the 
Optimum length range for primers and probes, but it is universally agreed that there 
must not be a G on the 5' end of the probe as it acts as an artificial quencher even 
after probe cleavage. Because the probe binding is very specific, Taqman® is 
good for low copy number templates. A melt curve cannot be done on the 
resulting products as the dye has been cleaved from the probe, so it is difficult to 
see if any non-specific amplification resulting in fluorescence is occurring. However, 
the probability of this is very low as the primer-dimers do not contribute towards the 
fluorescence, and the probability of three oligos all binding within the same region 
other than the one they were designed for is low. Despite this, random non-specific 
binding of primers and probe may cause a reduction in the efficiency of the PCR 
reaction even if it doesn't result in fluorescence. To ensure that consistent amounts 
of total RNA are present in each sample, the samples are also run using primers for 
a normaliser gene. Normaliser genes must be consistently expressed in a tissue of
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interest under all conditions in the study. Common normalisers include 18s rRNA, p- 
actin and GAPDH. They are discussed further in section 2.7.4.
The disadvantages of using real-time RT-PCR to quantify gene expression 
are similar to those of conventional RT-PCTR; since the reaction amplifies very low 
transcript levels, a negative control must always be run. Pre-reaction optimisation 
can also be extensive. Each real-time technology has its own advantages and 
disadvantages, as described above.
RNA obtained from tissues: finding new transcripts of interest
Microarrays
A 'Microarray' is the usual term for solid supports upon which a collection of gene- 
specific nucleic acids have been placed at defined locations, either by spotting or 
direct synthesis. In array analysis, a sample of nucleic acids is labelled and then 
hybridised to the gene-specific targets on the array. Information is gained about 
the specific nucleic acid composition of the sample based on the amount of 
probe hybridised to each target spot. Microarrays are often used for differential 
expression analysis of two or more RNA samples, but may also be used to identify 
polymorphisms in sequences. The major advantage of gene arrays is that they can 
provide information on thousands of targets in a single experiment. They are 
particularly useful if there is no prior information about global gene expression in 
your sample of interest.
Nucleic acid arrays are most often arranged on glass slides. Depending on 
the type of array, the target nucleic acids may be oligonucleotides, PCR products 
or cDNA vectors or purified inserts. The sequences may be representative of a 
whole genome or a group of related nucleic acids, for example tissue specific 
genes or functionally similar genes. Arrays can be custom prepared to the user's 
specification (if the user already knows what genes they're interested in) or a
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'standard' array used (if the user is 'fishing' for genes). Glass slide arrays are most 
often used to compare the expression profiles of two tissues, or two samples of the 
same tissue that have undergone different treatments. They are often used to 
compare expression profiles of normal and tumour tissues. More complex multiple 
sample comparisons can also be undertaken, for example time course studies of 
naturally occurring or experimentally induced changes.
In a typical experiment the total RNA is isolated from the samples to be 
compared, converted to cDNA via reverse transcription and each sample is 
labelled with a distinct fluorescently-labelled nucleotide before both samples (now 
called probes) are hybridized to the same array. Typically, one sample RNA is 
labelled with Cyanine 3-dNTP (Cy3) and the other with Cyanine 5-dNTP (Cy5). Each 
dye produces a different wavelength of fluorescence. The two labelled-RNA 
populations are hybridized to one glass slide, the excess probe washed off and the 
array scanned using a fluorescent imager to generate data. The basic principle is 
that if one of the samples is richer in an RNA transcript than the other, the 
corresponding spot on the array appears bright for the colour of the dye 
conjugated to the transcripts from that sample.
Although the above method is common, another method of array analysis 
also used is Affymetrix's GeneChip technology. The chips are glass slide arrays 
where the oligonucleotide spots are synthesised directly onto the array substrate 
(most arrays are printed onto the substrate). RNA samples are converted to biotin- 
labelled cDNA, and each sample is hybridized to a separate GeneChip. The 
hybridized cDNA is then stained with a streptavidin-phycoerythrin conjugate and 
visualised with an array scanner. The chips are designed so that every transcript 
represented on the chip has between 16 to 20 pairs of targets that match different 
parts of the 3' end of the mRNA sequence. Every target consists of a pair of 25 
residue oligonucleotides: one a perfect match to the transcript, the other a 
mismatch in which the middle residue has been changed. This probe-pairing
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strategy helps minimise the effects of non-specific hybridisation and background 
signal. All pairs contribute to an average difference score corresponding to the 
relative level of gene expression of the transcript they represent. Another 
technique used is one where arrays are spotted on nylon membranes and 
hybridised with radioactively labelled probes. Microarray technology is progressing 
quickly and new techniques are emerging all the time.
Array analysis can be a daunting task as a single array experiment can 
generate thousands of data points. There are many software programmes that can 
be used to normalise, filter and sort the raw data, generating useful lists of up and 
down regulated genes. The problem is that there is no standard protocol for array 
analysis and searching for useful data is often like looking for the golden needle in 
the haystack. Some array manufacturers offer custom analysis services, where they 
will take your raw data and send it back in a useful form. Others will perform the 
whole experimental process for you if you send them your RNA samples.
When useful data have been obtained, differences in expression of specific 
sequences are often validated by another method of analysis such as RT-PCR, 
Northern analysis or nuclease protection assays. These same methods can be used 
for relative or absolute quantification of specific messages of interest identified by 
array analysis (White and Salamonsen, 2005).
SAGE (Serial analysis o f gene expression)
SAGE is based upon the idea that a short sequence tag (10-14bp) contains 
sufficient information to uniquely identify a transcript provided that the tag is 
obtained from a unique position within each transcript. To perform SAGE, RNA is first 
extracted from two cell populations of interest and turned into cDNA. As with 
microarrays these two populations may be two different tissues or the same tissue 
under two different conditions. The RNAs are then cut using a restriction enzyme 
with a 4-base recoginition site, ensuring that every cDNA generated is cut at least
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once. The cut DNA is then bound to streptavidin beads by its poly-thymidine end 
and the cDNA population divided in half. Half are bound to one type of linker, half 
to another, using their sticky ends generated by restriction digest. A type IIS 
restriction endonuclease can attach to the linker and bluntly cleaves the cDNA at 
a defined distance up to 20 base pairs away from its recognition site. Once this is 
achieved, the cDNA tags bound to linkers A and B are ligated to each other to 
create ditags. These ditags have linker A on one end, linker B on the other, and 
both transcript tags are adjacent to one another in the middle. These ditags are 
then amplified by PCR, using primers that are complimentary to the sequence in 
either linker. They are then cleaved to remove the modules and leave the 
sequence from the two tags. All of the ditags generated are then ligated into a 
'concatemer': a long string of sequential tags. This collection of tags is then 
introduced into a vector to be cloned and sequenced. The sequences generated 
are compared to a SAGE database and matched to their transcript of origin. The 
number of times a tag is counted is a measure of its relative expression level in that 
cell population. Tags that are only counted once are generally excluded from an 
analysis to avoid error. Cell populations can then be compared to each other.
Although SAGE has potential problems, repeating experiments under slightly 
different conditions can often compensate for them. Certain genes, especially 
ones from the same family, may generate the same tag. Using longer tag 
sequences can eliminate this problem. Increasing tag length to 18 bp in an 
attempt to increase tag specificity has been reported to yield a better 
representation of DNA expression. Another potential problem is that certain species 
of mRNAs will not contain the enzyme recognition sequence. These transcripts 
cannot be cleaved by the enzyme, and consequently, are not included in the 
analysis. To avoid this problem, two different combinations of anchoring and 
tagging enzyme can be used and a gene expression profile created for each. The 
two profiles can then be correlated and compiled to represent accurately the
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majority of the genes expressed within a cell.
Technique Does it 
localise?
Does it 
quantify?
Advantages Disadvantages
In-situ Yes Semi Localises
Signal
Low sensitivity,
labour-intensive
optimisation
Northern No Semi Can
visualise size 
of RNA
Low sensitivity, 
does not work 
well with 
degraded RNAs
Nulease No Semi Can Lack of flexibility
protection visualise size,
assay more
efficient
than
Northerns
QRT-PCR No Quantitative Sensitive,
accurate
Labour-intensive
optimisation
Microarray No Quantitative Discovery of 
new
transcripts 
present in 
tissue/condit 
ion of 
interest
Results limited by 
sequences on 
array
SAGE No Quantitative Discovery of 
new
transcripts 
unlimited by 
array
boundaries
May need to run 
experiments 
under several 
different 
conditions.
Table 1.1: Summary of advantages and disadvantages of some of the techniques 
used in analysing gene expression, as discussed in section 7.3.1.
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1.3.2: Previous studies investigating the mouse uterine luminal epithelium
Before the advent of microarrays, most studies on gene expression in the uterus 
have looked at single genes. Important genes in implantation have been 
discovered by several means. The most common is serendipitous observation of 
reproductive problems in a mutant line, often generated for studies of processes 
other than implantation. Of the genes discussed in section 1.2.2, LIF was discovered 
to have maternal effects when a knockout line was generated to study embryonic 
expression, as was Hoxa-10 in developmental studies. Reproductive problems in 
Cox-2 deficient mice confirmed the importance of prostaglandin synthesis for 
implantation and extended our knowledge of its locus of action to include the LE. 
Many genes have been characterised in the peri-implantation period by intelligent 
guesswork: vasoactive factors such as VEGF were initially investigated in the uterus 
because of the knowledge that decidualisation involves angiogenic processes.
The discovery of an infertile phenotype in a strain of mice carrying a 
targeted mutation will usually lead to an investigation into the localisation, 
regulation and temporal expression of that gene. Because of this, the best- 
characterised genes are usually those that have the most severe effects on 
implantation, an example being LIF. Many other genes are identified as being 
expressed in the peri-implantation uterus, but mice carrying mutations in those 
genes often have less severe reproductive problems, so are not yet as well 
characterised. It may be that the gene in question is a member of a family of 
genes where expression of others compensates for lack of one, or where different 
parallel pathways can compensate for deficiencies in each.
Recently a number of microarray studies have been published that detail 
global gene expression differences between murine uteri under different 
conditions. These studies are described below. Although human microarray studies
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are not discussed in this introduction, murine and human microarray studies 
(Horcajadas et al., 2004) are compared in Chapter 6.
Progesterone receptor induced genes
To date, only a few genes regulated directly by the progesterone/PR complex 
have been identified. Further genes have been identified by two recent microarray 
studies compared in the table below:
Paper Conditions compared Experimental Analysis
Design Design
Affymetrix U74Av2 Score for each
Cheon et Pregnant mice chips, transcript is averaged
al. 2002 treated at day 3 with N=6 for each for 3 replicates,
PR antagonist vs condition, 2-fold change
untreated control. 3 array replicates applied as threshold,
Whole uterus of control/test pair. Lists analysed in
Genesprina.
Ovariectomised wild
Jeong et type vs PR null mice, Affymetrix U74Av2 Chips were pre­
al. 2005 sacrificed either after chips checked for viability
one progesterone N=5 for each using the MAS5
injection, condition, algorithm,
(acute treatment), 4 3 array replicates Score for each
injections (chronic of each transcript is averaged
treatment) or injection control/test pair for 3 replicates,
with vehicle only. 1.2-fold change
Whole uterus applied as threshold.
Table 1.2: Comparison of two microarray studies searching for genes regulated by 
progesterone. Variables are the conditions compared in each array, the 
experimental design and the analysis design.
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Aims of the studies
Cheon et al. (Cheon et al., 2002) used a progesterone receptor antagonist in 
pregnant mice to block effects of progesterone through the actions of the PR 
complex and then compared global gene expression in these two models. In 
Jeong et al. (Jeong et al., 2005), the study had two aims: to group genes into direct 
and indirect regulation by progesterone (defined by the expression response time), 
and to confirm whether the progesterone/PR complex directly regulates the action 
of progesterone on these genes (defined by its presence or absence in the 
experimental model).
Differences in design and implementation
Since both experiments used the same microarray chips, the differences in the 
gene lists generated are due to variation in the experimental design and analysis. 
In terms of experimental design, both papers have their advantages and 
disadvantages: Cheon et al. is closer to the conditions in early pregnancy whereas 
Jeong et al. does not use pregnant mice. Jeong et al. removes the influence of 
any non-PR effects of progesterone by using knockout mice, whereas Cheon et al. 
uses an antagonist to PR only. In terms of analysis, Cheon et al. has a higher 
threshold value for up/down-regulated genes, but Jeong et al. subjects the chips 
to rigorous test to determine the reliability of the data before even starting to 
generate lists of genes.
Discoveries, conclusions and comparisons
Cheon et al. found 78 genes to be down-regulated by the PR antagonist RU486 
and 70 genes up-regulated. Down-regulated genes included four previously known 
progesterone targets: Amphiregulin, Hoxa-lh Proenkephalin and Histidine 
decarboxylase. The study then selected seven novel genes, confirmed their 
regulation by progesterone and further investigated their expression over the peri-
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implantation period using northern blotting over a time course to determine 
temporal expression and in-situ hybridization to determine localisation. By pooling 
data from certain comparisons, Jeong et al. generated lists of genes up-regulated 
by the progesterone/progesterone receptor complex: 54 genes classed as early 
response, 13 as intermediate response (expressed in both early and late groups) 
and 130 as late response. The validity of their observations was confirmed by 
searching for genes on the lists already known to be up-regulated by P4/PR. Indian 
hedgehog and Hypoxia inducible factor were known to be 'early-responsive'; this 
was confirmed by the study. Amphiregulin and Histidine decarboxylase were 
similarly classified as 'intermediate-responsive' genes and found amongst that list, 
as were Calcitonin, Calbindin c/9k and Immune response gene 1. After functionally 
grouping the genes identified by this study, three genes involved in retinoic acid 
synthesis were identified and their expression further investigated using in-situ 
hybridisation and real-time RT-PCR.
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Blastocyst regulated genes
Two microarray papers and one SAGE paper have been published that have 
sought to define a set of genes activated not by the maternal preparation of the 
uterus for implantation, but by the presence of the blastocyst in the lumen of the 
uterus at apposition.
Paper Conditions compared Experimental Design Analysis Design
Reese et 
al. 2001
Manually dissected 
implantation sites and 
inter-implantation 
sites. 11-12 pm on day 
4 of pregnancy.
Affymetrix U74A
chips
N=12
3 array replicates
Genes differentially 
expressed (more than 2 
fold
increase/decrease) in 
4/9 comparisons were 
said to be up/down 
regulated.
Yoon et 
al. 2004
LE from implantation 
and inter­
implantation sites 
isolated by laser 
capture 
microdissection.
Mouse 6k cDNA 
chips from Digital 
genomics (S. Korea), 
cy dye labelling of 
cDNAs.
N=3
4 array replicates
Data analysed using 
SAM*,
1.2-fold change 
applied as threshold.
Ma et al. 
2006
Manually dissected 
implantation sites and 
inter-implantation 
sites. Day 5 of 
prepnancy.
SAGE libraries were 
created for each 
experimental 
condition.
Tags sequenced and 
compared.
Table 1.3: Comparison of three microarray studies searching for uterine genes 
regulated by the presence of an activated blastocyst. Variables are the conditions 
compared in each array, the experimental design and the analysis design. *SAM= 
Significance Analysis of Microarrays programme.
Aims of the studies
The studies by Reese et al. (Reese et al., 2001), Yoon et al. (Yoon et al., 2004) and 
Ma et ai. (Ma et a!., 2006) aim to characterise the differences between 
implantation sites and inter-implantation sites in the murine uterus. All studies rely on 
the observation that the initial increase in vascular permeability around the site of 
blastocyst apposition causes injected blue dye to accumulate around
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implantation sites in the uterus. Both Reese et al. and Ma et al. manually dissected 
implantation and inter-implantation sites before flash freezing, whereas Yoon et al. 
took samples of luminal epithelium at the apposition sites using laser capture 
microdissection. Because of this, Reese et al. and Ma et al. implantation site 
samples include the implanting blastocyst as well as the maternal whole uterine 
tissue, wheras Yoon et al. implantation samples contain maternal LE tissue only.
Differences in design and implementation
The type of arrays used in the two microarray studies are very different; the Reese 
study uses the Affymetrix U74A array similar to the one used in both the Cheon and 
Jeong studies, while the Yoon study uses a custom array and Cy dye labelling. 
Because of this, the two studies are not truly comparable, as the arrays may not 
contain a similar sample of genes. The analyses are also very different. The Reese 
study uses a combination of t-test to determine significantly expressed genes, and 
a statistical approach where each of the three implantation site chips are 
compared against each of the three inter-implantation chips, and if a gene is 
found to be significantly expressed in four of the nine possible outcomes then it is 
classed as up or down-regulated. The study recognises that four out of nine is a low 
threshold, but notes that if the threshold is increased then many genes known to be 
expressed at the implantation site are left out of the final lists. The Yoon study used 
a program called Significance Analysis of Microarray (SAM) program to exclude 
genes that were calculated to be significantly up or down-regulated, but were also 
calculated to have a high 'false discovery rate' score as defined by the 
programme, meaning that although they appear to be significant, statistically they 
are likely to be a false positive. This is a stringent test, but the results are very 
reliable, as backed up by the real-time RT-PCR verification.
The Ma et al. study uses the simple yet informative technique of SAGE 
(described in section 1.3.1) to compare the transcriptome of implantation and
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inter-implantation sites. SAGE libraries from implantation and inter-implantation sites 
were compared using SAGE2000 software. P values were calculated by SAGE2000 
software using the Monte Carlo simulation method, and represented a crude 
estimate for the possibility of detecting a difference for given abundances and fold 
differences between two libraries. Tags that were only found once in a library were 
not included in the analysis, as were tags that corresponded to more than one 
gene. SAGE experimental design cannot be compared to microarray experimental 
design directly, although the conditions used and the results obtained can be 
compared.
Discoveries, conclusions and comparisons
The Reese study found 36 genes to be up-regulated at implantation sites and 27 
down-regulated at implantation sites. 9 of the 36 up-regulated genes including 
Tenascin-c and interleukin 7 receptors I and II, and 6 of the 27 down-regulated 
genes, including Prostaglandin E receptor EPa, were previously known to be 
involved in the implantation process. Two up-regulated and two down-regulated 
genes were verified by in situ hybridisation. Because implantation sites taken 
included all uterine tissues and the blastocyst itself, it is possible that genes up- 
regulated in one uterine tissue at implantation sites would not have been identified 
by the microarray because of masking effects of the presence of other tissues and 
the blastocyst. It is highly likely that this is occurring in this study, since fewer genes 
were found to be up-regulated compared to the Yoon study, despite the less 
stringent analysis and the wider range of tissue taken.
The Yoon study found 73 genes highly ranked at implantation sites (53 with 
known functions) and 13 at inter-implantation sites (5 with known functions). 22 
genes from this list with a low 'false discovery rate' score were chosen to be verified 
using real-time RT-PCR, and 20 of them were confirmed to be up-regulated. The 
majority of genes identified as up-regulated at the implantation site by this study
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were genes related to structural remodelling, and though none of them was 
previously characterised as being involved in implantation, the authors proposed 
future study of this possibility. Although the aim and methods of this study were very 
specific, the lack of genes previously identified to be involved in implantation is 
interesting. It is possible that the analysis was so stringent that subtle variations in 
transcript levels were excluded so as not to also allow false positives through.
The Ma et al. study found 100 genes significantly up-regulated at inter­
implantation sites and 127 genes significantly up-regulated at implantation sites. 
This is higher than either the Reese et al. study or the Yoon et al. study. It is likely that 
this is because the study used SAGE instead of microarrays. Because SAGE does 
not use arrays, the only limit to the number of genes that can be investigated is the 
sequencing status of the genome being investigated. This is likely to lead to more 
transcripts being found to be up-regulated in a SAGE experiment. The lists of genes 
upregulated at the implantation site included genes previously found to be 
involved in implantation, including Follistatin, Igfbp3 and Igfbp4. The results were 
verified using real-time PCR and the transcripts then localised using in situ 
hybridisation on seven up-regulated and seven down-regulated genes. The Ma et 
al. study has the same complications as the Reese et al. study: the blastocyst is 
taken as well as the uterus. A combination of laser microdissection and SAGE is 
likely to yield the most accurate list of genes up-regulated at implantation sites. 
Comparisons of the lists of genes obtained from these three studies can be found in 
both Yoon et al. and Ma et al.
Nidatory oestrogen regulated genes
A surge in oestrogen on the morning of day 4 of pregnancy is vital for the uterus to 
become receptive. This surge is known to upregulate the expression of LIF by the 
glandular epithelium (described in 1.2.2). The downstream targets of LIF have been 
investigated in another microarray paper (Sherwin et al., 2004). The investigation of
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the indirect effect of oestrogen through LIF has been investigated more fully than 
direct effects of nidatory oestrogen. One paper (Reese et al., 2001), mentioned 
above, has also looked at global gene expression differences between mice in 
ovariectomy-induced delayed implantation, and mice where implantation has 
been restarted by an injection of oestrogen. Mice were ovariectomised on the 
morning of day 3 of pregnancy and kept in delayed implantation by daily 
injections of progesterone. On the third day of delayed implantation a single 
injection of oestrogen was given to the test group (of 6 mice). 12 hours later the test 
group and a control group not given an oestrogen injection were culled. 
Microarray analysis using Affymetrix GeneChip technology (as discussed above) 
showed up-regulation of 128 genes and down-regulation of 101 after termination 
of delayed implantation. Of the 128 genes up-regulated after termination of 
delayed implantation, only 3 were previously known to be involved in implantation: 
connexins 26 and 43 and prostaglandin E2 receptor EP2 subtype. Of the 101 genes 
up-regulated in delayed implantation, nearly 48% were immune-related genes. The 
study proposed that further investigation was needed into this phenomenon.
Often, two microarray studies investigating the same pathway will obtain 
very different comparative gene lists, due to differences in the chips used, the 
experimental design of the study, the statistical filters used and the interpretation of 
the results, as discussed above. When designing an analysis strategy for a 
microarray study, a balance must be struck between obtaining true data and 
letting through false positives, and this relies on the fine-tuning of analytical 
methods. As more general studies such as those detailed above are performed, 
more overlap may be found between outcomes to produce a focus of core genes 
of interest. However, the gene lists generated from microarrays need dedicated 
follow-up studies to confirm their validity and assess their significance for the basic 
mechanisms of implantation. This may involve investigating their spatial and
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temporal expression more finely, generating gene knock out lines and observing 
their reproductive phenotypes.
Gaps in the knowledge
Most studies on peri-implantation mice look at global transcription changes in the 
uterus as a whole. As discussed in section 1.1, the uterus has morphologically and 
transcriptionally distinct layers. A transcript may be highly up-regulated in a 
particular uterine tissue, but if it is highly down-regulated in another of the uterine 
tissues then it may not be identified in the resulting gene list. More specific 
investigations are required. Laser microdissection, as used in the Yoon study, is a 
useful technique for isolating individual uterine tissues and has been used in a 
recent study (Niklaus and Pollard, 2006) to compare the transcriptomes of 
glandular and luminal epithelium from pregnant mice. These studies are discussed 
in Chapter 6. Previous studies are also very restrictive in the timing of the samples 
that they take. Another recent study has taken samples of uterine luminal 
epithelium from five time points over the peri-implantation period, compared them 
to a reference and categorised genes expressed over that period into groups 
based on the patterns of their expression (Campbell et al.).
This dissertation will attempt to address the relatively neglected issues of 
uterine tissue heterogeneity and timing of gene expression in the peri-implantation 
period. An overview of the experiments is presented below.
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1.4: Overview of thesis
The general theme of these experiments is the investigation of changes in gene 
expression of tissues of the murine uterus around the time of implantation with a 
view to characterising molecular markers for each of the tissues. The work centres 
on a technique for separating the luminal epithelium from the rest of the uterine 
tissue using a mild enzymatic (dispose) digestion followed by mechanical 
extraction (Bigsby et al., 1986). This technique has been used successfully in several 
previous studies with down-stream techniques including co-cuituring of the 
epithelium and stroma and RNA extraction followed by RT-PCR or northern 
hybridisation. Papers using this technique are discussed in section 2.2.5.
First (Chapter 3), luminal epithelium and stroma from day 4 and 5 pseudo­
pregnant mice were obtained using the dispose method. These tissues were 
histologically evaluated. Markers for tissues in the peri-implantation uterus (days 4 
and 5) were tabulated after a literature search. Possible markers that were specific 
for uterine luminal epithelium, glands and stroma were identified. A set of paired 
luminal epithelium and stroma/giands tissues was obtained using the dispose 
technique and tested for the presence of these markers using real-time RT-PCR with 
Taqman® probes. In Chapter 4, luminal epithelium, glandular and stromal tissues 
were taken from peri-implantation mice using laser microdissection, and the 
markers evaluated in Chapter 3 were confirmed as tissue specific using Real-Time 
RT-PCR. The tissues were also hybridised to microarray chips and analysed to 
compare the global expression of genes in each of the three tissue types. In 
Chapter 5, luminal epithelium and stroma/glands samples were taken at regular 
time points from day 5 pseudo-pregnant mice, then evaluated for cycling of 
canonical circadian gene transcripts using real-time PCR.
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2.1: Solutions
Material Notes Source
PBS tablets Cat. no.: BR0014G Oxoid Ltd, UK
18 ohm water From Elga Purelab Ultra filtration Veolia Water, UK
DEPC
system
Cat. no.: D5758 Sigma-Aldrich, UK
Trizma base Cat. no.: T1503 Sigma-Aldrich, UK
EDTA Cat. no.: ED2SS Sigma-Aldrich, UK
Boric acid
Ethylene diamine tetraacetic acid 
Cat. no.: B7901 Sigma-Aldrich, UK
Tri-sodium citrate BDH brand, Cat. no.: 102425M VWR, UK
Sodium Cat. no.: P9146 Sigma-Aldrich, UK
pyrophosphate
Glycerol Cat. no.: G5516 Sigma-Aldrich, UK
Bromophenol blue Cat. no.: B8026 Sigma-Aldrich, UK
Table 2.1: Materials and equipment used in methods detailed in section 2.7
Cat. no. = Catalogue number.
All solutions are given at their stock concentrations. Dilution may be needed to 
achieve the concentration used in the methods; the appropriate section should be 
referred to.
lOx PBS
Dulbecco's modified calcium and magnesium free phosphate buffered saline 
(PBS) was made up using tablets. 1 tablet was added to each 100ml of 18 ohm 
water then autoclaved at 121°C for 15 minutes.
RNAse-free water
Diethyl pyrocarbonate (DEPC) is an alkylating reagent that inactivates any 
proteins, including RNAses, found in solutions. In a fume hood 1.8ml of DEPC were 
added to 1.8L of 18 ohm water to give 0.1% DEPC-treated water. The bottle was 
shaken vigorously and left overnight in the fume hood with the lid slightly loose to
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avoid accumulation of carbon dioxide. The water was then autoclaved to 
inactivate the DEPC.
lOx TBE
108 g Trizma base, 55 g Boric acid and 40 ml 0.5M EDTA (pH 8 using hydrochloric 
acid) were made up to 1 L with DEPC-treated water
20XSSC
175.3 g sodium chloride and 88.2 g Tri-sodium citrate were made up to 1 L with 
DEPC-treated water, then autoclaved.
Hybridization buffer
20ml formamide, 5ml Denhart's solution (50x stock), 12.5ml 20x SSC, 0,5ml sodium 
pyrophosphate (lOOmM stock), 2.5ml Tris pH 7.4 (1M stock) and 0.5ml SDS (10% 
stock) were made up to 50ml with DEPC-treated water, then filtered using a 0.22jjm 
filter and stored in 1.5ml aliquots at -20°C
6 x loading buffer (6x LB)
6ml giyceroi and 0.05g bromophenol blue were made up to 20ml using DEPC- 
treated water then filtered using a 0.22|jm filter and stored in aliquots at -20°C
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2.2: Mouse husbandry and tissue isolation
Material Notes Source
230mm glass Pasteur 
pipettes 
Superfrost slides 
Methylene blue 
Dispose
Fianks's Buffered Salt 
Solution (HBSS)
Trizol®
Dissecting
microscope
Volac brand, Cat. no.: Z310727
BDH brand, Cat. no.: 032K3483
Cat. no.: M9140
Cat. no.: 165859
Neutral protease, grade II from
Bacillus polymyxa EC 3.4.24.4
Cat. no.: 14170. No calcium, no
magnesium
Cat. no.: 15596-026
Sigma-Aldrich, UK 
VWR, UK
Sigma-Aldrich, UK 
Boehringer 
Mannheim, UK
InVitrogen, UK
Invitrogen, UK 
Wild Heerbrugg (now 
Leica, UK)
Table 2.2: Materials and equipment used in methods detailed in section 2.2,
Cat. no. = Catalogue number.
2.2.1: Maintenance of experimental mice
MF1 mice were kept in a 12 hour: 12 hour Light:Dark regime. 'Light' periods used a 
bright white light (500-700 lux) and 'Dark' periods a dim red light (5-20 lux). Where 
reverse-lighting has been used the mice were left for 2 weeks to adjust to the new 
lighting before experiments began. Food and water were available ad libitum. 
Mice were maintained under conditions specified in the Animals (Scientific 
Procedures) Act, 1986 and all experiments had local ethical approval. No Flome 
Office licensed procedures were performed.
2.2.2: Vaginal flushing
230 mm glass pasteur pipettes were shortened by cutting the tip of the pipette and 
flaming until a smooth round end was formed. Approximately 0.25 ml autoclaved 
PBS was taken up in the tip of the pipette. The mouse was placed on top of the 
cage and its tail lifted to expose the vagina. The tip of the pipette was inserted into 
the vagina and the PBS squeezed into the vagina then refluxed a few times before 
being taken back into the pipette. The liquid was dropped onto a pre-prepared 
slide marked out using a wax pen to keep each sample separate. The samples
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were air dried/stained with 1% methylene blue and rinsed under tap water once or 
twice. The slides were then allowed to dry before being viewed under a light 
microscope. The days of the oestrous cycle were scored as follows (Rugh, 1990): 
Day 1 (oestrus): smear is just squamous epithelial cells. In early oestrus some cells 
may still have nuclei and seem stringy. Day 2 (metoestrus): approximately equal 
numbers of leukocytes and epithelial cells, the epithelial cells are large, folded and 
often with transparent nuclei. Day 3 (dioestrus): almost exclusively leukocytes with 
some nucleated epithelial cells. There may also be mucus present. Day 4 
(proestrus): largely nucleated, some cornified epithelium. There may also be some 
leukocytes.
2.2.3: Establishment of pseudopregnancy
Female mice were placed into the cages of vasectomised male MF1 mice, just 
after lights-out. The next morning, before 10am, the female mice were checked for 
the presence of a vaginal plug of coagulated semen to indicate mating. If a plug 
was present, the female was removed from the cage and caged separately away 
from other males. If no plug was present the female was placed back in the cage 
and left with the male for another 24 hours before being checked again. Day of 
plug was designated Day 1 of pseudopregnancy.
2.2.4: Dissection and mechanical isolation of uterine tissues (Bigsby et al., 1986)
0.5% dispase in HBSS was made up no more than 1 hour in advance of the 
procedure. Mice were killed by cervical dislocation. The abdomen was opened 
after spraying the fur with 70% ethanol and peeling back the skin. The inner 
abdominal musculature was cut open, taking care not to snip the internal organs. 
The uterus was located after pushing the coils of gut to the side. The first horn,
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oviduct and ovary was separated from the posterior peritoneal wall and any 
associated fat, mesentery and blood vessels by gripping the ovarian fat pad under 
the kidney with one set of forceps, whilst cutting away the horn with the other. The 
horns were then cut across the vaginal vault, so that the two horns remain joined. 
Any residual mesentery/fat/blood vessels were then trimmed away from the 
remaining horn, and the ovary cut away from the fat pad, so the uterus and 
ovaries were stili joined.
The dissected uterine horns (approx. 1 cm long and not slit open) were 
placed into Ix sterile PBS, where any remaining cleaning dissection was 
completed. Once the uterine horns were in the PBS, they were trimmed into two 
separate horns whilst being viewed under a dissecting microscope. The ovaries and 
oviducts were removed by cutting the uterus just before the oviduct/uterus 
junction. One horn was cut away from the cervix, then the other. If the mouse had 
been mated, the ovaries were checked for the presence of corpora lutea (dark 
pink spots seen on the pale pink ovaries) to confirm ovulation induction. Any uteri 
from mice lacking corpora lutea were discarded. The horns were then placed in 3 
ml of 0.5% dispose in HBSS in a small petri dish, and incubated at room temperature 
for 2.5 to 3 hours. During this time, any remaining mesentery/fat was trimmed from 
the horns under a dissecting microscope.
After incubation, the endometrial tissues were removed under a dissecting 
microscope by holding one end of the uterine horn with forceps and applying 
pressure along the horn with a sealed glass Pasteur pipette bent into a right angle. 
The resulting extrudate was separated using forceps into stroma and epithelium 
based on its appearance. Each tissue was transferred into sterile Ix PBS by mouth 
pipetting with a flame-polished Pasteur pipette. The tissue was washed in the PBS 
then transferred in minimal PBS to a labelled 1.5 ml Eppendorf tube containing 100 
(j| Trizol. The tubes were immediately frozen in liquid nitrogen then stored at -80 °C.
51
2.2.5: Discussion of previous studies utilising the dispose isolation technique
The dispose treatment and mechanical separation technique described in section
2.2.4 (Bigsby et al., 1986) has provided the means of removing and separating 
epithelial and stromal cells that have been used in several downstream techniques. 
RNA extracted from these tissues has been used successfully in many of the 
techniques described in section 1.3.1, including northern blotting (Cheng et al., 
2001; Kurita et al., 2001; Kurita et al., 2000; Sidhu and Kimber, 1999), conventional 
RT-PCR (Illingworth et al., 2000; Tong et al., 1996), real-time RT-PCR (Catalano et al.,
2005), ribonuclease protection assays (Cheng et al., 2001) and microarrays on both 
pseudopregnant (Campbell et al., 2006) and neonatal (Hu et al., 2004) tissue. 
Protein extracted from these tissues has been assessed by western blotting 
(Catalano et al., 2005; Cheng et al., 2001; Illingworth et al., 2000) and used in 
enzyme assays (White and Kimber, 1994).
Populations of intact cells have been cultured successfully, including 
experiments where the epithelium of a mouse of one genotype is recombined with 
the stroma of a mouse of another genotype and grafted onto the renal capsule of 
a host mouse (Buchanan et al., 1998; Cooke et al., 1997; Kurita et al., 2000; Kurita et 
al., 1998; Mericskay et al., 2004; Miller and Sassoon, 1998; Pavlova et al., 1994). In 
one study RNA was extracted from the tissue recombinants after removal of the 
graft and used in northern blotting experiments (Buchanan et al., 1999). Sheets of 
intact epithelium have also been fixed on a slide, immunostained then viewed 
under a confocal microscope (Illingworth et al., 2000).
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2.3: Histological analysis of fixed tissue sections
Material Notes Source
Bouins fix 
Xylene
Haematoxylin
Eosin
DPX
Gift
BDH brand, Cat. no.: 102936H 
Cat. no.: H 9627 
BDH brand, Cat. no.: 341972Q 
BDH brand, Cat. no.: 360294H
Physiology 
department, 
Cambridge University 
VWR, UK
Sigma-Aldrich, UK 
VWR, UK 
VWR, UK
Table 2.3: Materials and equipment used in methods detailed in section 2.3,
Cat. no. = Catalogue number.
2.3.1: Dehydration and paraffin embedding of tissues
After dissection, tissues were placed in a 7 ml glass squat tube containing a 50:50 
mix of Bouin's fix and 70% ethanol. The tissue was then left overnight at room 
temperature. The fix was replaced serially for 2 hours each by 100% methanol, 100% 
ethanol, and finally xylene to clear the tissue. The tissues were then placed, using 
forceps, into small glass dishes and molten paraffin wax pipetted onto each 
sample until it was covered. The samples were then placed in an incubator at 60°C 
and the wax changed every half hour for two hours. A plastic pipette was used to 
remove old wax. Plastic moulds were taken and their bases lined with a little molten 
wax, which was then allowed to solidify slightly. The tissue was removed from its 
molten wax bath in the incubator and oriented on its end in the mould. More 
molten wax was then added until the sample was covered. The samples were 
labelled and then left to cool and fully solidify.
2.3.2: Sectioning embedded tissues
The sample was removed from its plastic mould and the block trimmed to give a 
cuboid structure using a hot scalpel or razor blade. The sample was attached to 
the microtome block by melting a little wax onto the block and orienting the 
sample so the leading face was a flat plane. The samples were cut in ribbons at a
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thickness of 8 |jnn, then the ribbons cut into smaller segments of approximately 6 
samples. Samples were taken at regular intervals so enough samples were 
mounted to get 10 slides, each with 2 segments (of 6 samples each). The samples 
were mounted by picking up each segment of ribbon by a corner using a scalpel, 
then placing it gently onto the surface of a pre-heated 50 °C water bath using a 
rolling motion. The wax was allowed to melt slightly and then was caught from 
underneath using a glass slide. This was repeated for another segment so two 
ribbon segments were mounted on each slide. The slides were left to drain on a 
slide rack and then placed in a 37 °C incubator overnight to dry.
2.3.3: Haematoxylin and Eosin staining of histological samples
The slides were placed in slide racks of up to 25 at a time, and then sequentially 
transferred to large glass baths containing: first xylene for 15 minutes, then 100% 
ethanol for 10 minutes, then through dilutions of methanol at 100%, 70%, 50% and 
30% for 2 minutes each followed by distilled water for at least 5 minutes (up to an 
hour). The racks were then transferred to a Haematoxylin bath for 3 minutes, 
washed under running tap water for 5 minutes, then transferred to an acidic 
ethanol bath for 15 seconds. To counter-stain the slides were left in a bath of 1% 
eosin for 30 seconds, before being washed with distilled water. The slides were then 
dehydrated by being sequentially transferred through methanol baths of 
increasing concentrations for 30 seconds each. The slides were then transferred to 
a 100% ethanol bath for 5 minutes then xyiene for 5-10 minutes. After at least 5 
minutes in xylene, the slides were taken two at a time and mounted with coverslips 
using DPX.
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2.4: Laser microdissection of frozen tissue sections
Material Notes Source
OCT Sakura Tissue-Tek brand Bayer, UK
LCM staining kit Cat. no.: 1935 Ambion, UK
Cresyl violet
PicoPure™ RNA Cat.no.: KIT0214 Arcturus, UK
extraction kit
Cryostat Leica, UK
Nanodrop Model ND-1000 Labtech, UK
spectrophotometer
RNaseZap® Wipes Cat. no.: AM9786 Ambion, UK
Table 2.4: Materials and equipment used in methods detailed in section 2.4,
Cat. no. = Catalogue number.
2.4.1: RNase-free technique
RNases are ubiquitous and very difficult to remove from lab equipment and 
plasticware. All plasticware and tips used were certified DNase and RNase free 
and all bench areas, pipettes and racks wiped with RNase Zap then rinsed with 
DEPC-treted distilled water. All water used was treated with DEPC before use. The 
degradation of RNA by RNases is a time and temperature dependent reaction, so 
all procedures were performed as quickly as possible and samples were kept on 
ice. Freezing of RNA samples was avoided where possible by performing reverse 
transcription reactions immediately after RNA extractions, but when freezing was 
unavoidable the samples were frozen at -80 °C and allowed to thaw on ice to 
minimise damage by fast thawing. Gloves were worn at all times during contact 
with the material and plasticware.
2.4.2: Sectioning tissues on cryostat
The samples were removed from the -80 °C freezer and kept on dry ice to avoid 
thawing. The sections were mounted longitudinally in OCT on pieces of chilled 
aluminium foil, and then placed on dry ice for the OCT to freeze. Samples were 
mounted on a cryostat block with additional OCT, then left to equilibrate inside the
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cryostat chamber for 20 minutes. Sections were cut at thicknesses of 12 Mm and the 
initial sections containing no uterus tissue or only mesentery/myometrium were 
discarded. Sections were mounted on membrane slides, and allowed to dry. A 
maximum of 3 slides with 8-12 sections on each was taken for each sample. Slides 
were then kept at -20 °C if not needed for immediate use.
2.4.3: Discussion of the techniques of laser microdissection and laser capture 
microdissection
Laser microdissection and laser capture microdissection are techniques that allow 
the fine dissection of specific areas of tissue when viewed as thin sections under a 
microscope. The laser capture system uses a heat sensitive membrane placed over 
a slide on which sections of the tissue of interest have been mounted. An infrared 
laser causes the membrane to distort and attach to a user-defined area of the 
tissue: this can be a single cell or a larger area of tissue. The membrane is then 
removed with the area of tissue attached. To facilitate the removal of the 
membrane and subsequent downstream applications, it can be attached to the 
inside of a specially designed 0.5 \il tube lid. Because the laser is infra-red and the 
membrane absorbs most of the energy, there is little damage to the cell 
macromolecules using this technique (Arcturus, 2004). Laser microdissection is a 
slightly different technique, this time using an ultra-violet laser to ablate the tissue 
around an area of interest, causing the tissue in that area to become loosened 
from the slide and either drop into the lid of an Eppendorf tube situated below the 
inverted slide, or be catapulted by the action of the laser into a lid situated above 
a non-inverted slide.
Laser microdissection appeared to be well suited to the task of obtaining 
pure samples of uterine tissues, particularly glands and stroma, which cannot be 
obtained by conventional dissection. Laser microdissection has been recently used 
successfully to isolate pure samples of stroma and luminal epithelium (but not
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glands) from secretory-phase human biopsies for use in a microarray (Yanaihara et 
al., 2005) and luminal and glandular epithelium (but not stroma) from peri- 
implantation pregnant mice (Niklaus and Pollard, 2006), studies discussed further in 
Chapter 6
2.4.4: Cresyl Violet staining
Tissues were stained using the Ambion LCM staining kit. Cresyl Violet is a basic 
synthetic dye that binds acidic components such as RNA-rich ribosomes, nuclei, 
and nucleoli. This histological stain has been used to stain neurological tissues and is 
especially useful for allowing researchers to identify cellular morphology and tissue 
architecture. All alcohol solutions were made using nuclease-free water. All 
plasticware was either certified RNase free and came with the kit, or was treated 
with RNase Zap prior to use. The slides were taken through the protocol 4 at a time. 
The slides were first washed in 95% ethanol for 30-40 seconds, then immediately 
taken to 75% ethanol for another 30-40 seconds before washing in 50% ethanol for 
25-30 seconds. In all three of these steps the slides were agitated gently in the 
solutions by moving up and down using a pair of tweezers to grip the frosted end of 
the slide. The slides were then drained on an absorbent lint-free tissue and the area 
to be stained marked with a barrier pen. 300 pi of cresyl violet stain were pipetted 
onto each slide and left for 40 seconds. Excess cresyl violet was drained from the 
slide, then the slides washed with 50% and 75% alcohol for 25-30 seconds each. The 
slides were not agitated during these steps. The slides were then washed once in 
95% ethanol and twice in 100% ethanol. The slides were then agitated in xylene, 
then left for 5 minutes in a second tube of xylene. The slides were removed from the 
xylene and left in a fume hood to dry. When dry, the slides were immediately taken 
for laser microdissection.
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2.4.5: Laser microdissection of tissues
Laser microdissection was performed using a Leica LMD6000. The LMD6000 is an 
inverted laser microdissection set-up. Up to four 0.2 ml tubes may be suspended 
with the inside of their caps facing up underneath the inverted slide. The laser is first 
calibrated on the objective intended for use when cutting the samples, in this case 
the x40 objective. The slide is moved until the section of interest is in view on the 
computer monitor. The appropriate tube cap for collection is selected, the 
machine will then move the cap directly underneath the area of the slide being 
visualised on the computer monitor. The 'close line' tool is used to draw around the 
region of interest, then the 'combined mode' cut tool is used to cut around the 
region of interest before pulsing the tissue with the laser to loosen it from the slide 
and allow it to fall into the tube lid below. The 'collector' tool is used to change the 
microscope to xlO objective and focus on the tube lid to check the progress of 
section collecting. The area obtained with each laser cutting is recorded in the 
'shape list' window and can be copied and pasted into a Microsoft Excel™ 
spreadsheet to keep note of the total area recorded.
2.4.6: RNA Extraction from tissues obtained by laser microdissection
This protocol was modified from the Arcturus PicoPure RNA extraction kit protocol. 
All reagents and plastic-ware used were from the kit.
Immediately after a tissue sample had been collected using laser 
microdissection, the 0.2 ml Eppendorf tube was frozen at -20 °C for 30 minutes. The 
tube was then briefly pulse spun. 50 pi of Extraction Buffer (XB) were pipetted onto 
the cap and the tube was spun again before being incubated at 42 °C for 30 
minutes, then frozen at -80 °C until needed.
When all samples had been collected, the RNA purification columns were 
pre-conditioned by pipetting 250 pi of Conditioning Buffer (CB) onto the purification 
column filter membrane and incubating for 5 minutes at room temperature. The
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columns were then spun at 16,000 x g for one minute to remove the CB. 50 pi of 
70% ethanol were added to the cell extract/extraction buffer mix and pipetted up 
and down a few times to mix. The cell extract/ethanol mixture was then pipetted 
into the pre-conditioned purification column and centrifuged for 2 minutes at 100 x 
g, to bind the RNA to the column then 16,000 x g for 30 seconds to remove flow­
through. 100 pi of Wash Buffer (Wl) were pipetted into the purification column and 
the column centrifuged for one minute at 8,000 x g. 100 pi of Wash Buffer 2 (W2) 
were pipetted into the purification column and centrifuged for one minute at 8,000 
x g, followed by another 100 pi of Wash Buffer (W2) and centrifuged for two minutes 
at 16,000 x g. The purification column was checked for any residual wash buffer 
and re-centrifuged at 16,000 x g for one minute if any remained. The purification 
column was transferred to a new 0.5 ml microcentrifuge tube and 11 pil of Elution 
Buffer (EB) pipetted directly onto the membrane of the purification column. The 
purification column was then incubated for one minute at room temperature, 
before being centrifuged for one minute at 1,000 x g to distribute EB in the column, 
then for one minute at 16,000 x g to elute RNA. The concentration of the isolated 
RNA was then quantified using a Nanodrop spectrophotometer then stored at -80 
°C until use. Yields are discussed in Chapter 5.
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2.5: Microarrays
Material Notes Source
Amplitaq DNA Cat. no.:N8080171 Applied Biosystems,
polymerase UK
PCR machine Techne, Model: 'Genius' VWR, UK
SMART™ PCR cDNA Cat. no.: K1052-1 Kit contains BD Bioscience
Synthesis Kit SMART™ CDS Primer IIA, SMART™ 
TS Primer, SMART IIA 
Oligonucleotide
Clontech UK,
BioPrime DNA Cat. no.: 18094-011 Invitrogen, UK
Labeling System Kit contains Klenow, random 
primer, buffer, low c dNTP, STOP 
buffer.
dNTPs Cat. no.: 27-2035-01 Amersham, UK
PowerScript Reverse Cat. no.: 8460-1 BD Bioscience
Transcriptase Kit contains: buffer, DTT Clontech UK
Cy3-dCTP Cat. no.: PA53023 Amersham, UK
Cy5-dCTP Cat. no.: PA55023 Amersham, UK
Auto-seq G50 
columns
Cat. no.: 27-5340-02 Amersham, UK
Cot-1 DNA Cat. no.: 18440016 Invitrogen, UK
PolyA Cat. no.: 27-7988 Amersham 
Bioscience, UK
Denhardt's solution Cat. no.: D2532
1 mM sodium pyrophosphate, 50 
mM Tris pH 7.4,
Sigma-Aldrich, UK
Yeast tRNA Cat. no.: R5636 Sigma-Aldrich, UK
Bluefuse Cambridge Blue 
Gnome, UK
Axon scanner Model: Genepix 4000 Molecular devices, UK
Genespring Agilent Technologies, 
UK
Microarrays Array name:
RFCGR HGMP_Mouse_Mm_SGC 
_Av2 from MRC RFCGR 
Microarray Programme
(Hinxton, UK)
Table 2.5: Materials and equipment used in methods detailed in section 2.5,
Cat. no. = Catalogue number
2.5.1: Microarray -  SMART™ based protocol
All SMART™ reagents used are from the SMART™ PCR cDNA Synthesis Kit
1st strand synthesis
0.5 jjg total RNA, 1 fjl 3' SMART™ CDS Primer IIA (10 pM), 1 pi SMART™ TS Primer (10 
pM), were made up in a sterile thin walled 0.2 ml tube and nuclease-free water
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added to 5 |jl. The tube was vortexed, pulse spun, then incubated at 72 °C for 2 
minutes, before being placed on ice. 2 pi of 5 x First Strand Buffer, 1 pi of 20 mM DTT, 
1 pi of 10 mM dNTPs and 1 |jl of Powerscript RT were then made up to a master mix 
and 5 pi aliquotted into each tube. The tube was vorfexed, pulse spun, then 
incubated for 60 minutes at 42 °C (in a pre-heated block), placed on ice and 
stored at -20 °C if not immediately needed.
cDNA amplification
75 pii of RNase-free water, 10 |jl of 10 x PCR Buffer II, 2 pi of 10 mM dNTPs, 4 pi of IIA 
Primer, 5 pi of 25 mM MgChand 2 pi of AmpliTaq (5 U/pl) were made up to a master 
mix. The tube was vortexed, pulse spun and then 98 pi added to tubes containing 2 
pi 1st Strand synthesis product. The tubes were then vortexed and pulse spun again 
before being placed on a pre-warmed 95 °C PCR hot block. The cDNA was 
amplified on a Techne Genius PCR machine first for 1 minute at 95°C to activate 
the enzyme, then 14 cycles of 95 °C for 5 seconds, then 65 °C for 5 seconds, and 
finishing with 68 °C for 6 minutes.
Klenow labelling
Klenow labelling was performed using reagents from the Bioprime labelling system 
kit (2.1.2), 21 pi of amplified cDNA were taken and added to 20 pi of 2.5 x Random 
Primer Buffer in a sterile thin wall 0.2 ml tube. The tubes were mixed, pulse spun, 
incubated at 95 °C for 5 minutes then placed on ice. 5 pi of 10 x Low C-dNTPs, 2 pi 
of Cy3 or Cy5-dCTP andl pi of Klenow polymerase (40 U/pl) were added to the mix 
individually and the tube incubated at 37 °C for 2 hours. After 2 hours, 5 pi of STOP 
Buffer were added to each tube to stop the reaction.
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Purification of labelled cDNA using G50 columns
The G50 columns were prepared two at a time by first vortexing to resuspend the 
resin. The cap was then loosened and the bottom closure snapped off. The column 
was placed in a 1.5 ml tube and spun at 2,000 x g for 1 minute. The column was 
then transferred to a new tube. 1 |jl of the eluate was taken for cDNA 
quantification using a Nanodrop spectrophotometer. The rest of each sample was 
applied to the centre of the column and spun at 2,000 x g for 1 minute. The purified 
Cy3 and Cy5 labelled products were combined (using a light tight container). 2 pi 
of Human Cot-1 DNA (used as a carrier), 10 pi of 3M sodium acetate (pH 5.2), and 
250 pi of 100% ethanol were added to each tube. The tubes were inverted to mix, 
and the DNA precipitated for a minimum of 2 hours (overnight if possible) at -20 °C. 
The tubes were spun at 12,000 x g for 15 minutes at 4 °C, then washed with 750 pi of 
75% ethanol, then spun at 12,000 x g for 5 minutes. The supernatant was discarded 
and the pellet allowed to air dry in the dark.
Hybridisation
Coverslips stored in 70% ethanol were cleaned by wiping gently with 70% ethanol, 
rinsed under a tap of distilled water, then were rinsed twice in Millipore filtered 
water, and once in isopropanol and left to air dry. The hybridisation buffer was 
warmed to 50 °C then vortexed and pulse spun. The coverslip was placed 1 mm 
from the bottom edge of the slide, then 50 pi of buffer pipetted onto the gap 
between coverslip and slide, allowing it to flow underneath the coverslip by 
capillary action. The slides were pre-hybridised for 2 hours at 50 °C (with buffer but 
no Denhart's solution) in a humidified box placed in a water bath. The coverslips 
were removed by immersing slides in 2 x SSC then washed as described above. The 
slides were washed once in 2 x SSC then rocked for 5 minutes, twice in Millipore 
filtered water and once in isopropanol, then air dried. The probe was re-suspended 
in 50 pi of warm hybridisation buffer containing 2 pi of human Cot-1 DNA (as a
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carrier) (1 M9/ mD' 1 Ml of poly(A) (8 |jg/|jl), 1 Ml of yeast tRNA (4 pg/pl). The probe mix 
was incubated for 95 °C for 5 minutes then spun for 5 minutes at 13,000 x g. The 
coverslip was applied to the slide and the probe added to the slide. The arrays 
were then hybridised for 16-18 hours at 50 °C in a humidified box placed in a water 
bath.
Washing slides
The coverslips were removed by immersing slides in 2 x SSC. The slides were washed 
in the dark on a rocking platform, twice for 5 minutes in 2 x SSC, twice for 5 minutes 
in 0.1 x SSC, 0.1% SDS, twice for 5 minutes in 0.1 x SSC. The slides were then rinsed 
twice in 0.1 x SSC, once in Millipore water and once in isopropanol. They were then 
dried immediately by centrifugation at 100 x g for 2 minutes.
2.5.2: Post-hybridisation data analysis
Post washing and drying, the hybridised microarray was kept in an opaque slide 
box in the dark. Slides were scanned on an Axon scanner and imported into 
Bluefuse for analysis. Bluefuse generates fluorescence readings for each address 
and flags data by checking that the fluorescence at each address is homogenous 
and not a smudge or artefact on the array chip. The address is assigned a 
confidence level between 0 and 1 (highest). The resulting data were uploaded to 
http://www.obgyn.cam.ac.uk/RMRG/analysis.html for normalisation using the per- 
spot, per-chip intensity dependent Loess algorithm. The purpose of the 
normalisation is to compensate for the differences in levels of fluorescence of each 
dye due to quenching of the fluorophore. The log2 ratio of cy3 to cy5 was then 
calculated for each address. Data were imported into GeneSpring where 
Condition Tree analysis was performed to check that the two tissue chip replicates 
were more similar to each other than they were to the other chips. The Condition 
Tree is an algorithm in GeneSpring that extracts meaningful patterns from large
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quantities of data by grouping similar samples/conditions together based on similar 
expression profiles. It then displays gene similarities as a dendrogram, a tree-like 
structure made up of "branches". Smaller branches nest within larger ones until 
eventually one stem joins all branches. This nested structure forces all genes to be 
related at a certain level, with larger branches representing the more distantly 
related genes.
The data were then filtered. Addresses where the raw fluorescence did not 
exceed 150 arbitrary units for either cy3 or cy5 channels were removed, as were 
addresses with confidence levels below 0.5. Filtering using the raw fluorescence 
levels is to prevent false positives where the log2 ratio cy3/cy5 appears to be 
significant even if the raw levels imply there is little or no binding to the address. This 
process of elimination has been previously used with a fluorescence cut off point of 
250 arbitrary units and a flag cut-off of 0.5 as defined by BlueFuse (Campbell et al.,
2006).. but because the overall fluorescence level of these arrays appeared to be 
low, the lower cut-off was proposed. Genes with less than a twofold difference to 
the reference were removed and the resulting lists classed as 'up-regulated' and 
'down-regulated'.
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2.6: PCR and Gel Electrophoresis
Material Notes Source
MacVector Accelrys, UK
BIOTAQ™ DNA Cat. no.: 21040 Bioline, UK
Polymerase Includes buffer
Agarose Low melting point 
Cat. no.: 15517-022
Invitrogen, UK
Ethidium bromide Cat. no.: El510 Sigma-Aidrich, UK
Gel tank Bio-Rad, UK
UV transilluminator BioDoc-IT system UVP, UK
1KB ladder Cat. no.: N32325 NEB, UK
Table 2.6: Materials and equipment used in methods detailed in section 2.6,
C at no. = Catalogue number.
2.6.1 PCR
PCR mastermix specific for the number of samples was made up to 24 |jl for each 
reaction using lx  Bioline buffer (2.5 pi of Bioline lOx buffer), 0.5 mM dNTPs (1.25 pil of 
10 mM total dNTPs), 2.5 mM MgCh (2.5 pi of 25 mM MgCh), 0.5 pM 5' primer (0.5 pi 
of 25 pM 5' primer), 0.5 pM 3' primer (0.5 pi of 25 pM 3' primer) and 16.75 pi of sterile 
Millipore water. The master mix was vortexed, spun down and aliquotted. 20 ng 
DNA in a volume of 0.5 pi was added to each tube, followed by 0.5 pi of Bioline Taq 
polymerase. The tubes were gently vortexed, spun down and cycled on a PCR 
machine for 95 °C for 1 minute, followed by 40 cycles of 95 °C for 30 seconds, 67 °C 
for 30 seconds and 72 °C for 90 seconds, then an incubation at 72 °C for 5 minutes.
2.6.2: PCR primer information
Primers were designed using Accelrys MacVector and ordered from Sigma 
Genosys. Primers were resuspended to a stock concentration of 100 mM then 
diluted to a working concentration of 25 pM using nuclease-free water.
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E?2
Sequences: 5':GATGCTCCTGCTGCTTATCGTG,
3': GCAAAGATTGTGAAAGGCAAGG, Product size: 243 bp
EPa
Sequences:5':CAATCAGATGTCGGTTGAGCAATG,
3': GCTGGAAGCATAGTTGGTGTGG, Product size: 187 bp
2.6.3: Gel electrophoresis
The percentage (w/v) agarose was determined by the size of the product: 
3% for 100-200bp, 2% for 200-1 OOObp, 1.5% for 1000-1500bp or 1% for >1500bp. 
The relevant weight of agarose powder was poured into a conical flask 
containing Ix TBE and plugged with tissue. The flask was then heated in a 
microwave for periods of 1 minute, mixing between each, until no solid 
agarose or viscous fluid movement could be seen. The flask was allowed to 
stand for a few minutes until cool enough to pour.
The agarose was carefully poured into a gel tank with inserted combs 
and allowed to set for 30 minutes at 4 °C. The combs were then eased out of 
the set gel and the gel placed in the running tank containing Ix TBE. More lx 
TBE was poured into the tank until the gel was covered. 10 pi of PCR product 
was mixed with 2 pi of Loading buffer and pipetted into its designated well. 
One well at either end of each comb was loaded with 10 pi of NEB 1KB 
ladder. The samples were loaded as quickly as possible, then run at max 
(200A) current and 100V (120V with larger gel tank) until the blue dye front 
had reached the end of the gel. The gel was placed in a sealed box 
containing 0.5 mg/ml ethidium bromide solution for 5 to 10 minutes, then de­
stained in distilled water for the same length of time. The gel was then viewed 
in a UV transilluminator and photographed for reference.
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2.7: RNA extraction and real-time RT-PCR
Material Notes Source
RNeasy micro kit Cat. no.: 74004 Qiagen, UK
RNase zap wipes Cat. no.: 9786 Ambion, UK
Chloroform Cat. no.: C5312 Sigma-Aldrich, UK
Linear acrylamide Cat. no.: 9520 Ambion, UK
MMLV Reverse Cat. no.: M l701 Promega, UK
transcriptase Buffer included
Random primers Cat. no.: 48190-011 Invitrogen, UK
(Pdn6)
BSA Cat. no.: 27-89-14 Amersham, UK
Real-time RT-PCR 2x Cat. no.: AB1142 ABgene, UK
mastermix
18s primers/probe Cat. no.: 4310893E Applied Biosystems, 
UK
Table 2.7: Materials and equipment used in methods detailed in section 2.7,
Cat. no. = Catalogue number.
2.7.1: RNA extraction from whole tissues
For whole tissues, a frozen tissue homogenisation step was performed followed by a 
phenol/chloroform step, then isolation of pure RNA using Qiagen RNeasy Mini kit 
columns. For dissected luminal epithelium and stroma, the freezing and crushing 
steps were omitted. The protocol began with the phenol/chloroform step and was 
followed by isolation of pure RNA using Qiagen RNeasy Micro kit columns. The 
bench area and pipettes used were treated with RNase Zap wipes before 
extraction commenced. All tips and tubes used were certified DNase and RNase 
free.
Crushing step
The samples contained in 1.5 ml Eppendorf tubes were taken out of the -80 °C 
freezer and transported on dry ice to prevent thawing. Care was taken to avoid 
thawing at all steps up to the addition of Trizol. The mortar was pre-cooled by 
addition of a little liquid nitrogen. An insulating glove was worn on the hand holding 
the mortar to prevent freeze-burn. The sample was removed from its tube without
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thawing and placed in the mortar. The sample was quickly covered with a piece of 
tinfoil and a little liquid nitrogen poured on to the tinfoil to cool it. The sample was 
then ground underneath the tin foil using the pestle. More liquid nitrogen was 
added if the mortar appeared to be warming above freezing. The powdered tissue 
was washed from the mortar and tinfoil using more liquid nitrogen into a pre­
weighed tube that had been cooled on dry ice. The lid was held down but not shut 
tight to allow excess gaseous nitrogen to escape whilst preventing the tissue from 
popping out of the tube. The lid was then sealed and the tube weighed quickly to 
determine tissue yield. 500 |j| of Trizol were added to the tube, which was kept on 
dry ice until all samples had been ground.
Trizol step
Samples were taken through this section of the extraction process in groups of 6 or 
8. An extra 400 pi Trizol was added if the tube contained dissected LE and stroma in 
lOOpI Trizol. The samples were thawed, vortexed well, dispersed with a Gilson tip 
and left for 5 minutes at 4 °C before vortexing/dispersing again. The samples were 
spun for 10 minutes, at 16,000 x g at 4 °C for whole tissues or 2 minutes at 16,000 x g 
for dissected LE or stroma, and the supernatants taken to fresh pre-labelled 1.5 ml 
Eppendorf tubes, leaving the pellet of remaining non-soluble extracted tissue 
behind.
In a fume hood, 100 pi of chloroform were added to the tube, which was 
then shaken vigorously by hand for 15 seconds then left at room temperature for 2 
minutes. The tube was then spun at 12,000 x g at 4°C for 15 minutes. The upper 
aqueous layer (approx 300 pi) was then taken to a fresh, pre-labelled 1.5 ml 
Eppendorf tube. 2.4 pi of 5 mg/ml linear acrylamide (a co-precipitant that does not 
interfere with spectrophotometer readings) and 300 pi of 70% ethanol were added 
to the tube, which was then vortexed well and kept on ice prior to the next step.
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Qiagen column step
This step is performed outside the fume hood. The ethanol/RNA mix was applied to 
either a Qiagen RNeasy mini column (whole tissues) or a micro column (dissected 
LE or stroma), which was then spun for 1 minute at 8,000 x g. The eluate was 
reapplied to the same column and spun again. The eluate was then discarded. 
350|jl of buffer RW1 (a buffer to bind RNA to the membrane of the spin column, 
supplied with the Qiagen kit) were applied to the column, which was then spun for 
15 seconds at 8,000 x g. The eluate was discarded. 10 pil of DNase 1 stock solution 
were added to 70 |jl of RDD buffer (a buffer to dilute the DNase and supply the 
enzyme with cofactors and optimum pH conditions, supplied with the Qiagen kit) 
and mixed by gently inverting a few times. The DNase mix was then applied to the 
column, and the column left at room temperature for 15 minutes, 350 |jl of buffer 
RW1 (a buffer to wash the RNA bound to the column membrane, supplied with the 
Qiagen kit) were applied to the column, which was then spun for 15 seconds at 
8,000 x g. The eluate was then discarded. The column was transferred to a fresh 
collecting tube, 500 |jl of buffer RPE were applied and the column spun at 8,000 x g 
for 15 seconds. The eluate was then discarded. 500 |jl of 80% ethanol were applied 
to the column, which was then spun for 2 minutes at 8,000 x g. The eluate was then 
discarded. The column was transferred to a fresh collecting tube then loaded into 
the centrifuge with its cap open and spun for 5 minutes at maximum speed to 
remove all residual ethanol and dry the membrane. The collecting tube was 
discarded and the column transferred to a fresh 1.5 ml collecting tube. 14 pi of 
RNase-free water were pipetted onto the column membrane and the tube spun at 
maximum speed for 1 minute to elute the RNA.
The yield was assessed using a Nanodrop spectrophotometer and either 
taken straight to the reverse transcription step, or frozen at -80 °C.
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2.7.2: Precipitation of nucleic acids
0.1 volumes of 3 M sodium acetate (pH 5.2), 2.5 volumes of 100% ethanol and 
Linear Acrylamide to a final concentration of 10 |jg/ml were added to the sample. 
The tube was vortexed to mix and precipitated for a minimum of 24 hours at -20 °C. 
The tubes were then spun at 12,000 x g for 15 minutes at 4 °C. The supernatant was 
removed with progressively finer pipette tips to avoid removing the pellet, then 
washed with 750 pi of 75% ethanol, before being spun at 13,000 x g for 5 minutes. 
The supernatant was then removed again and the pellet allowed to air dry in the 
dark, before being resuspended in an appropriate volume of nuclease-free water.
2.7.3: Reverse transcription of RNA for use in real-time RT-PCR
4 pi of Promega 5 X first strand buffer, 2 pi of 10 mM dNTPs, 2 pi of random primers 
and 2 pi of Pharmacia 1 mg/ml BSA were made up in a master mix for the 
appropriate number of tubes being reverse transcribed, then 10 pi aliquotted into 
individual tubes. 400 ng of RNA was made up to 9 pi using RNase-free water, then 
added to the appropriate tube.
The tubes were then placed on a PCR block pre-warmed to 65 °C for 1 
minute (to remove RNA secondary structure and allow binding of random primers), 
placed on ice for 3 minutes (to avoid reforming secondary structure) then pulse 
spun down. 1 pi Promega MMLV reverse transcriptase (RT) was added to each 
tube, (1 pi of sterile water for a -MMLV control reaction) and the tube placed in the 
PCR machine at 37 °C for 1 hour, then 95 °C for 10 minutes (to destroy the enzyme 
and the RNA). The resulting samples were diluted 1 in 5 with 80 pi of sterile double 
distilled water and aliquotted into 6.5 pi samples.
The 'standard curve' method in real-time RT-PCR relies on relative rather 
than absolute quantification, using a dilution series of DNA containing the 
sequence of the gene or transcript of interest. Popular standard curve materials 
include genomic DNA, a total cDNA population from the tissue of interest or a
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cloned copy of the gene of interest. The only criterion is that the expression level of 
the gene in the real-time RT-PCR samples to be measured must fall within the range 
of the standard curve. Standard stocks in these experiments were made from a 
pool of RNA comprising an equal amount from each of the unknown samples. The 
pool was made up to the same concentration as the unknowns using nuclease- 
free water, then a master mix made up as above. The RNA pool was aliquotted 
into individual tubes with master mix for reverse transcription, then the cDNA 
products combined, mixed and re-aiiquotted into 15 pi aliquots.
2.7.4: Taqman® assay design
Assay design for real-time RT-PCR involves careful consideration of different 
technologies and techniques, which are discussed in section 1.3.1. It was decided 
that Taqman® was the most appropriate technique to use for these assays as 
collaborators had been using this technology previously and assays were running 
smoothly. Although the reactions are difficult to optimise, once working the assays 
are reliable and accurate (Bustin and Nolan, 2004). The use of 18s rRNA (a small 
RNA component of the eukaryotic ribosome) as a housekeeping gene is 
considered more reliable than other popular housekeeping genes such as GAPDH 
(glyceraidehyde 3-phosphate dehydrogenase, a metabolic enzyme) and beta- 
actin (Bustin, 2000), a cytoskeletal protein. Absolute quantification in real-time PCR 
is very difficult because reaction efficiencies are not always constant, although it is 
possible to obtain an absolute standard curve by using plasmid DNA. Unless it is 
essential that an absolute quantification of gene expression needs to be achieved, 
then relative quantification is an adequate substitute. Relative quantification was 
used in this work for this reason (Dorak, 2006).
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2.7.5: Designing, ordering and storing of primers and probes for Taqman®
Primers and probes were designed using Beacon Designer Software or Primer 
Express Software using gene information downloaded from Ensembl 
(http://www.ensembi.org/Mus_musculus/). Where possible, probes were designed 
to span exon-exon boundaries to avoid amplification of any contaminating 
genomic DNA. Primers and probes were blasted against the mouse genome to 
ensure specific binding (nucleotide-nucieotide blast at 
http://www.ncbi.nlm.nih.gov/BLAST/).
Primers/probes were ordered online from Sigma Genosys, the probe was 
modified with a 5' conjugated 5-carboxyfluorescein (FAM) as a fluorophore and a 
3' conjugated 5-carboxytetramethylrhodamine (TAMRA) as a quencher. Primers 
and probes were stored lyophilised at -20 °C until needed. Then they were 
resuspended in their original tubes to lOOpM and kept at -20 °C as a stock solution. 
Working solutions were made by diluting the stock to 10 pM for primers and 5 pM for 
probes. All dilutions were made using sterile double-distilled nuclease-free water. 
Probes are light sensitive so all tubes containing aliquots of probe were wrapped in 
aluminium foil. All aliquots of primers and probes were stored in an opaque black 
box at -20°C.
Figure legend for Tables 2.8 and 2.9
The tables summarise the sequence of each primer/probe set used in these studies, 
if they are positioned across an exon/exon boundary in the gene of interest the 
RefSeq database accession number of the gene and the Ensembl transcript 
number of the gene (used to acquire the gene sequences to design the primers 
and probe), and whether the oligonucleotides were designed in house or acquired 
from a collaborator.
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Table 2.8: Taqman primers/probe sets for Circadian genes
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Table 2.9: Taqman primers/probe sets for uterine marker genes
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2.7.6: Running real-time RT-PCR
Plate set up
All cDNA samples to be run with 18s primer/probes were diluted 1 in 100 before 
adding to the master mix: 5 pi of RNA were added to 495 |jl of nuclease-free 
Millipore water. To make a standard curve, a 1 in 2 serial dilution series was made 
starting with a 6.5 pi aliquot of standard to which 6.5 |jl nuclease-free Millipore 
water were added. The tube was vortexed gently to mix and with a fresh pipette 
tip, 6.5 pi of this mix were removed and taken to a fresh Eppendorf tube and the 
dilution series continued thus until the dilution reached 1 in 128.
For 18s primers/probe, a master mix of 6 pi ABI 18s mix, 60 pi Abgene buffer 
and 48 pi nuclease-free Millipore water was made up, 6 pi of the diluted RNA or 
relevant standard curve dilution were added to it. For other primers, a master mix of 
60 pi ABI mix, 300 nM of primers and 200 nM of probes was made up to 114 pi with 
nuclease-free Millipore water, then 6 pi of the diluted RNA or relevant standard 
curve dilution were added to it. The final mix tubes were vortexed and spun down. 
36 pi of each mix were pipetted into each of 3 wells on a 96 well plate (reaction 
triplication). The plate was sealed with optical lid strips and spun briefly in a 
centrifuge. The plate was either run immediately or stored wrapped in aluminium 
foil at 4 °C for up to 24 hours. The plate was run on either an MJ DNA engine 
Opticon 2 or an ABI Prism 7700 for 2 minutes at 50 °C, 15 minutes a t 95 °C, then 40 
cycles of 15 sec at 95 °C and 1 minute at 60 °C, with fluorescence acquisition at 
the end of each cycle.
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2.7.7: Taqman® data analysis protocol
After running each plate with a primer probe set to genera te  fluorescence data , 
the m achine software (ABI SDS for the ABI Prism 7700 and O p tic o n  M on ito r for the 
MJ O pticon) was used to generate  a Ct value for each well (defined as the cycle 
a t which the fluorescence intensity reaches a threshold level). This is illustrated in 
Figure 2.1.
o-
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Figure 2.1: Example of a  fluorescence plot generated by MJ Opticon 2 Monitor 
software. The p lo t shows the  n um be r o f cycles on the  x axis a n d  the  log  o f the  
fluo rescence  leve l re c o rd e d  by  the d e te c to r  on the y axis. Several sam ples are  
rep resen ted  on this p lo t  e a c h  b y  a  d iffe ren t co lour. The first 10 cycles are  
b a c k g ro u n d  fluo rescence ; the fluorescence  levels in the  h ighest c o n ce n tra tio n  
sam ples b eg in  to increase e xpo ne n tia lly  a ro u n d  cyc le  18, w here the g ra d ie n t o f  
the  line b eco m e s  constan t. Low er c o n ce n tra tio n  sam ples b eg in  to  increase  
a ro u n d  cyc le  21. The threshold leve l is the  b la c k  d ashed  line in tersecting  the y axis 
a t a ro u n d  -1.2. It is user-defined  a n d  must be  w ithin the e xpo ne n tia l phase o f DNA 
rep lica tion . The p o in t a t  w h ich  e a c h  sa m p le ’s cu rve  crosses the  threshold leve l is 
c a lle d  the C t
The fluorescence plots were scanned and the well numbers of any unusual plots 
noted. The Ct da ta  were transferred into Microsoft Excel™. A standard curve was 
crea ted  by plotting the 3 rep licate Cts of each of the 1 -in-2 standard dilution series
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samples against their relative dilution level, A line of best fit through the points on 
the standard curve was genera ted with a correlation value r2 >0.95, outlying 
examples were excluded a t this point, The Cts of the 'unknown' samples were then 
converted to  arbitrary values using the equation of line through the standard 
curve. An exam ple is given below.
Fig 2.2: An example of a  standard curve 
generated by a  serial dilution of DNA
36 i
y = -3.4232X + 41,587__
R2 = 0.989
2 2.5 3 3.5 4 4.5
Log 10 relative concentration
Figure 2.2: An example of a standard curve generated by a serial dilution of DNA, 
generated by Opticon Monitor 2 software from real-time RT-PCR results. The C t o f
th e  sam p les  is p lo t te d  a g a in s t th e  Log 10 v a lu e  o f  its re la tiv e  c o n c e n tra t io n  a n d  a  
line  o f  b e s t fit d ra w n  th ro u g h  th e  results. A n  e ff ic ie n t re a c t io n  sh o u ld  g iv e  a  
g ra d ie n t o f  c lose  to  -3.3 (in this ca s e  th e  g ra d ie n t is -3.4, w h ich  is a c c e p ta b le .  A  
c o rre la tio n  (R2)  v a lu e  o f  1 in d ic a te s  th a t  th e  th re e  re p lic a te s  fo r e a c h  
c o n c e n tra t io n  a re  re p ro d u c ib le  (in this c a s e  th e  R2 v a lu e  is 0.989, w h ic h  is 
a c c e p ta b le .
The three triplicates for each sample were then averaged. For single un-replicated 
conditions, the value was simply normalised to  its corresponding 18s value. If more 
than one rep licate  set was involved, values were first com pared  to  the m ean of
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their set and a ratio calculated and then normalised to their 18s value to control for 
variation between sets. The replicates for each value were then averaged and 
plotted on a graph with the standard error of the mean (SEM) for each time point 
(calculated as the standard deviation of the data set divided by the square root of 
the number of replicates).
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Chapter 3: Tissue type markers for the 
pseudopregnant mouse uterus
Summary
3.1: Introduction
3.2: Observations from preliminary histological studies
3.3 Collection of experimental material
3.4: Histological analysis of samples
3.5: Identification and establishment of molecular markers
3.6: Real-Time PCR analysis using Taqman®
3.7: Testing markers on a panel of samples for use in a microarray 
3.8: Discussion of Chapter 3
3.1: Introduction
The aim of this part of the research was to validate and develop molecular markers 
for the luminal epithelium (LE) and stroma (S) of uterine endometrium in early 
pregnancy using real time RT-PCR on dissected tissue components, and to relate 
the molecular and histological data. The objective was ultimately to be able to 
identify confidently which tissue components were present in a dissected sample to 
be used for downstream application such as Taqman® and microarrays. The initial 
studies focussed on enzymically dissected stroma and luminal epithelial tissues. 
However, during this part of the study, it became clear from observing histological 
sections that the stroma contained glandular epithelial tissue and the luminal 
epithelium also sometimes had attached material that resembled glandular 
epithelium histologically. Therefore, in the second part of the study, markers were 
used to try to distinguish all three tissues, so that the extent of glandular 
contamination could be assessed. The approach used was to investigate the 
transcriptome of each tissue around the time of implantation. Because the 
presence of an embryo complicates the tissue architecture through both its 
presence and the decidual reaction it induces, markers were sought in uteri from 
pseudopregnant mice. The presence or absence of the markers was investigated 
with real-time RT-PCR using Taqman® fluorogenic probes on cDNA made from RNA 
extracted from samples of pseudopregnant mouse uterus.
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3.2: Observations from preliminary histological studies
Preliminary studies were undertaken to characterise the material recovered by the 
dispase-dissection procedure by relating macroscopic observations on the 
dissected tissues to their histological structure.
Macroscopic
In preliminary studies on pseudopregnant uteri the dispose separation technique 
(section 2.2.4) seemed to yield luminal epithelium contaminated with stroma.
The luminal epithelium appeared as a sleeve (with an appearance like chiffon), 
attached to what appeared to be stroma (with a 'cotton wool' appearance). In 
the cases where the epithelium and stroma came out whole and attached to 
each other, the extract seemed to be 'inside out' with the stroma on the outside 
and the epithelium on the inside. The two tissues were separated by gently picking 
off the epithelium using forceps, or pulling the epithelium out from the inside of the 
stroma using a gentle tugging motion with the forceps. Sometimes this could be 
achieved by peeling it off like a sleeve and at other times it came off in strips. 
Occasionally the isolated LE appeared to be slightly woolly in appearance, which 
was speculated to be due to the presence of stromal contamination. Furthermore, 
epithelia from day 5 of pseudopregnancy appeared to have spiky projections from 
the LE pointing into the stroma and it was speculated that these were endometrial 
glands. The various macroscopic patterns of epithelium observed were recorded 
for comparison with microscopic images.
Microscopic
Histological studies were undertaken to investigate the macroscopic observations 
recorded above. 4 and 5 day pseudopregnant mice were obtained by mating 
female MF1 mice with vasectomised males (2.2.3). One example of each of the
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following tissues from both days were removed to an Eppendorf tube containing 1 
ml of a 50:50 mix of Bouin's fix and 70% ethanol for subsequent histological 
processing and analysis (see materials and methods): 1: Whole uterus incubated for 
2 1/2 hours in HBSS (no dispose), then removed for fixing; 2: Whole uterus incubated 
in 0.5% dispose in HBSS for 2 1/2 hours, then removed for fixing; 2: Whole uterus 
incubated in 0.5% dispose in HBSS for 2 1 /2 hours, then subjected to mechanical 
separation of stroma/luminal epithelium. Both (a) the stroma/epithelium and (b) 
the residual parts of the uterus were removed for fixing separately.
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Representative photos
1. Untreated whole uterus
500nm
Figure 3.1: Transverse H&E stained section through untreated whole uterus (also 
shown as Figure 1.1). The pa le -s ta in ing  o u te r m esenchym a l laye r (A) c a n  b e  seen  
on the outside surrounding the strongly sta in ing m yom etrium  (B), c o m p o s e d  first o f 
a laye r o f lon g itu d in a l sm ooth  m uscle, then  a  laye r o f c ircu la r sm ooth  m uscle. The 
endom etrium , w h ich  lies inside the m uscu la ture , consists o f a  diffuse s trom a  th a t is 
denser a n d  stains d a rke r in the a re a  surrounding the lum ina l ep ith lium  (C.J The 
strom q conta ins dark ly  staining c ircu la r p a tc h e s  o f g la n d u la r e p ith e lium  (D) 
th roughou t. The c e n tra l lum en (F) is su rrounded  by  the co lu m n a r lum ina l ep ith e lium  
(E), w h ich  is s e p a ra te d  from  the  strom a b y  an e p ithe lia l b ase m e n t m e m b ra n e .
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2. Dispase-treated uterus
500[xm
Figure 3.2: Transverse H&E stained section through dispose treated uterus:
the structure o f the uterus is sim ilar to the u n tre a te d  uterine section  shown  
in Figure 3.1, b u t in the tre a te d  uterus shown here in Figure 3.2 the  lum ina l 
ep ithe lium  c a n  be  seen to h ave  d issoc ia ted  from  the underly ing s trom a in 
m ost p laces. This is a  result o f the dispose trea tm en t.
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500nm
Figure 3.3. Longitudinal/oblique H&E stained section through dispase-treated uterus:
the dissociation from  the underly ing  strom a c a n  b e  seen m ore  c le a rly  in this o b liqu e  
section. The zig-zag a p p e a ra n c e  o f the lum en I is due  to  ‘w rink ling ’ o f the  section  
be fo re  e m b e d d in g .
3. Epithelium and stroma extracted from dispase-treated uterus
lOO^m
Figure 3.4. H&E stained extracted epithelium/stroma showing epithelium partly 
dissociated from stroma and glands: this is a  result o f dispose tre a tm e n t a n d  
m e c h a n ic a l ex trac tion  on a p se u d o p re g n a n t uterus, show ing th a t the e p ith e lium  is 
still p a rtia lly  a tta c h e d  to  the  s trom a, b u t it is possible fo r it to be  p ic k e d  off.
500nm
Figure 3.5 . H&E stained extracted epithelium/strom a showing epithelium in several 
small pieces, some still a ttached to stroma: the  ep ithe lium  is very d e lic a te , so o fte n  
rips as it is b e ing  p ic k e d  o ff the strom a a fte r  extrac tion .
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Conclusions from preliminary studies
Dispose treatment followed by mechanical extraction of epithelium on 
pseudopregnant uterine horns yields epithelium attached to underlying stroma. 
Picking off stroma does not guarantee that all stromal or glandular contamination is 
removed. This must be assessed in other ways. Glandular epithelium is embedded 
in the stroma. It would not be possible for it to be removed by mechanical means, 
so contamination must be assessed in other ways. The composition of extracted 
epithelial samples isolated from stroma was not assessed at this time, but later 
experiments to view mechanically extracted epithelia under the microscope in 
tandem with molecular biology results addressed this.
Histology is a useful way of looking qualitatively at the composition of 
samples extracted using the dispose technique, but it has its limitations (as 
discussed above.) Also, once a uterine horn is embedded and sectioned for 
histological analysis, the tissue is essentially destroyed and molecular techniques 
such as real-time RT-PCR cannot be performed on it. The solution to this (and the 
problem of minor stromal contamination that may not be readily detected by 
histological analysis), is to research genes expressed discretely in each of the three 
tissue types to use as 'molecular markers' for tissue composition.
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3.3: Collection of experimental material
After observing that the dispose treatment technique could work on 
pseudopregnant uteri, it was decided that the constitution of 4 and 5 day 
pseudopregnant samples would be assessed in two ways: one histological (H and E 
stained thin sections viewed under a light microscope) and one molecular (real­
time PCR using dual-labelled fluorogenic Taqman® probes). The histological 
findings, as well as confirming the macroscopic observations, would then be 
backed up by the outcome from experiments using PCR-based markers for tissue 
type. The uterus was separated into two horns before the dispose treatment, so the 
epithelium and stroma from one horn could be used for histological analysis and 
the other for real-time PCR.
It was decided to focus on days 4 and 5 post-implantation: this being the 
peri-implantation period, and the most important (and therefore most studied) time 
in early pregnancy. Because of this, preliminary PubMed searching showed a large 
number of differentially expressed markers that had been characterised for this 
time by in-situ hybridisation and/or immunocytochemistry. It was decided to use 
pseudopregnant rather than pregnant mice. There were two reasons for this: so no 
embryos were present to complicate the collecting of uterine tissues, and so the 
gene expression of the uterus was not complicated by signalling between the 
implanting embryo and the endometrium leading to massive stromal 
decidualisation. Because this complication was removed, the only effects 
observed will be the maternal responses to the hormonal changes set in train by 
mating rather than the presence of the embryo itself.
Four females in day 5 of pseudopregnancy and 3 females in day 4 of 
pseudopregnancy (section 2.2.3) were sacrificed. Their uteri were removed and 
incubated in 0.5% dispose in HBSS at room temperature for 2.5 hours, before being 
subjected to mechanical extraction of the epithelium and attached stroma
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(section 2.2.4). Notes were made on the appearance of the uteri at removal and 
the ease of extraction. The extracted products from each of the uterine horns were 
separated as much as possible into epithelium and stroma/glands and removed to 
either an Eppendorf tube containing 1 ml of 50:50 Bouin's fix: 70% ethanol (for 
histological analysis) or an Eppendorf containing lOOpI Trizol (for RNA extraction). 
The Trizol tubes were then frozen and stored at -80°C.
Results
Three mice were sacrificed on day four of pseudopregnancy, four mice were 
sacrificed on day five. Observations from the dissection of the uterus and and 
separation of stroma and glands are recorded in Table 3.1.
Day Mouse number Histological
analysis
RNA
analysis
Observations
4 1 Yes Yes Easy and clean extractions
4 2 Yes Yes Easy and clean extractions
4 3 Yes No Difficult extraction, quite 'sticky' 
epithelia
5 1 Yes Yes Difficult extractions, appears to 
be glands contaminating LE
5 2 Yes No Difficult extractions
5 3 Yes Yes Easy extractions
5 4 Yes Yes Easy extraction but potential 
GE contamination of LE
Table 3 .1: Observations from epithelial extractions of day 4 and 5 pseudopregnant 
mice, showing the day of pseudopregnancy, the number of mice used for each 
day, whether samples could be obtained for both histological analysis and RNA 
analysis and notes on the ease of extraction of the epithelium. Two dissections 
were difficult and only yielded enough epithelium for histological analysis; they 
were fixed for histology in preference to being taken for RNA extraction as it was
89
thought that more relevant data could be obtained that way. Two further 
dissections may have produced cross-contaminated samples, and three were 
scored as clean. Comparison of visual scoring macroscopically with both histology 
and molecular markers could thus be performed informatively on these variable 
samples. GE = glandular epithelium, LE = luminal epithelium.
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3.4: Histological analysis of samples
The samples taken for histology as described above were fixed, em bedded in 
paraffin wax (section 2.3.1) and microtomed as 7|jm sections (section 2.3.2) before 
being mounted on slides and H&E stained (section 2.3.3). The slides were viewed 
with the x4, xlO and x20 objectives and notes made on the appearance of the 
sections.
lOOfim
Figure 3.6: A sam ple of H&E stained “pure" luminal epithelium (x20 objective).
“ Purity" is ch a rac te rise d  b y  the  abse nce  o f a n y  c le a r s trom a l cells; ribbons o f  
ep ithe lium  c a n  be  seen w ith the basa l lam ina  still in ta c t.
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LE
GE
Figure 3.7: Luminal epithelium (LE) contam inated with glandular epithelium  
(G) and stroma (S). G la nd u la r tissue c a n  be  seen as da rk  c ircu la r p a tc h e s  
a tta c h e d  to the ep ithe lium  in som e samples. Stromal tissue ca n  also be  
seen in som e sam ples as diffuse dark ly  sta in ing nuclei.
To assess contamination of the em bedded samples a systematic scoring method 
was employed, as shown in Table 3.2. The em bedded sections were cut using a 
microtome into long ribbons, then the ribbons cut into smaller ribbons of 6 sections 
each. Alternate ribbons were systematically mounted onto slides so one ribbon was 
at the top and one at the bottom to give ten slides in total, each bearing two 
ribbons. If there were too many ribbons to mount on ten slides then every second 
ribbon was discarded and the remainder were mounted. If the sample was 
particularly small, all sections were mounted, even if the number cam e to less than 
ten slides. To score for glandular and stromal contamination, each ribbon of six was 
scanned through and the number of glands counted. Because each 6 were
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consecutive samples, glands were often present in the same place on all of the 
sections in a ribbon.
Day and Row Number o f glands in slide number. .
Average 
number of
Sample l 2 3 4 5 6 7 8 9 10 Glands
4.1 Top 0 0 0 0 0 0 0 0 0 0 0
bottom 0 0 0 0 0 0 0 0 0 0
Stroma?
4.2 top 0 2 0 2 0 0 0 0 1 1 0.7
bottom 2 0 1 2 0 0 0 0 2 1
Stroma? Y Y
5.1 top 9 13 9 7 16 5 4 3 2 6.45
bottom 6 9 11 3 16 8 4 2 2
Stroma? Y Y Y
5.3 top 3 3 1 0 0 2 4 4 3 4 2.1
bottom 5 3 1 0 0 3 0 3 2 1
Stroma?
5.4 top 3 2 0 0 1 0 1 2 1 1 1.15
bottom 3 2 1 0 1 2 2 1 0 0
Stroma?
Table 3.2: Histological assessment of epithelial samples for glandular and stromal 
contamination. Numbers refer to numbers of glands. Stroma?= stromal 
contamination present on slide? Y = yes.
The number of glands in each set of six was counted, rather than the number of 
glands in each individual section. Stromal contamination was noted if present. The 
average number of glands per ribbon of 6 sections was calculated. The results 
were recorded in Table 3.2.
The histological analysis after dispose treatment and mechanical extraction 
indicates that day 5 epithelial samples appear to contain more glands than day 4
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samples. Although the epithelium up-regulates expression of adhesion molecules as 
the window of implantation progresses, they have been found to be present in the 
apical membrane (to promote trophoblast attachment), rather than the basal 
membrane (which would promote epithelial attachment to stroma and result in the 
'stickiness' described above) (Aplin, 1997) (Kimber and Spanswick, 2000). Despite 
this, the stroma and glandular epithelium also express integrins (Bowen and Hunt, 
2000) although the type and temporal expression has not been fully characterised 
in mice. The stroma also contains extra-cellular matrix proteins that act as ligands 
for integrins on the trophoblast as it invades the stroma and promotes 
decidualisation. The complex patterns of adhesion molecule expression in the 
uterus mean that it is likely that the layers of the uterus adhere to each other as well 
as to the trophoblast around the window of implantation, making the layers of the 
uterus more difficult to remove from each other. This is discussed further in section 
5.2.
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3.5: Identification and establishment of molecular markers
The histological observations were then tested by finding markers for each tissue 
type, and their expression investigated using PCR.
Search for peri-implantation molecular markers
The identification of molecular markers for pregnant uterus tissue subtypes was 
initially based on a PubMed (http://www.pubmed.net) search of previously 
published literature. The aim was to pull out some possible markers. These included 
markers described as only being expressed over this period and markers that were 
described as being localised immunohistochemically (IHC) or by in situ hybridisation 
(ISH) in restricted anatomical locations. Markers concerned with implantation were 
of particular interest. The PubMed search string used was 'mouse uterus 
implantation'. The abstracts of papers found were read to see if they contained 
information of relevance, then the paper downloaded if it was thought to be 
useful.
Discussion of papers containing evidence for potential markers 
The markers were narrowed down to those that displayed single-tissue expression. 
Literature databases were searched for papers containing these markers. The 
evidence found in these papers is discussed below.
In the discussion of all these papers the notation used is day 1 as day of plug. This 
has been converted from any different notation used by the authors of the paper 
under discussion.
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Epithelial markers
1. Osf2
Osf-2 (Osteoblast stimulating factor 2) was discovered by a microarray analysis to 
be strongly downregulated by a progesterone inhibitor in the peri-implantation 
pregnant uterus, implying it is progesterone-regulated (Cheon et al., 2002). 
Northern blot analysis of whole uterus extract showed Osf-2 was undetectable on 
days 1 -3 of pregnancy then highly expressed on day 4, and expressed at a slightly 
lower level on day 5. In situ hybridisation revealed that Osf-2 was localised 
specifically to the luminal epithelium between days 3 and 5 of pregnancy, with a 
peak of intensity on day 4.
2. E?2
EP2 is a subtype of prostaglandin E2 receptor (prostaglandin E2 receptor subtype 
EP2). Northern biots using whole uterus extract show that the level of expression of 
the EP2 transcript is barely detectable on day 1 of pseudopregnancy, low levels are 
found on days 2-4 and a sudden increase causes a peak on day 5 and a 
subsequent fall to pre-day 5 levels. This pattern is the same in both pregnant (Lim 
and Dey, 1997) and pseudopregnant mouse uteri (Katsuyama et al., 1996).
In situ hybridizations on pregnant uteri (Lim and Dey, 1997) revealed distinct 
temporal and cell-specific localization of the EP2 mRNA during the peri-implantation 
period. On days 1 and 2, no specific signals for EP2 mRNA were detected in any 
uterine cell type. In contrast, weak signals were first detected exclusively in the 
luminal epithelium on day 3 followed by augmentation of these signals on days 4 
and 5 of pregnancy. Pseudopregnant uteri (Katsuyama et al., 1996) were found 
not to express EP2 on day 0 of pregnancy (pro-oestrus), but strong expression 
exclusive to the luminal epithelium was found on day 5. No accumulation was 
noted in the glandular epithelium in pregnant mice (Lim and Dey, 1997). The same
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paper also suggested that luminal epithelial expression of E P 2  mRNA is regulated 
primarily by circulating steroid hormones, but not by resident blastocysts, implying 
that the situation would be similar in pseudopregnant mice. E P 2  has previously been 
used as a successful marker for luminal epithelium (Cheng et al., 2001).
Stromal markers
1. Tn-c
Tn-c (Tenascin-C) is an extracellular matrix glycoprotein, localised along the 
basement membrane between the luminal epithelium and stroma during early 
pregnancy. In situ hybridisation shows that subluminal stromal cells express Tn-c on 
days 1-3 of pregnancy or pseudopregnancy, expression is reduced on day 4 but 
reappears on day 5 (Noda et al., 2000). Expression of Tn-c is not observed in non­
pregnant mice at either the protein or the mRNA level.
2. EP3
EP3, like EP2, is a subtype of Prostaglandin receptor E2 (prostaglandin E2 receptor 
subtype EP3). Northern blots on whole pseudopregnant mouse uterus extract 
indicate a similar pattern of temporal expression to E P 2  (Katsuyama et al., 1996). E P3  
mRNA was hardly detected on day 0 (pro-oestrus). Beginning on day 1, the 
transcript progressively increased in abundance to reach the maximum on day 5, 
which was about 13-fold the level observed on day 1. On days 7 and 9, expression 
decreased to lower levels than those on day 1. Northern blots on whole pregnant 
mouse uterus indicate high levels of E P3  present on days 3 and 4 of pregnancy. 
Lower levels are present on days 1-2 and day 5 (Yang et al., 1997). In situ 
hybridisation indicates that EP3  mRNA accumulates in the circular muscle of the 
myometrium and in the stroma at the mesometrial pole on day 4 of pregnancy, 
with expression declining on day 5. Expression is similar on day 4 of
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pseudopregnancy (Vang et al., 1997). However, another study showed EP3 to be 
exclusively in the myometrium of pseudopregnant mice on day 4 of 
pseudopregnancy (Katsuyama et al., 1996).
Glandular marker
LIF
LIF (leukaemia inhibitory factor) is a cytokine expressed at low levels in a variety of 
organs, and at a particularly high level in day 4 pregnant uteri, as well as at lower 
levels on days 1-3 and day 5 onwards (Bhatt et al., 1991). In situ hybridisation 
showed that LIF was localised specifically in the endometrial glands on day 4 of 
pregnancy. Low signals were present throughout the endometrium on days 1-3. As 
the endometrial glands degenerated from day 5 onwards, their LIF expression 
declined. Day 4 pseudopregnant females also exhibited strong LIF expression, 
implying that expression is maternally controlled. LIF is expressed by the glandular 
epithelium and binds to LIF receptors in the luminal epithelium, where it initiates a 
transcription cascade to prepare the epithelium for implantation. LIF has previously 
been used as a successful marker for glandular epithelium (Cheng et al., 2001).
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Prostaglandin receptor expression
Based on the evidence presented above, it was dec ided  initially to  undertake 
preliminary studies on the tw o  prostaglandin receptors EP2 and EP3 as markers for 
luminal epithelium and stroma respectively. It was dec ided  to  test them  using 
conventional RT-PCR (see figure 3.8) a t first, then move on to  real-time RT-PCR if this 
gave  grounds for doing so.
| 1
Figure 3.8: Gel electrophoresis of EP2 and EP3 PCR products. Primers were optim ised  
using a stock o f day 4 pseudopregnant whole-uterus cDNA. They were then used in 
PCR reactions with the sample sets from day 4 and  5 pseudopregnant uteri (section 
2.6.1). Lanes a t the extreme edges o f the ge l are NEB Ikb m olecular mass markers. 
Details o f primers and  PCR p roduc t size expected  are de ta iled  in section 2.6.2. Key: 
epi = epithelium , stroma = stromal tissue, Numbers ind ica te  the day o f 
pseudopregnancy and  the sample number.
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The results from Figure 3.8 show that sample 4.1 has EP2 present in epithelium but 
not stroma and EP3 present in stroma but not epithelium. Sample 4.2 has EP2 present 
in epithelium but not stroma and EP3 present strongly in stroma, weaker in 
epithelium. Sample 5.1 has EP2 present strongly in epithelium, weakly in stroma and 
EP3 present strongly in epithelium and stroma. Sample 5.3 has EP2 present in 
epithelium but not stroma and EP3 present strongly in stroma, weakly in epithelium. 
Sample 5.4 has EP2 present in epithelium but not stroma and EP3 present in stroma 
but not epithelium. For verification that these results were real and not a result of 
the PCR failing, the PCR was repeated, with the same outcome.
EP2  appeared to be a good marker for luminal epithelium, because it 
clearly distinguished between luminal epithelium and stroma. In the case of sample 
5.1 (where it appears to be present in the stroma), some luminal epithelium 
contaminating the stromal preparation could be seen (data not shown). EP3  was 
present in all of the stromal samples, but also in 3 out of 5 of the epithelial samples. 
There are several interpretations of this finding. If it is assumed that the paper 
indicating EP3  as a stromal marker is reliable, then the result might represent the 
presence of stromal contamination in the epithelial preparations. Alternatively, EP3  
may be expressed in glandular tissue (or some other uterine component), or the 
luminal epithelium may express EP3  at a low level. The gross observations recorded 
when the epithelia were extracted (see earlier) do not help resolve which of these 
explanations is correct: there was no correlation between the presence of EP3  in 
epithelial preparations and the difficulty of the extraction. The validity of EP3  as a 
stromal marker needed to be confirmed by real-time RT-PCR with a range of 
samples, and other markers tested as well. Although EP2 appeared to be a good 
marker of luminal epithelium, it was considered a good idea to look at other 
potential markers also. In addition, standard RT-PCR is not quantitative, as the PCR 
product is visualised on a gel at the plateau phase of amplification. The presence 
or absence of gene expression is evident, but it is not possible to quantify it.
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Therefore, sets of Taqman® primers and probes for both EP2 and EPs were 
designed (Table 2.8) and samples of Taqman® primer/probe sets for the potential 
markers Tn-C (stroma), Osf-2 (luminal epithelium) and LIF (glandular epithelium) 
were obtained from collaborators (Table 2.9) with the aim of defining suitable 
markers for each tissue type.
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3.6: Real-Time PCR analysis using Taqman®
Following RNA extraction and reverse transcription, real-time RT-PCR analysis was 
perform ed with prim er/probe sets for the genes EP2, EP3, Tn-c, /./Fand 18s (section 
2.7.5) using an ABI Prism 7700 Real-Time PCR m achine (section 2.7.6) and the da ta  
obta ined were analysed using O pticon Monitor Software and Microsoft Excel™ 
(section 2.7.7). The technology behind Taqman®, the relative merits of different 
protocols for real-time PCR and how a decision was arrived a t on which of them  to  
use is discussed in sections 2.7.4 and 2,7.5.
Using 18s rRNA as a normaliser gene
The samples were run using the 18s rRNA gene as a normaliser in tw o  technica l 
replicates, which are shown in Figure 3.9. An average of the tw o techn ica l 
replicates was used when obtain ing the normalised ratio of the gene of interest.
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Figure 3.9: Results obtained by Real-time RT-PCR using Taqman®, comparing two 
replicate experiments quantifying 18s rRNA gene expression in manually dissected 
samples of luminal epithelium (LE), stroma/glands (S) and whole uterus from days 4 
and 5 of pseudopregnancy. An average of the two technical replicates was used 
when obtaining the normalised ratio o f the gene of interest.
Quantification of specific marker genes
As discussed in section 3.5, two of the tissue types have more than one gene 
identified to test as a potential marker. The results obtained by testing each of the 
Taqman® sets on the pseudopregnant uterine tissues and the results of the 
histological examination of the corresponding uterine horns were compared to 
decide which of the potential markers was the most appropriate to use as an 
indicator of the composition of uterine tissue samples. The results are discussed in 
section 3.8.
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Luminal epithelium markers
Two potentia l luminal epithelium markers were availab le  for analysis, Osf-2 and EP2 . 
Their patterns of expression are shown in Figures 3.10 and 3.11.
Osf-2
0.7
day 4 day 4 day 5 day 5 day 5 whole uterus
sample 1 sample 2 sample 1 sample 3 sample 4 day 4
Figure 3.10: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of Osf-2 expression to 18s expression in manually dissected samples of luminal 
epithelium (LE), stroma/glands (S&G) and whole uterus from days 4 and 5 of 
pseudopregnancy.
Despite evidence indicating tha t Osf-2 is expressed specifically in the luminal 
epithelium  (Cheon et al., 2002), it is present a t higher levels in the S&G samples than 
it is in the LE samples. It is also present a t a very high level in the whole uterus 
sample. There does not appear to  be any correlation betw een the day the 
samples were taken and the levels of Osf-2 present, It is present in the whole uterus 
sample a t a much higher level than individual S&G or LE samples.
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E?2
1 A
day 4 day 4 day 5 day 5 day 5 whole uterus
sample 1 sample 2 sample 1 sample 3 sample 4 day 4
Figure 3.11: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of E?2 expression to 18s expression in manually dissected samples of luminal 
epithelium (LE), stroma/glands (S&G) and whole uterus from days 4 and 5 of 
pseudopregnancy.
Figure 3.11 shows tha t EP2 is present a t high levels in the LE samples, and a t low 
levels (if a t all) in S&G samples. The day 5 S&G samples conta in  a higher level of EP2 
than the day 4 S&G samples. There does not appear to  be any correlation 
between the day of sample and level of EP2 present in the  LE samples. EP2 is 
present a t a higher level in LE samples than it is in the whole uterus sample in all LE 
samples apart from 4.1.
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Stromal markers
Two potentia l stromal markers were availab le for analysis: Tn-c and EP3. Their 
expression patterns are shown in Figures 3.12 and 3.13.
Tn-c
1 A
day 4 day 4 day 5 day 5 day 5 whole uterus
sample 1 sample 2 sample 1 sample 3 sample 4 day 4
Figure 3.12: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of Tn-C expression to 18s expression in manually dissected samples of luminal 
epithelium (LE), stroma/glands (S&G) and whole uterus from days 4 and 5 of 
pseudopregnancy.
Figure 3.12 shows tha t Tn-c is present in the S&G samples a t a much higher level 
than in the LE samples. There appears to  be a slightly higher level of Tn-c in day 5 
S&G samples com pared to  day 4. Some Tn-c is present in all LE samples, but the 
level does not seem to  correlate with day. Tn-c is present a t higher levels in the day 
5 S&G samples than in the whole uterus sample. For day 4 S&G samples it is a t the 
same level or slightly lower than the whole uterus sample.
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Figure 3.13: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of EP3 expression to 18s expression in manually dissected samples of luminal 
epithelium (LE), stroma/glands (S&G) and whole uterus from days 4 and 5 of 
pseudopregnancy.
Figure 3.13 shows tha t EP3 is present in the S&G samples a t a higher level than the LE 
samples. There does not seem to  be much of a difference in level of expression 
betw een day 4 and day 5 samples. Some EP3 is present in all LE samples but the 
level of expression does not seem to  correlate with day. EP3 is present a t a higher 
level in the whole uterus sample than it is in the S&G samples. NB: There was not 
enough cDNA left from the day 4 sample 2 LE to  run using this primer set, The 
sample has been included in the graph above so tha t the paired fo rm at is kept, 
but a red cross has been p laced  through its column to  ind icate  tha t the  sample 
was not run with EP3 .
■ S&G
.— ......................................
day 4 day 4 day 5 day 5 day 5 whole uterus
sample 1 sample 2 sample 1 sample 3 sample 4 day 4
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Glandular epithelium marker- LIF
O n ly  o n e  g e n e  w as id e n t if ie d  as a  p o te n t ia l m a rke r o f  g la n d u la r  e p ith e liu m : LIF. 
Figure 3.14 shows its expression p a tte rn .
day 4 day 4 day 5 day 5 day 5 whole uterus
sample 1 sample 2 sample 1 sample 3 sample 4 day 4
Figure 3.14: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of LIF expression to 18s expression in manually dissected samples of luminal 
epithelium (LE), stroma/glands (S&G) and whole uterus from days 4 and 5 of 
pseudopregnancy.
Figure 3.14 shows tha t LIF appears to  be present a t slightly higher levels in the S&G 
samples of each pair. It is present a t very high levels in both the LE and S&G of 
sample 5.1. It is present a t a slightly higher level in the whole uterus sample than in 
individual S&G or LE samples (except sample 5.1).
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3.7: Testing markers on a panel of samples for use in a microarray
To test their usefulness in a practica l situation, the uterine tissue type  Taqman® 
prim er/probe sets discussed in section 3.6 (with the exception of the set for Osf-2) 
were used to  assess the composition of 12 luminal epithelium and stroma/glands 
samples taken from across the peri-im plantation period (two from Day 3 21:00, 
three from day 4 09:00, tw o  from day 4 21:00, tw o  from day 5 09:00 and three from 
day 5 21:00) for use in a m icroarray study (Cam pbell e t al., 2006). The results are 
shown in Figure 3.15.
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Figure 3.15: Results obtained by Real-time RT-PCR using Taqman®, showing the 
mean and SEM of EP2, LIF, EP3 and Tn-c expression in relation to 18s expression in 
manually dissected samples of luminal epithelium (LE) and stroma/glands (S&G) 
from days 3, 4 and 5 of pseudopregnancy.
109
The means and SEMs shown in Figure 3.15 were calculated for the 12 samples. The 
results are similar to those obtained in section 3.6. EP2 was strongly expressed in LE 
samples, S&G samples were enriched for EP3 and Tn-c and LIF was found to be 
present in both LE and S&G samples, although at a slightly higher level in the S&G 
samples.
The tissues tested above were used successfully in a subsequent microarray study 
(Campbell et al., 2006). This is discussed in Chapter 5.
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3.8: Discussion of Chapter 3
The aim of this part of the research was to validate and develop molecular markers 
for the luminal epithelium (LE) and stroma (S) of uterine endometrium in early 
pregnancy using real-time RT-PCR on dissected tissue components, and to relate 
the molecular and histological data. The initial studies focussed on enzymically 
dissected stroma and luminal epithelial tissues. This technique (Bigsby et al., 1986) 
had been used before in non-pregnant, pregnant and pseudopregnant mice RNA 
extracted from these tissues has been used successfully in many of the techniques 
described in section 1.3.1, including northern blotting (Cheng et al., 2001; Kurita et 
a!., 2001; Kurita et al., 2000; Sidhu and Kimber, 1999), conventional RT-PCR 
(Illingworth et al., 2000; Tong et al., 1996), real-time RT-PCR (Catalano et al., 2005), 
ribonuclease protection assays (Cheng et al., 2001) and microarrays on both 
pseudopregnant (Campbell et al., 2006) and neonatal (Hu et al., 2004) tissue.
Preliminary studies were undertaken to look at the complications of using 
this technique in pseudopregnant animals. During this part of the study, it was 
observed that in pseudopregnant animals the extraction procedure resulted in LE 
remaining attached to the stroma, and it was separated by picking off using 
forceps. Day 5 pseudopregnant epithelia were also observed to contain glandular 
epithelium. The stroma also contained glandular epithelium. Therefore, in the 
second part of the study, markers that distinguished all three tissues were identified 
by a PubMed search. Markers were picked for further study if they appeared to be 
exclusive to one tissue type. Taqman® primer and probe sets were designed or 
obtained for these marker genes, and used to look at samples of stroma and 
epithelium from day 4 and 5 pseudopregnant mice. These results were validated 
by histological studies confirming the relative purity of the samples, as shown in 
Table 3.3.
Ill
Sample
number
Tissue EP2 Tn-c EP3 LIF Histology observations
4.1 LE V X X X No glandular or stromal contamination in
S&G X vv V V LE samples
4.2 LE X n/a ■sj Slight glandular and stromal
S&G X vv •V contamination in LE samples
5.1 LE VV X vv Relatively high glandular contamination
S&G X vv vv vv and slight stromal contamination in LE 
samples
5.3 LE vv X X V Slight glandular contamination in LE
S&G X vv V V samples, no stromal contamination
5.4 LE vv V X V Slight glandular contamination in LE
S&G X vv V V samples, no stromal contamination
Whole
uterus
Whole
uterus
vv vv vv V
Table 3.3: A comparison of Taqman® results for the genes EPi, Tn-c, EPs and LIF with 
histological observations from day 4 and 5 LE and stroma/glands samples used in 
Chapter 3. The Taqman® results were scored as follows; VV: the normalised value for 
the appropriate sample was between the highest value recorded for that primer 
set and half the highest value recorded for that primer set (excluding the whole 
uterus value), V: the normalised value for the appropriate sample was between half 
the highest value recorded for that primer set and 1/10th of the highest value 
recorded for that primer set (excluding whole uterus), X: the normalised value for 
the appropriate sample was below 1/10th of the highest value recorded for that 
primer set (excluding the whole uterus value). N/a = data not available.
Epithelial markers
When comparing the real-time RT-PCR results as represented by Figure 3.10 and 
Figure 3.11, the immediate conclusion is that EP2 is a more appropriate marker for 
epithelium than Osf-2. High levels of EP2 are present in LE samples on both day 4
112
and day 5, backing up previous results from other papers (Urn and Dey, 1997) 
(Katsuyama et al., 1996). It is assumed on the basis of the histology results that the 
LE samples are composed mainly of luminal epithelium (Table 3.2), so this implies 
that the luminal epithelium expresses EP2 at a much higher level than the stroma. 
This result contrasts with Osf-2, which was found to be present at a higher level in 
S&G samples than it was in LE samples.
A possible reason why these experiments indicate a very different 
expression pattern of Osf-2, is that the original experiments used pregnant animals 
and the ones in these studies used pseudopregnant animals (Cheon et al., 2002). 
The expression of Osf-2 may be induced by or affected by the presence of an 
embryo, which could explain the difference in results. A further explanation is that 
Osf-2 may be expressed in glandular epithelium or stroma in pseudopregnant 
animals, as this would concur with the pattern of expression shown by the real-time 
RT-PCR. Another point to note is the distinctly higher expression of Osf-2 in the whole 
uterus sample compared to individual S&G and LE samples. This may be due to 
expression in another uterine tissue such as myometrium. This could be investigated 
by performing RNA extraction and real-time RT-PCR on the residual uterine tissue 
left after dispose treatment and mechanical extraction of the luminal epithelium 
and stroma, or by laser capture microdissection, as described in Chapter 4.
The explanation for the presence of traces of EP2 in S&G samples from day 5 
could be explained in one of two ways. Either the stroma or glands expressed EP2 
only on day 5, or the day 5 samples were more likely to have contaminating 
luminal epithelium in the stroma samples. Since previous papers (Lim and Dey, 
1997) (Katsuyama et al., 1996) indicate exclusive expression in the luminal 
epithelium it is most likely to be due to small amounts of contamination of luminal 
epithelium in my S&G samples.
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Stromal markers
Tn-c is a convincing marker for stroma. Its gene product is present at much higher 
levels in S&G samples than in luminal epithelium samples, implying that the stroma 
expresses it at a higher level than the LE. The presence of low levels of Tn-c in all the 
epithelium samples could have three explanations. Either the luminal epithelium 
expresses Tn-c at a very low level, the glandular epithelium also expresses Tn-c (and 
GE is present in the LE samples), or the luminal epithelium preps are contaminated 
with low levels of stroma. Looking at the histological assessment of epithelial 
samples (Table 3.2), stroma is noted in only 2 of them. Stromal contamination is 
difficult to score unless it is present in large fragments, so it is possible that smaller 
fragments were present in the sections that were unable to be scored accurately. 
Also, two separate uterine horns from the same uterus are used for RNA extraction 
and histology and it is possible that each had different levels of stromal 
contamination, as no two extractions are the same. The possibility that the 
glandular epithelium expresses low levels of Tn-c, is investigated further in Chapter 4 
using laser microdissection.
EPs  is a less certain stromal marker. Although it is present at higher levels in 
stroma samples than it is in epithelial samples, it is present at quite a low level even 
in these stroma samples compared to the whole uterus. The only stroma sample 
that seems to contain EP3  at a high level is day 5 sample 1.
EP3  is expressed in the myometrium as well as the stroma (Vang et al., 1997), 
although there is some disagreement about whether the expression is in the 
myometrium only (Katsuyama et al., 1996). Myometrial expression would explain 
why the whole uterus sample has a higher level of EP3 than the individual LE or S&G 
samples. It is unlikely that the level of EP3 in the S&G or LE samples shown here is due 
to myometrial contamination because the dispose treatment and mechanical 
dissection is unlikely to affect the myometrial layers of the uterus, but this cannot be 
ruled out. Laser microdissection is used in Chapter 4 to investigate this further.
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Glandular epithelium marker
Levels of LIF mRNA are particularly high in both sample 5 LE and S&G. Histological 
analysis shows that LE sample 5.1 seems to be enriched for glandular epithelium 
(Table 3.2), which implies that glandular epithelium is expressing LIF. Previous studies 
(Bhatt et al., 1991) on pregnant mice show LIF as being expressed strongly only on 
day 4, with day 5 levels declining. This is because in pregnant animals the 
endometrial glands are starting to disintegrate on day 5 and LIF signal is being lost. 
Since day 5 pseudopregnant mice still have intact glandular epithelium they should 
still be expressing LIF. It cannot be concluded that LIF is a good marker for 
glandular epithelium without further study. Unlike the luminal epithelium and stroma 
samples, it is difficult to obtain glandular epithelium in relatively pure amounts using 
mechanical extraction alone. This problem will be further addressed in Chapter 4.
Investigating localisation of potential marker genes in this part of the study resulted 
in promising data to verify their exclusive expression for use as markers for each 
tissue type. Despite this, the experiments did not confirm for certain that LIF is 
exclusively expressed in glandular epithelium. Previous studies show exclusive 
expression in the glandular epithelium (Bhatt et al., 1991) and in this study higher 
levels of LIF were observed in samples containing more glandular epithelium. But in 
order to confirm these results, it is desirable to obtain a pure sample of glandular 
epithelium. In Chapter 4 this problem is addressed using laser microdissection.
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Chapter 4: Markers specific for uterine sub­
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4.1: Introduction
The epithelial and stromal samples obtained using enzymatic separation and 
manual dissection cannot be assumed to be pure samples of one cell type. 
Glandular epithelium is clearly embedded in the uterine stroma and impossible to 
remove by manual dissection, as seen in the dissected tissues discussed in Chapter
3. In addition, some epithelial samples, especially those obtained on day 5 of 
pseudopregnancy have some dilations that look as though some glandular tissue 
may have been isolated as a contaminant. On current evidence, the tissues can 
only be described as 'enriched' rather than pure. In order to test whether the 
markers used on these luminal epithelial and stroma samples are tissue specific, 
tissue samples of more certain composition were obtained. The technique chosen 
to obtain pure samples was laser microdissection, the value of which is discussed in 
section 2.4.3.
Using laser microdissection, putatively pure samples of luminal epithelium, 
glands and stroma were obtained from day 5 pseudopregnant uteri. Real-time RT- 
PCR was run on these samples to confirm that the markers identified in Chapter 3 
were indeed tissue specific, followed by a microarray experiment aiming to find 
more markers specific for each tissue type.
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4.2: Laser microdissection of uterine tissues
4.2.1: Obtaining samples
The original aim of this experiment was to confirm that the previously identified 
markers were specific and to run a microarray experiment to find new markers, and 
also to look at the expression of circadian genes in each individual tissue over a 24 
hour period. This method was used to obtain duplicate sets of three uterine tissues 
(LE, stroma and glands) from seven time points spaced every 4 hours around day 5 
of pseudo-pregnancy. This aim was modified during the experiment after only low 
amounts of RNA were obtained from the tissues.
Duplicate sets of tissues were obtained from pseudopregnant mice 
sacrificed at 7 time points from days 5 and 6, giving a total of 14 samples (sections 
2.2.3, 2.2.4). The first time-point taken was ZTO (ZT= 'zeitgeber time', ZTO is defined as 
the 'lights on' in a laboratory 12 hour light: 12 hour dark lighting schedule) on day 5, 
then samples were taken at 4 hour time points until 6am on day 6: designated ZT24. 
After removing the uterine horns, half of one horn was placed into a sterile 1.5ml 
Eppendorf tube, flash-frozen in liquid nitrogen then stored at -80°C. These half horns 
were taken for laser microdissection preparation. The epithelium and stroma from 
the remaining 1.5 horns were removed after dispose treatment and mechanical 
extraction as before, then placed in a 1.5ml Eppendorf tube containing 1 OOpil Trizol 
and frozen at -80°C. These samples were taken for RNA extraction (see Chapter 5).
The half-horns destined for laser microdissection were embedded in OCT 
embedding medium and sectioned using a cryostat to a thickness of 12pm 
(section 2.4.2). The sections were mounted on membrane slides and stained with 
cresyl violet (section 2.4.4) before being taken immediately for laser microdissection 
on a Leica LMD6000 microscope (section 2.4.5). Luminal epithelium, glandular 
epithelium and sub-luminal stroma were microdissected for each sample. Each
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tissue type from each sample was dissected for approximately half an hour 
to obtain similar amounts, and the areas dissected were recorded in Table 4.1
Figure 4.1: Representative photos before (a) and after (b) laser microdissection of 
luminal epithelium from frozen sections of whole uterus stained with cresyl violet.
Figure 4.2: Representative photos before (a), during (b) and after (c) laser 
microdissection of glandular epithelium from frozen sections of whole uterus stained  
with cresyl violet.
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Figure 4.3: Representative photos of the sub-luminal stroma before (a) and after (b) 
laser microdissection from frozen sections of whole uterus stained with cresyl violet.
Sample
ZT (hrs)
LE ( m m 2) Stroma ( m m 2)
Glands
( m m 2)
1 4 0.051 0 .0 6 0.037
2 4 0.113 0 .0 8 3 0.026
3 16 0.062 0.070 0.030
4 16 0.113 0.109 0.047
5 20 0 0 0
6 20 0.110 0.071 0.044
7 24 0.205 0.148 0.082
8 24 0.071 0.071 0.055
9 0 0.220 0.227 0.110
10 0 0.182 0.106 0.036
11 8 0.160 0.101 0.052
12 8 0.281 0.170 0.070
13 12 0.168 0.116 0.048
14 12 0.070 0.036 0.041
Average
SEM
0.139
±0.019
0.106
±0.014
0.052
±0.006
Total
(mm2) 1.804 1.371 0.678
Table 4.1: Summary of the area of laser microdissected samples obtained from 
each of the 14 tissue samples , The o v e r a g e  a n d  s ta n d a r d  e r ro r  o f  th e  m e a n  
o b t a in e d  fo r  e a c h  tissue ty p e  (LE, s tr o m a  a n d  g la n d s ) a n d  th e  to ta l  a r e a  (in  m m 2) 
o b t a in e d  fro m  e a c h  tissue ty p e  is a ls o  g iv e n . S e c tio n s  fro m  s a m p le  5  (C T  2 0 )  c o u ld  
n o t  b e  o b t a in e d  o n  th e  c ry o s ta t , le a v in g  13 s a m p le s  w ith  n o  d u p l ic a t e  fo r  th e  2 0 -  
h o u r  t im e  p o in t . ZT= z e i tg e b e r  t im e , L E -  lu m in a l e p ith e liu m .
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All tissue types were easily identifiable using the cresyl violet staining method. The 
boundaries between each tissue type were clear, allowing defined areas to be 
selected for microdissection. Luminal epithelium and subluminal stroma were easy 
to obtain, since large areas could be cut. However there were fewer areas present 
to take, since if luminal epithelium was cut from one particular area, the 
surrounding subluminal stroma was not used for the stoma sample to ensure no 
remaining luminal epithelium was removed with it. Areas of luminal epithelium also 
contained the lumen of the uterus, seen on the photographs as the gap between 
two layers of epithelium. This meant that although the area of luminal epithelium 
obtained was the largest of the three tissues (see Table 4.1), the amount of RNA 
obtained per unit area was the smallest. Since stromal tissue is not dense 
compared to epithelial tissue, the yield of RNA per unit area was also relatively low. 
It would have been possible to cut thin strips of epithelium to avoid taking the 
lumen space, but smaller areas of tissue do not detach as easily from the slide as 
larger areas.
Glandular epithelium was more difficult to obtain. Since the glands are 
relatively small, less tissue is obtained from the same length of cutting time (as can 
be seen in Table 4.1). But because the glandular tissue is dense, it yields 
proportionately more RNA per unit area. At several points during the cutting of 
each sample, the cut sections were visualised in the tube cap underneath the 
slide. This verified that the sections were detaching from the slide and collecting in 
the cap.
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4.2.2: Obtaining RNA
After obtaining microdissected tissues, RNA was extracted from the samples using 
the Arcturus PicoPure RNA extraction kit (section 2.4.6). 1 pii RNA was quantified 
using a NanoDrop spectrophotometer, leaving 1 Opil RNA remaining in each sample. 
Yields are shown in Table 4.2.
Sample ZT (hrs)
LE total RNA 
(ng)
S total RNA 
(ng)
G total 
RNA (ng)
1 4 20 None 17
2 4 13.5 25 21.7
3 16 19.8 32.7 20.3
4 16 58.1 48.2 31.9
6 20 26.1 13.7 22
7 24 73.7 50.9 37.5
8 24 48.3 114.3 57.2
9 0 71.3 43 46.3
10 0 20.2 22.3 45.3
11 8 51.3 50.3 47.8
12 8 42.8 52 26.7
13 12 46.8 44.3 56.9
14 12 51 & 54 30 27
Average + .SEM 
Total
Yield per unit area 
(ng/mm2)
42.6
±5.25
596.9
330.7
43.9
±7.38
526.7
384.0
35.2
±_3.93
457.6
674.5
Table 4.2: Amount of RNA obtained from laser microdissection samples using the 
Arcturus PicoPure RNA extraction kit. Units are given in nanograms (ng). Amount of 
RNA per area of tissue obtained from laser microdissection is also shown, given in 
nanograms per millimetre squared (ng/mm2). Sample 1 stroma tube shattered in 
the centrifuge during RNA extraction, so no RNA was obtained. Two samples of 
tissue were taken for sample 14 LE. LE= luminal epithelium, S= subluminal stroma, G= 
glandular epithelium.
As detailed in section 4.2.1, the original aim of taking duplicate samples of each 
tissue at four-hourly time points was to investigate whether each tissue had a 
separate peripheral circadian rhythm, as well as confirming tissue-specific marker 
expression and running a microarray. A 500ng RNA sample is required for the pre­
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microarray reverse transcription reaction. 1st strand product can be subsequently 
sampled from this pool after reverse transcription and taken for Taqman®; lOOng at 
a time is then labelled for use for a microarray. As shown in Table 4.2, there was 
insufficient material in each individual sample to perform duplicate microarray and 
Taqman® analysis on each tissue for each time point. This left four options:
1. Combine all time points but not replicates, giving 2 replicates of each of the 
three tissues containing samples from all 7 time-points.
LE (ng) S (ng) G (ng)
Set 1 (samples 1,3,6,7,9,11,13) 
Set 2 (samples 2,4,8,10,12,14)
309
287.9
234.9
291.8
247.8
209.8
Table 4.3: Amount of RNA that would be obtained from making two pools of 
the RNA from samples obtained by laser microdissection of day 5 
pseudopregnant uterus, each pool containing one of the replicates from 
each time point. Values are for luminal epithelium (LE), stroma (S) and 
glands (G) samples in nanograms of RNA (ng).
2. Combine the duplicate biological replicates, giving 7 time points with 2 
replicates in each for each of the three tissues.
ZT Samples L (ng) S (ng) G (ng)
0 9, 10 91.5 65.3 91.6
4 1,2 33.5 25 38.7
8 11,12 94.1 50.3 74.5
12 13,14 151.8 74.3 83.9
16 3,4 77.9 80.9 52.2
20 6 26.1 13.7 22
24 7,8 122 165.2 94.7
Table 4.4
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Table 4.4: Amount of RNA that would be obtained from pooling both of the 
replicates of the RNA from samples obtained by laser microdissection of 
day 5 pseudopregnant uterus sections from each time point sample. Values 
are for luminal epithelium (LE), stroma (S) and glands (G) samples in 
nanograms of RNA (ng).
3. Combine replicates for the early time point samples (ct 0, 4, 8, 12) and late 
time point samples (16, 20, 24) giving two pools for each tissue type.
LE (ng) S (ng) G(ng)
ZT 0-12 (samples 9,10, 1,2,11, 12, 13, 14) 
ZT 16- 24 (samples 3,4,6,7,8)
370.9
226
266.9
259.8
288.7
168.9
Table 4.5: Amount of RNA that would be obtained from making two pools of RNA, 
one containing all samples with a  ZT of between 0-12 and the other containing all 
samples with a ZT of between 16-24, Values are for luminal epithelium (LE), stroma 
(S) and glands (G) samples in nanograms of RNA (ng).
4. Combine ail samples of each tissue type
Sample Total amount of RNA(ng)
Luminal
epithelium 596.9
Stroma 526.7
Glands 457.6
Table 4.6: Amount of RNA that would be obtained from combining all samples from 
each tissue.
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Option 4 was chosen, as it was the only one to yield the 500ng necessary for the 1st 
strand RT reaction. Although this meant that the option of quantifying canonical 
circadian genes in separate uterine tissues over the course of the peri-implantation 
period was now not possible, the primary objective of confirming existing potential 
markers of tissues using Taqman® and searching for new ones using microarrays 
was still possible.
Since the samples were now in a total volume of 120 to 140 pi and needed 
to be in a total volume of 3|jl for the first strand reaction, all samples for each tissue 
were pooled as discussed above, the RNA precipitated using sodium acetate and 
ethanol (section 2.7.2) and resuspended in 3.5pl nuclease-free water. 0.5|jl RNA was 
made into a 1 in 4 dilution (with 1.5|jl nuclease-free water) and quantified using a 
NanoDrop spectrophotometer. The concentrations after precipitation are shown in 
Table 4.7
RNA Concentration of 1 in 4 
dilution (ng/gl) Total amount of RNA (ng)
LE 34.47 413.64
S 20.06 360.96
G 30.08 240.72
Table 4.7: Total RNA available for first strand synthesis, Values are given in 
nanograms per microlitre (ng/fjl) or nanograms (ng) and are calculated using the 
NanoDrop spectrophotometer readings and multiplying by a dilution factor o f 4, 
then by the total volume of the remaining sample. LE= luminal epithelium, S= 
subluminal stroma, G= glandular epithelium.
Microarray 1st strand synthesis (section 2.5.1) was performed on the remaining 3(jl of 
undiluted RNA. Despite none of the samples containing more than 500ng after 
precipitation the first strand reaction was run with the full amount of RNA for each, 
as the concentration would be assessed again after the microarray amplification
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reaction to ensure equal amounts were used for the microarray. After 1st strand 
synthesis, the RNA was in a volume of lOpl. 2pl were taken for cDNA amplification 
for microarray analysis (section 4.4), the other 8jjI were used for reai-time PCR using 
Taqman® (section 4.3).
126
4.3: Confirming specificity of uterine tissue markers using Taqman®
Following RNA extraction and reverse transcription, real-time RT-PCR analysis was 
performed with primer/probe sets for the genes E P z  E P z  Tn-c, LIF and 18s (section
2.7.6) using an MJ DNA Opticon 2 Real-Time PCR machine, and the data obtained 
were analysed using Opticon Monitor Software and Microsoft Excel™ (section
2.7.7). Results are shown below. The technology behind Taqman®, the relative 
merits of different protocols for real-time PCR and how a decision was arrived at on 
which of these to use is discussed in sections 2.7.4 and 2.7.5. The results of the Real- 
Time PCR are discussed in section 4.5.
4.3.1: Luminal epithelium marker- EP2
In Chapter 3, two potential luminal epithelium markers were tested: Osf-2 and EP2. 
Real-time PCR results showed more Osf-2 in the stroma/glands samples than in the 
epithelium samples, so it was removed from consideration as a luminal epithelium 
marker. Thus, only E P 2  was tested on the laser microdissection samples. Results are 
shown in Figure 4.4.
127
450 
400 
350 
300 
250 
200 
150 
100 
50 
0
Figure 4.4: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of EP2 expression to 18s expression in samples consisting of luminal epithelium (LE), 
sub-luminal stroma (S) and glands (G) laser microdissected from frozen sections of 
uterus on day 5 of pseudopregnancy.
In Chapter 3, it was shown tha t LE samples obta ined by manual dissection (and 
therefore potentia lly containing glands and /o r stroma) expressed EP2 a t a high 
level. Stroma and glands samples had com parative ly very low levels of EP2 (less 
than one tenth the value of the epithelium samples). In Figure 4.4, a high level of 
EP2 was shown to  be present in the luminal epithelium (LE) sample. Some EP2 was 
present in the stroma sample (S: 1 /8th of the LE sample) and a negligible am ount in 
the glandular epithelium (G) sample.
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4.3.2: Stromal markers: T n -c  and EP3
In Chapter 3, tw o  potentia l stromal markers were tested: Tn-c and EP3. Real-time 
PCR results showed both Tn-c and EP3 were present a t higher levels in the 
stroma/glands samples than in the LE samples, so both were tested on the laser 
microdissection samples. The aim was to  ascertain whether the markers were 
exclusive to  the stroma or were also expressed in the glands, Results are shown in 
Figures 4.5 and 4.6.
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Figure 4.5: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of Tn-c expression to 18s expression in samples of luminal epithelium (LE), sub­
luminal stroma (S) and glands (G) laser microdissected from frozen sections of 
uterus on day 5 of pseudopregnancy.
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In Chapter 3, it was shown tha t stroma/glands samples expressed Tn-c a t a high 
level. LE samples had com parative ly very low levels of Tn-c. From these results it 
could not be determ ined whether the expression of EP3 was in the stroma, the 
glands or both. In Figure 4.5, a high level of Tn-c was present in the stroma sample 
(S). Some Tn-c was present in the glands (G) and LE samples (around 1 /8 th of the 
level in the stroma sample).
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Figure 4.6: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of EP3 expression to 18s expression in samples of luminal epithelium (LE), sub­
luminal stroma (S) and glands (G) laser microdissected from frozen sections of 
uterus on day 5 of pseudopregnancy
In C hapter 3, it was shown tha t stroma/glands samples expressed EP3 a t a higher 
level than their corresponding paired LE samples, but from these results it could not 
be established whether the expression of EP3 was in the stroma, the glands or both. 
In Figure 4,6, a high level of EP3 was present in the stroma sample. No EP3 was 
present in the LE and a negligible am ount was present in the glandular epithelium 
sample.
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4.3.3: Glandular epithelium marker- LIF
In C hapter 3, LIF was tested as a potentia l g landular epithelium marker. Real-time 
PCR results showed more LIF in stroma/glands samples than luminal epithelium 
samples. It could not be ascertained whether LIF was exclusively expressed in the 
glandular epithelium, as pure samples could not be obta ined  from m echanical 
dissection. Laser microdissection gave pure samples to  be tested for specificity of 
LIF using Taqman®. The results are shown in Figure 4.7.
Tissue type
Figure 4.7: Results obtained by Real-time RT-PCR using Taqman®, showing the ratio 
of LIF expression to 18s expression in samples of luminal epithelium (LE), sub-luminal 
stroma (S) and glands (G) laser microdissected from frozen sections of uterus on 
day 5 of pseudopregnancy.
In C hapter 3, it was shown tha t stroma/glands samples expressed LIF a t a slightly 
higher level than LE samples. LE levels of LIF were around half to  three-quarters of
131
the level expressed in the corresponding paired stroma/giands samples. From these 
results it could not be determined whether the expression of LIF was specifically in 
the glands, or in more than one uterine tissue. In Figure 4.7, a comparatively high 
level of LIF was present in the glands sample. No LIF was present in the LE or stroma 
samples.
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4.4: Searching for new uterine tissue markers using microarrays
4.4.1: Running the microarray
2pl of the 1st strand reaction volume was amplified for 15 cycles using the SMART™ 
PCR cDNA Synthesis kit. 21 pi of the final volume of 1 OOpil was then labelled by 
incorporation of cy3-dCTP and purified (section 2.5.1). 21 pi of RNA from pooled 
luminal epithelium (PLE, a pool of manually dissected luminal epithelium taken from 
five mice at each of the following time points: day 3 21:00, day 4 9:00, day 4 21:00, 
day 5 9:00 and day 5 21:00) was labelled with cy5-dCTP and used as the reference. 
Incorporation of the dyes was checked using a NanoDrop spectrophotometer to 
measure absorbance at 550nm for cy3 and 649nm for cy5.
The concentration of cDNA in each pool was too low to hybridise to more than one 
array for each condition, so 63jjI of the remaining amplified cDNA were amplified 
and labelled. This gave enough labelled cDNA to hybridise to three array 
experiments for each of the conditions: one from the first labelling attempt and two 
from the second, as summarised in Table 4.8. The cy3 and cy5 labelled products 
were combined, precipitated and hybridised (section 2.5.1) to 
RFCGR_HGMP_Mouse_Mm_SGC_Av2 array chips (section 2.1.2). Slides were 
scanned on a Genepix Axon scanner and imported into Bluefuse for analysis. A 
summary of the microarray analyses undertaken is shown in Table 4.8.
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Sample
First attempt 
cDNA (ng/pl)
Chips
hybridised
Second
attempt cDNA 
(ng/pl)
Chips
hybridised
Reference 138.8 3 726.67 6
LE 26.53 1 773.9 2
G 352.08 1 759.8 2
S 317.22 1 767.89 2
Table 4.8: A summary of the amount of labelled cDNA generated for hybridising to 
the microarray chips, and the number of chips that were hybridised using each 
pool of cDNA. LE= luminal epithelium S= stroma' G= glandular epithelium.
4.4.2: Analysing the microarray
The data generated by Bluefuse were analysed and filtered as detailed in section 
2.5.2. Condition Tree analysis was performed. This showed that the tissue specific 
gene expression profiles from the three arrays obtained from the first set of labelling 
were very different from the profiles generated by the two arrays run from the 
second set of labelling. It was decided that analysis would concentrate on the six 
chips obtained from the second set of labelling experiments, as the duplicated runs 
allowed data obtained to be verified.
Lists of genes apparently upregulated ('Up' gene lists) from both of the 
arrays performed on each tissue were combined in Microsoft Excel™ and a pivot 
table created to show how many of the four possible addresses for each gene 
were classed as up-regulated. The 'Down' gene lists (genes apparently down- 
regulated) were also amalgamated in this way, giving six pivot tables in all. Data 
for all of the six chips were then merged and a further pivot table generated. This 
allowed the genes that were specifically up or down-regulated in one tissue but 
not in other tissues to be selected. Since each gene is represented by two 
addresses and each tissue by two chips, there were a total of four sets of data for
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each gene in each tissue. Genes that were present in 4 or 3 out of the 4 addresses 
of one or two tissues but in one or none of the addresses of the other tissues were 
considered specifically up/down-reguiated.
Information on each gene was sought from a variety of sources, including 
Pubmed (www.pubmed.net), the Jackson Laboratory website (www.jax.org), and 
Embl Bioinformatics Harvester (http://harvester.embl.de/). If the gene itself, its gene 
family or a process it is involved in had previously been investigated in the uterus it 
was designated 'previously investigated'. The literature referring to the genes in 
these lists will be discussed further in section 4.2.2. Genes identified in this way are 
listed in Tables 4.9 to 4.19 and their functions classified in Table 4.20.
Gene name Accessionnumber Description
Previously
reported?
DNMT1 associated 
protein-1 ([Dmapl)
AF265229 Transcription factors & 
DNA/chromatin modifiers
No
Claudin 4 (Cldn4) NM_009903 Associated with cell adhesion & junctions
Yes
Cleavage and 
polyadenylation 
specificity factor 1 (Cpsfl)
NMJD08484 RNA processing No
Formin binding protein 4 
(Fnbp4)
NM_018785 Cytoskeletal No
Laminin, beta 3 (Lamb3) NM_008484 Associated with cell adhesion & junctions
Yes
Per-hexamer repeat gene 
5 (Phxr5)
NMJD08836 Other No
Transcription factor 2 
(Jcf2)
NM.009330 Transcription factors and 
DNA/chromatin modifiers
Yes
Table 4.9: Genes up-regulated in the LE samples, showing gene name (and 
acronym if used), GenBank Accession number, a brief description o f its function 
and whether it has been previously reported in literature or gene databases as 
being involved in implantation.
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Gene name Accessionnumber Description
Previously
reported?
BALB/c elongation factor 
2
U89415 Translation related No
1 -acyl-sn-glycerol-3- 
phosphate
acyltransferase (Agaptl)
NM_018862 Other
metabolism/catabolism
Yes
TNF receptor-associated 
factor 1 (Jrafl)
NIVL009421 Apoptosis Yes
Regulated secretory 
protein-23
U64446 Endomembrane pathway No
Solute carrier family 1, 
member 7 {Sicla7)
NM_009201 Ion transport and binding Yes
Transcytosis associated 
protein p i 15
AF096868 Endomembrane pathway No
Table 4.10: Genes up-regulated in the glandular samples, showing gene name 
(and acronym if used), GenBank Accession number, a brief description of its 
function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
Gene name Accessionnumber Description
Previously
reported?
Microtubule-actin 
crosslinking factor (Macf)
AF150755 Cytoskeletal No
Table 4.11: Genes up-regulated in the stromal samples, showing gene name (and 
acronym if used), GenBank Accession number, a brief description of its function 
and whether it has been previously reported in literature or gene databases as 
being involved in implantation.
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Gene name Accession
number
Description Previously
reported?
Poly(A) binding protein, 
nuclear 1 (Pabpn 7)
NM_019402 RNA processing No
Bright and dead ringer 
gene product 
homologous protein Bdp 
(LOC56380)
NM_019689 Transcription factors and 
DNA/chromatin modifiers
No
GTP binding protein 2 
(Gtpbp2)
NM_019581 Translation related No
Hypermethylated in 
cancer 1 (H id)
NM_010430 Cell cycle and oncogene No
Table 4.12: Genes up-regulated in the LE and glandular samples, showing gene 
name (and acronym if used), GenBank Accession number, a brief description of its 
function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
Gene name Accession
number
Description Previously
reported?
Beta-galactoside AF153680 Endomembrane pathway Yes
alpha2,6-sialyltransferase (St6gal 7)
Alpha-2 type IV collagen J04695 Extracellular matrix Yes
Table 4.13: Genes up-regulated in the glandular and stromal samples, showing 
gene name (and acronym if used), GenBank Accession number, a brief description 
of its function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
Gene name Accession
number
Description Previously
reported?
Ribosomal protein LI 0A 
CRpllOa)
NM_011287 RNA processing Yes
Table 4.14: Genes up-regulated in the LE and stromal samples, showing gene name 
(and acronym if used), GenBank Accession number, a brief description of its 
function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
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Tables of genes specifically down-regulated in one or two of the three tissues of 
interest
Gene name Accession
number
Description Previously
reported?
Proteasome (prosome, 
macropain) subunit, 
alpha type 6 (Psma6)
NM_008946 Protein
metabolism/catabolism
No
Zinc finger protein 162 
CZfpl62)
NM_011750 RNA processing No
Mouse 1400 base pair 
ubiquitin
M81747 Protein
metabolism/catabolism
Yes
Table 4.15: Genes down-regulated in the LE samples, showing gene name (and 
acronym if used), GenBank Accession number, a brief description of its function 
and whether it has been previously reported in literature or gene databases as 
being involved in implantation.
Gene name Accession Description Previously
number reported?
Ubiquitin C (Ubc) NM_019639 Protein
metabolism/catabolism
Yes
Table 4.16: Genes down-regulated in the glandular samples, showing gene name 
(and acronym if used), GenBank Accession number, a brief description of its 
function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
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Gene name Accession
number
Description Previously
reported?
Hypothetical protein, 
clone:2-31 (LOC57423)
NM_020582 Ion transport and binding No
Claudin 4 (C/c/n4) NM_009903 Associated with cell 
adhesion & junctions
Yes
Complement 
component 1 inhibitor 
(C/nh)
NM_009776 Immune function Yes
Cytochrome c oxidase, 
subunit IV (Cox4)
NMJD09941 Mitochondrial and 
oxidation/reduction
Yes
Tumor protein D52 
(Tpd52)
NMJD09412 Cell cycle and oncogene No
Table 4.17: Genes down-regulated in the stromal samples, showing gene name 
(and acronym if used), GenBank Accession number, a brief description o f its 
function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
Gene name Accession
number
Description Previously
reported?
Cd63 antigen (Cd63) NM_007653 Endomembrane pathway Yes
Transketolase (Tkf) NM_009388 Other No
metabolism/catabolism
Table 4.18: Genes down-regulated In the glandular and stromal samples, showing 
gene name (and acronym if used), GenBank Accession number, a brief description 
of its function and whether it has been previously reported in literature or gene 
databases as being involved in implantation.
Gene name Accession Description Previously
number reported?
Calpain 4 (Capn4) NM_009795 Protein
metabolism/catabolism
Yes
Table 4.19: Genes down-regulated in the LE and stromal samples, showing gene 
name (and acronym if used), GenBank Accession number, a brief description of its 
function and whether it has been previously reported in literature or gene 
databases as being in volved in implantation.
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The results of this system of filtering did not contain E P z  E P z  Tn-c and LIF: the 
markers that had earlier been verified for each tissue. Ribosomal proteins were also 
present in the lists, even though their expression levels are known to be constant in 
changing conditions. These results raised the prospect of the chip data being 
unreliable and the genes being identified by chance. The data were therefore 
investigated further to test this possibility.
Firstly, the paired chip data files were searched for the tissue markers E P z  
E P z  Tn-c and LIF. Since each gene is represented by two addresses and each tissue 
is represented by two chips, there were a total of four sets of data for each gene in 
each tissue. Although all of the data from the marker gene addresses would be 
filtered out because they were designated confidence levels of less than 0.5, most 
of the data would have been filtered out before that because the fluorescence 
levels in the cy3 or cy5 channels were below the 150 used as a cut off point for 
valid data (data not shown). Despite all values being under 150, the fluorescence 
levels found for E P 2  in the cy5 channel (the labelled reference) were at least twice 
as high as the other fluorescence values. This is probably because the reference is 
pooled luminal epithelium and would be expressing E P2  strongly. But the levels of 
cy3 for E P2  in the luminal epithelium chips (where it is expected to be high) is much 
lower than the reference, This implies that the laser microdissected tissue is not 
expressing EP2  sufficiently. The implications of this are discussed in section 4.5. 
Because of these results the markers cannot be used to validate the micro array 
data.
Each chip contains 14 genes that are repeated 48 times. These genes are 
housekeeping genes that should theoretically be consistently expressed in all tissues 
and conditions. The percentage of the 288 addresses over 6 chips for each control 
gene that have confidence levels above 0.5, and the average and standard 
deviation of the log cy3/cy5 ratios for these addresses were collated (data not
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shown), The results are varied; some genes have a relatively high percentage of 
addresses above 0,5, an average log cy3/cy5 close to 0 and a small range of 
values (as would be expected for a control gene), such as L3 and Rps4,x. Other 
genes have very few addresses registering a confidence level above 0.5. Since the 
control genes are supposed to be consistently expressed across all tissues and 
conditions this may mean that the data are not reliable.
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4.5: Discussion of Chapter 4
4.5.1: Discussion of real-time PCR data
Although relative, rather than absolute differences in the expression level of 
markers are seen with the quantitative real-time RT-PCR on the laser 
microdissection samples, they are more likely to reflect genuine differences in 
expression level than contamination, but elimination of contamination cannot 
formally be shown from this work.
Since Osf-2 was eliminated early in the work, as reported in Chapter 3, as a 
potential marker for the luminal epithelium, the only epithelial marker tested on 
laser microdissected samples was EP2. In Chapter 3, it was shown that LE samples 
obtained by manual dissection (and therefore potentially containing glands 
and/or stroma) expressed E P2  at a high level. Stroma/glands samples had 
comparatively very low levels of E P 2  (less than one tenth the value of the epithelium 
samples). Figure 4.4 shows that a high level of EP2  was present in the luminai 
epithelium sample. Some E P 2  was present in the stroma sample (1 /8th of the LE 
sample) and a negligible amount in the glandular epithelium sample. Since the 
laser microdissection samples are pure samples of tissues, the low levels of E P 2  in the 
manually dissected samples of stroma/glands is likely to be from the stromal tissue 
in these samples. It is therefore a good marker to check that luminal epithelium 
tissue has been obtained from a manual dissection, but not to test stroma/glands 
samples for the presence of luminal epithelium tissue.
Two markers were tested in Chapter 3 as potential stromal markers. 
Stroma/glands samples were enriched for both EP3  and Tn-c compared to luminal 
epithelium samples. From these results it could not be determined whether the 
expression of these markers was in the stroma, the glands or both. Since previously 
published results found EP3  to be present in the myometrium of pseudopregnant 
mice and not in the stroma or glands at all (Katsuyama et al., 1996), there was also
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the possibility of myometrial contamination. Figure 4.5 shows that a high level of Tn- 
c  was present in the stroma sample. Some Tn-c was present in the glands and LE 
samples (around 1 /8th of the level in the stroma sample. Figure 4.6 shows that a 
high level of EP3  was present in the stroma sample. No EP3  was present in the LE and 
a negligible amount was present in the glandular epithelium sample. This result 
confirms that EP3  is expressed in the stroma, and not the glands or luminal 
epithelium. Since myometrial samples were not taken for Taqman® analysis, 
myometrial contamination in the manually dissected samples cannot be ruled out, 
but the laser microdissected samples are pure and express high levels of E P 3 . This 
result confirms that the stroma is an independent source of EP3, contradicting 
previously published results (Ichikawa, 2003). This may be because the previous 
study used in situ hybridisation, which is less sensitive than real-time PCR. Since both 
EP3  and Tn-c are expressed predominantly in the stroma, they are both potential 
markers for contamination of luminal epithelium by stroma in mechanical 
dissections. However, Tn-c appears to have a low expression level in LE and GE, 
making EP3  the better marker if the sample is required to be ultra-pure.
In Chapter 3, it was shown that stroma/glands samples expressed LIF at a 
slightly higher level than LE samples. LE levels of LIF were around half to three- 
quarters of the level expressed in the corresponding paired stroma/glands samples. 
From these results it could not be elucidated whether the expression of LIF was 
specifically in the glands, or in more than one uterine tissue. Figure 4.7 shows a 
comparatively high level of LIF was present in the glands sample. No LIF was 
present in the LE or stroma samples. This result confirms that LIF is expressed 
exclusively in the glandular epithelium, making it a good marker for relative 
composition of uterine tissue dissections. Chapter 3 results on late day 4 and late 
day 5 samples imply that there is glandular contamination in the majority of 
manually dissected luminal epithelium samples. However, since the epithelium 
becomes 'stickier' as pseudopregnancy advances, cleaner sample preparations
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may be obtained by taking samples at slightly earlier times. These problems are 
discussed further in Chapter 6.
It would not be possible to identify an unknown tissue sample exclusively 
from testing the levels of these four markers on it because of the problem of relativ 
expression levels. The raw fluorescence levels (see section 2.7.7) for E P 2  and Tn-c 
were relatively high, as shown by the units on the y axis of Figures 4.4 and 4.5. The 
raw fluorescence levels for EP3  were slightly lower, and those for LIF were very low. 
Although the LIF level for glands is high when compared with the levels for stroma 
or LE, the raw fluorescence level is much lower than the other markers, so a glands 
sample would have a lower Ct for EP2, EP3  and Tn-c than for LIF. Raw fluorescence 
level is not necessarily an indicator of the expression levels of the gene of interest, 
although if the efficiency of the assay is close to 100% and the standard curve used 
is the same for each run, then it may be. But Taqman® runs vary from one run to 
the next, and it is not possible to compare two samples that were not run on the 
same plate, with the same reagents.
4.5.2: Discussion of microarray data
When looking to analyse the data generated by the microarray, the reference 
used must be taken into consideration. The reference used was taken from a pool 
of manually dissected luminal epithelium taken from five mice at each of the 
following time points: day 3 21:00, day 4 9:00, day 4 21:00, day 5 9:00 and day 5 
21:00. A reference taken from a pool of whole uterus would have been preferable, 
as comparisons between the levels of expression in each tissue compared to the 
uterus as a whole would have been possible. But the results can still be interpreted 
when using luminal epithelium as a reference. The analysis is simple when looking at 
genes exclusively up or down regulated in glands, stroma or glands and stroma. 
Since the luminal epithelium is the reference used to judge whether they are up or
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down regulated, a gene found to be exclusively up regulated in the glandular 
epithelium compared to the reference luminal epithelium can also be thought of 
as being down regulated in the reference luminal epithelium compared to the 
glands. When considering the gene lists where genes appear to be up or down 
regulated in the laser capture luminal epithelium compared to the reference 
luminal epithelium or luminal epithelium and stroma or glands, the analysis is slightly 
less clear-cut. The pooled luminal epithelium is taken from time points that are, on 
average, earlier in the luteal phase of pseudopregnancy (samples average is day 
5, reference average is day 4 21:00), so the comparison is between the laser 
microdissected luminal epithelium taken around and just after the window of 
implantation, and the reference luminal epithelium with an average time of just 
before the window of implantation. So a gene that appears to be up-regulated in 
test laser microdissected LE is up-regulated in comparison to an earlier time point, 
or a gene that appears to be down-regulated in test laser microdissected LE is 
down-regulated in comparison to an earlier time point.
Filtering the microarray data as described in section 4.4.2 generated lists of 
genes up or down regulated in one or two uterine tissues. Information on each 
gene was sought from a variety of sources, including Pubmed (www.pubmed.net), 
the Jackson Laboratory website (www.jax.org), and Embl Bioinformatics Harvester 
(http://harvester.embl.de/). If the gene itself, its gene family or a process it is 
involved in had previously been investigated in the uterus it was designated 
'previously investigated'. It was found that 14 out of 31 genes had previously been 
investigated in the uterus. Their expression patterns were then analysed in the 
context of the reference. The gene functions are summarised in Table 4.20 and 
further discussed below.
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Class of gene function Number of Previously
genes Investigated
Associated with cell adhesion & junctions 2 2
Cytoskeletal 2 0
Extracellular matrix 1 1
Ion transport and binding 2 1
Transcription factors and DNA/chromatin modifiers 3 1
Apoptosis 1 1
Cell cycle and oncogene 2 0
Protein metabolism/catabolism 3 2
Other metabolism/catabolism 2 1
Mitochondrial and oxidation/reduction related 1 1
RNA processing 4 1
Translation related 2 0
Immune function 1 1
Endomembrane pathway 4 2
Other 1 0
Total 31 14
Table 4.20: Classification of genes identified by microarray into categories 
describing their function, showing the number of genes that are classified by each 
category, and, o f these, the number that have been previously implicated in 
implantation.
It is interesting to note that none of the genes were described by these three 
categories: Growth factors & hormones, Receptors and associated molecules and 
Second messengers and intra-cellular signalling. These categories contain genes 
such as the steroid hormone receptors for oestrogen and progesterone, the 
cytokine LIF and the growth factor HB-EGF that have previously been a focus of 
implantation research, yet are not present in these microarray results. These genes 
have very specific roles in implantation and when they are knocked out or 
mutated they often result in an infertile phenotype (see discussions on previous 
literature in Chapter 1). The genes identified by this microarray are mainly coding 
for proteins such as enzymes and transcription factors, which may have functional
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redundancy: their lost activity is compensated for by the activity of a different 
gene or genetic pathway. If so, null mutations in these redundant genes are 
unlikely to give an infertile phenotype, as other genes will compensate for their 
activity, so it would have been unlikely that they were identified in functional 
studies.
Genes found in more than one of the microarray lists
Of these genes, only claudin 4 has been previously associated with implantation. 
Claudin 4 (Cldn4) was present in both the 'up-regulated in LE' and the 'down- 
regulated in stroma' lists. Because of the reference used it is both up-regulated in 
day 5 pseudopregnant luminal epithelium with respect to luminal epithelium from 
an earlier time point, as well as being down-regulated in stroma with respect to 
luminal epithelium from an earlier time point. Claudin 4 is a protein found in the 
tight junctions mediating intercellular adhesion. Tight junctions have been found to 
be induced as a transitory permeability barrier created by decidual cells 
immediately surrounding the implanting embryo (Wang et al„ 2003). Cldnl 
transcripts are found at low levels in the luminal epithelium on day 4 of pregnancy. 
After implantation on day 5, Cldn 1 is found in the luminal epithelium and stromal 
cells surrounding the blastocyst (Wang et al., 2003). Cldn4 has been identified by 
microarray in two studies as up-regulated in receptive compared to prereceptive 
human endometrium (Riesewijk et al., 2003); (Carson et al., 2002). Its transcript has 
been verified as being expressed in luminal epithelium by immunohistochemistry 
(Carson et al., 2002).
Genes up-regulated in the LE samples (Table 4.9)
Among those previously identified in or associated with implantation are laminin 
beta 3 and transcription factor 2, and several that have not been involved in this
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process: Dam nuclear methyltransferase, Cleavage and polyadenylation 
specificity factor 1, Formin binding protein 4 and Per-hexamer repeat gene 5.
Laminin, beta 3 (Lamb3) is part of the extracellular matrix in the uterus. It is a 
well-characterised adhesion molecule in implantation, binding to a variety of 
molecules including integrins (Aplin, 1997). Previous microarray studies show that 
Lomb3 is up-regulated in human receptive endometrium compared to late 
proliferative phase (Kao et al., 2002). Lamb3 has also been identified in two 
previous microarray studies as being down-regulated by chronic progesterone 
treatment in the uterus (Jeong et al., 2005) and up-regulated after treatment with a 
progesterone inhibitor (Cheon et al., 2002), By comparing the microarray data to 
the reference, it can be concluded that Lamb3 is up-regulated in the luminal 
epithelium compared to luminal epithelium from an earlier time point, which 
correlates with previous data.
Transcription factor 2 (Tcf2) is a transcription factor previously found to be 
regulated in the luminal epithelium of pseudopregnant mice, showing a gradual 
increase in expression from late day 3 to late day 5 (Campbell et al.)
Genes not previously identified in implantation but shown here to be 
upregulated are as follows: DNMT-associated protein; Dam nuclear
methyltransferase is a histone methyltransferase. Although DNMT has not been 
specifically characterised in the uterus, another histone/protein methyltransferase is 
required for optimal estrogen response in female reproductive tissues (Carling et 
al., 2004). Cleavage and polyadenylation specificity factor 1 (Cpsfl) is involved in 
post-transcriptional processing of RNA (Murthy and Manley, 1995). Formin binding 
protein 4 (Fnbp4) is a protein that binds Formin, a regulator of actin assembly 
(Kovar, 2006). Per-hexamer repeat gene 5 (Phxr5) is a member of the Per hexamer 
repeat genes which are murine homologues of hexamer repeats associated with 
the Drosophila period gene, a component of the circadian clock (Shin et al., 1985).
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Genes up-regulated in the glandular samples (Table 4.10)
Up-regulated genes previously identified in or associated with implantation include 
Agpat 1, TNF receptor-associated factor 1, and Solute carrier family 1, member 7. 
Those not previously implicated in implantation include BALB/c elongation factor 2, 
Regulated secretory protein-23, and Transcytosis associated protein p i 15.
Agpatl (1-acyl-sn-glycerol-3-phosphate transferase) converts LPA
(lysophosphatidic acid or 1-acyl-sn-glycerol-3-phosphate) into phosphatidic acid. 
It is an important enzyme in the generation of glycerolipids. Although Agpatl itself 
has not been fully investigated in the uterus, LPA is known to be involved in 
downstream activation of implantation genes such as Cox-2 and HB-EGF (Shah 
and Catt, 2005).
TNF receptor-associated factor 1 (Trafl): The TNF-alpha signalling pathway 
has been previously documented in implantation. It is thought to be involved in 
apoptosis of epithelial cells (Joswig et al., 2003). TRAFs are a family of proteins that 
associate with TNF-alpha receptors. TRAF1 has been shown to be a negative 
regulator of TNF-alpha signaling (Tsitskov et al., 2001). Although Trafl transcript has 
not been shown to be present in the uterus, Traf5 is known to be regulated in the 
luminal epithelium over the peri-implantation period, with a gradual increase over 
the window of receptivity (Campbell et al.).
Solute carrier family 1, member 7 (Slcla7) is a glutamate transporter with 
around 40% homology to other members of the solute carrier family 1 protein 
family. It has not previously been characterised in the uterus but has been 
characterised in the retina (Arriza et al., 1997). However, S lc la l has been identified 
by microarray as being up-regulated during secretory phase of the human 
menstrual cycle (Riesewijk et al., 2003), and Slcla5 is down-regulated in response to 
progesterone treatment in the uterus (Jeong et al., 2005).
Other genes identified in this group have not been previously implicated in 
the process of implantation. BALB/c elongation factor 2 is a translation elongation
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factor in protein synthesis (Chu and Paul, 1998). Regulated secretory protein-23 is 
also known as storage granule protein-23. It is involved in the endomembrane 
secretory pathway (Lang et al., 1996). Transcytosis associated protein p i 15 is a 
general fusion factor required for binding of vesicles to acceptor membranes . It is 
not surprising that both regulated secretory protein-23 and transcytosis associated 
protein p i 15 are up-regulated in secretory glandular epithelium as both are 
involved in the endomembrane secretory pathway, which is highly active in 
glandular epithelium.
Genes up-regulated in the stromal samples (Table 4.11)
Microtubule-actin crosslinking factor (Macf) is an actin/calcium binding protein, 
and has not previously been identified in implantation (Leung et al., 1999).
Genes up-regulated in the LE and glandular samples (Table 4.12)
Several genes are in this group that have not previously been identified in 
implantation. Poly(A) binding protein, nuclear 1 (Pabpnl) is involved in poly-Atail 
synthesis of mRNAs (Marie-Josee Sasseville et al., 2006). Bright and dead ringer 
gene product homologous protein Bdp (LOC56380) binds to AT rich sequences 
called ARIDs (Kortschak et al., 2000). GTP binding protein 2 (Gtpbp2) is a putative 
GTPase structurally related to peptidyl elongation factors (Kudo et al., 2000). 
Hypermethylated in cancer 1 (Hicl) is a tumour suppressor gene (Chen et al.,
2003).
Genes up-regulated in the glandular and stromal samples (Table 4.13)
Two of these genes have previously been identified in or associated with 
implantation: Beta-galactoside alpha2,6-sialyltransferase and Alpha-2 type IV 
collagen.
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Beta-galactoside alpha2,6-sialyltransferase (St6gall):Sialyltransferases add 
sialic acid residues to proteins. Glycoproteins play an important role in receptivity 
and implantation. A layer of glycoproteins known as the glycocalyx is present on 
the apical surface of the pre-receptive luminal epithelium to prevent premature 
attachment of the embryo to the luminal epithelium. As the implantation window 
begins the glycocalyx becomes thinner (Carson et al., 1998). Alpha 2-6 linked sialic 
acid residues are reduced in the luminal epithelium around the time of 
implantation, although stromal residues remain constantly high (Kimber et al., 
2001). St6gall has also been shown to be expressed in the luminal epithelium over 
the implantation period, with an expression pattern that decreases from late day 3 
to late day 5 (Campbell et al.). Since the reference used is luminal epithelium, 
St6gall can be said to be down-regulated in luminal epithelium with respect to 
glands and stroma, meaning fewer glycosylated proteins and a thinner glycocalyx. 
This correlates with previous research (Carson et al., 1998).
Alpha-2 type IV collagen encodes one of the six subunits of type IV 
collagen, a major structural component of epithelial basement membranes. 
Extracellular matrix proteins such as type IV collagen, laminin and fibronectin, are 
ligands for integrins. Integrins are expressed in both the basement membrane of 
epithelium and the trophoblast of the embryo and are important adhesion 
molecules of implantation (Kimber and Spanswick, 2000).
Genes up-regulated in the LE and stromal samples (Table 4.14)
Ribosomal protein LlOa has been previously identified in or associated with 
implantation . It is identified by SAGE (Serial Analysis of Gene Expression) as being 
highly up-regulated at the implantation site in whole mouse uterus (Ma et al., 2006). 
Ribsomal proteins have previously been thought to be 'housekeeping' genes, 
ubiquitously expressed in all tissues (Eisenberg and Levanon, 2003).
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Genes down-regulated in the LE samples (Table 4.15)
Mouse 1400 base pair ubiquitin has previously been identified in or associated with 
implantation. It appears to be the 5' end of Ubiquitin C, and is used uniquely in this 
microarray. The role of Ubiquitin in implantation is detailed below. Zinc finger 
protein 162 (Zfpl62), also known as Zfml and Sfl (splicing factor 1), has not 
previously been identified in implantation. It has been shown to be down-regulated 
in smooth muscle cells treated with lnterleukin-1 beta and TNF alpha (Cattaruzza et 
al., 2002). Another gene not previously implicated in implantation is Proteasome 
(prosome, macropain) subunit, alpha type 6 (Psma6). This gene is a subumit of the 
ubiquitin-26s proteasome system, the essential cellular complex that digests 
proteins into short polypeptides and amino acids (Coux et al., 1996).
Genes down-regulated in the glandular samples (Table 4.16)
Expression of genes involved in the ubiquitin proteasome pathway have been 
reported in early pregnancy in several animals, but the system has not been fully 
elucidated. Down-regulation of ubiquitin C appears to inhibit embryo implantation 
by down-regulating matrix metalloproteinases involved in remodelling of the uterus 
during early pregnancy (Wang et al., 2004).
Genes down-regulated in the stromal samples (Table 4.17)
Two identified genes have previously been identified in or associated with 
implantation: Complement component 1 inhibitor and Cytochrome c oxidase, 
subunit IV. Complement component 1 inhibitor (Clnh); is a Cl inhibitor that 
regulates the first component of complement (C l) by inhibition of the proteolytic 
activity of its subcomponents C lr and Cl s. This inhibits downstream activation of 
other complement components. Cl inhibitor also inhibits several other serine 
proteinoses including kallikrein. Clnh has been found to be down-regulated by a 
progesterone inhibitor in a microarray study (Cheon et al., 2002) and kallikrein has
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been found to be down-regulated by chronic progesterone treatment (Jeong et 
al., 2005). Cytochrome c oxidase, subunit IV (Cox4): Cytochrome c oxidase is part 
of the mitochrondrial electron transport chain of respiration. Another subunit of 
cytochrome c oxidase, subunit VIII has been found to be present in the luminal 
epithelium of early pseudopregnant mice, peaking at early day 4 (Campbell et 
al.).
Other genes identified here have not previously been identified in 
implantation. Hypothetical protein, clone:2-31 (LOC57423) is a synonym for ATP 
synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2 (Leyva et 
al., 2003). Tumor protein D52 (Tpd52) gene was initially identified as being 
overexpressed in human breast, lung, and prostate carcinomas. The function of its 
proteins is unclear (Byrne et al., 1998).
Genes down-regulated in the glandular and stromal samples (Table 4.18)
Cd63 antigen has been previously identified in or associated with implantation. It is 
a lysosomal membrane protein, and has been identified by a PCR differential- 
display method as being down-regulated by progesterone (but not oestrogen) in 
human endometrial stromal cells (Okada et al., 1999). Cd63 has also been 
identified by SAGE as up-regulated at implantation sites (compared to inter­
implantation sites) in mouse uterus, and subsequently localised to the subluminal 
stroma cells (Ma et al., 2006). These two results are apparently contradictory, but 
the later study uses pregnant uteri, whereas the earlier study is equivalent to human 
secretory phase (receptive) endometrium. The presence of an embryo changes 
gene expression in the uterus (as summarised in section 1.2.1). Cd63 has also been 
found to have a gradual increase in luminal epithelium from day 3 to day 5 of 
pregnancy (Campbell et al.).
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Transketolase (Tkt) has not previously been identified in implantation. It is an 
enzyme involved in both the Pentose Phosphate Pathway and the Calvin Cycle of 
photosynthesis (Alberts, 2002),
Genes down-regulated in the LE and stromal samples (Table 4.20)Ca!pain 4 has not 
previously been found in the uterus/though two other calpains have: Calpain 6 
(Jeong et al., 2005) and Calpain 7 (Yoon et al., 2004).
When interpreting microarray data the way the data are filtered can make a 
significant difference to the results generated. The filtering method used in this array 
has previously been employed (Campbell et al.). To make sure that real results are 
not being overlooked because of the filtering method used, four alternative ways 
of filtering the data were tested. One of the alternative filtering methods differed 
by the chip data entered into the analysis, two of the alternative filtering methods 
differed by the filtering of raw data and one differed by the subsequent analysis of 
filtered raw data using pivot tables.
Method 1 is to add the initial 3 chips to the analysis. As shown in Table 4.8, 
an initial chip was run with the cDNA obtained from each tissue type then 
subsequently another two chips were run for each tissue type. The data filtering in 
the analysis used for this array was performed using only the second pair of 
replicate chips for each tissue, because the data extracted from the first set of 
chips were shown to be very different from the paired replicates using a function of 
Genespring called Condition Trees.
Method 2 is to use results that have a ‘C ’ flag or above rather than a ‘0.5’ 
confidence level or above. Bluefuse ranks each address with a confidence level 
(expressed as a decimal) as well as a confidence grade (from A to E) based on the 
reliability of the raw fluorescence data at that address. Addresses with a 
confidence level of 0.5 or under were rejected in this study, although the
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confidence grade 'C ' ranges from 0.3 to 0.7. So filtering was repeated with 
rejection of any address with confidence level below C grade.
Method 3 is to remove the initial filtering steps. The initial filtering steps 
involve removing all data from the analysis that have raw fluorescence values 
lower than 250 arbitrary units and a confidence level lower than 0.5, then classing 
genes with log-2 ratios of cy3/cy5 greater than 1 or less than -1 as up or down 
regulated. The aim of filtering the data in this way was to remove false positives 
from the analysis, but it was also likely to be removing true positives from the 
analysis if their expression level was not strong enough to show a fluorescence level 
above 250 arbitrary units. In order to let these genes through, the confidence and 
fluorescence level filtering could have been removed.
Method 4 is to change the pivot table parameters. In order to categorise 
genes that are specific to each tissue, a pivot table method was applied to the 
resulting lists of up or down regulated genes for each chip. Each gene had a total 
of 4 addresses over two chips representing each tissue type. If a gene appeared in 
3 or 4 of the addresses for one tissue and only 0 or 1 of the addresses for the other 
tissues, it was considered up/down regulated for that condition. The stringency of 
the filtering was relaxed so that genes found in 4, 3 or 2 of the addresses for that 
tissue and 0 or 1 of the addresses for other tissues were considered up/down 
regulated.
Although the methods detailed above allow genes through that may be 
significant but were scored as false by Bluefuse (so called 'false negatives')/ they 
also allow more genuine negatives to be let through by the filter. Because of this, 
the subsequent pivot table filtering is compromised. The original method of filtering 
used in this array appeared to be the most reliable after some testing of the other 
options.
A problem encountered during this array analysis was that the tissue 
specific markers under investigation in the previous chapters did not appear in the
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gene lists, and were in fact filtered out by both flag and raw fluorescence level in 
the initial data filtering steps. As discussed in section 4.4.2, most of the markers fail to 
survive the filtering because of both low raw fluorescence values and low 
confidence levels. The raw fluorescence value does have some impact on the 
confidence level. Low fluorescence levels in both the reference and the sample 
channels implies that the transcript is present at very low levels in the populations of 
cDNA hybridised to the chip. A reason for this could be that their expression levels 
in the uterus are very low. Quantitative real-time RT-PCR, as used earlier in this 
chapter and in Chapter 3, is a very sensitive technique that can pick up expression 
at very low levels. The microarray technology may not be sensitive enough to do 
this.
4.5.3: General conclusions and potential future directions
Although the lists generated did not return large numbers of potential genes up- 
regulated specifically in one uterine tissue, it gave a high proportion of genes that 
appeared to have already been investigated, and several candidates that have 
not. Although many of these genes have been previously investigated in 
implantation, their exact site of expression has not, so they cannot be used to 
validate the microarray data without further studies into their sites of expression. 
Unfortunately the luminal epithelium, the tissue that had already been investigated 
in the most depth, generated the largest number of potential markers. There were 
also six potential glandular markers, all worth investigating further using quantitative 
real-time RT-PCR on samples of luminal epithelium, glands and stroma produced by 
laser microdissection. The stroma yielded the fewest potential markers. This might 
have been because the stroma needs the presence of an implantation embryo to 
change its transcriptome, whereas the luminal epithelium changes its 
transcriptome rapidly through the oestrous cycle under hormonal stimulation.
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The genes that would be worth investigating further consist of both genes 
that have already been identified in implantation, and potentially interesting genes 
that have not. Lamb3 and Claudin 4 appear to be LE-specific markers, but this 
cannot be definitely verified due to the nature of the reference used in the array. It 
would be interesting to see if Lamb3 is specific to the luminal epithelium as well as 
being up-regulated in the luminal epithelium over the peri-implantation period. 
Glandular tissue gave a rich range of potential markers to investigate. Traf, Agpat 
and Scla7 have already been linked with implantation so their site of expression 
would be worth investigating further. Regulated secretory protein 23 and 
Transcytosis associated factor p i  15, although not previously linked to implantation, 
appear to be specific to glands because they are involved in the secretory 
pathway, which is very active in glandular tissue. Microtubule actin cross-linking 
factor is the only stromal-specific marker identified so it would definitely be worth 
investigating further, as well as the gland and stroma specific markers Alpha type IV 
collagen and St6gall. Ribosomal protein LlOa is a mysterious candidate, as it has 
been identified in this study and also another transcriptional study (ref) as changing 
in the peri-implantation uterus, contrary to the previously accepted view that 
ribosomal proteins are'housekeeping genes'.
The microarray would benefit from being repeated with a more appropriate 
reference representative of the whole uterus during the period of peri-implantation. 
The absence of the marker genes discussed in Chapter 3 from the results and the 
anomalous data for the housekeeping control genes (as discussed in section 4.4.2) 
suggest that the data obtained from these chips might not be reliable. However, 
the presence in the results lists of so many genes previously identified in 
implantation implies that the data may be useful after all. The best way to verify this 
would be to check some of the genes identified by the array using quantitative 
real-time RT-PCR.
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Chapter 5: Investigation of expression of canonical 
circadian genes in uterine tissue
Summary
5.1: Introduction to Chapter 5
5.2: Collection of experimental material
5.3: Real-Time RT-PCR analysis using Taqman®
5.3.1: Results from Taqman® on epithelial samples 
5.3.2: Results from Taqman® on stromal samples 
5.4: Discussion of Chapter 5
5.1: Introduction
A circadian rhythm is a biological rhythm that persists under constant 
environmental conditions with a period of approximately 24 hours. An interruption 
to these conditions can cause shifting of the cycle. The term 'circadian' is an 
amalgamation of the Latin words for 'about' (circa) and 'day' (dies). Circadian 
rhythms are found in animals, plants, fungi, single cell eukaryotes and 
cyanobacteria (Dunlap, 1999), allowing organisms to anticipate changing 
environments in ways that enhance their survival, for example, nocturnal mammals 
such as mice and diurnal mammals such as humans respond behaviourally and 
physiologically in opposite ways to changing levels of light. When kept in constant 
darkness, nocturnal rodents typically have a circadian period ( t )  of less than 24
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hours (Zheng et al., 2001). In laboratory conditions mice are entrained to a 
circadian period of exactly 24 hours by subjecting them to periods of 12 hours of 
light followed by 12 hours of dark. A strong entraining cue such as light is called a 
Zeitgeber (German for 'timekeeper'). The time of 'lights-on' is designated Zeitgeber 
time 0 (ZTO) and the time of 'lights-off' is designated ZT12 (Jud et al., 2005) . 
Circadian rhythms are very flexible because of their entrainability, demonstrated by 
the ability of humans to move through different time zones and adapt to working 
changing shift pattern. However, the human circadian rhythm cannot be reset 
immediately and sudden time shifts result in 'Jet lag'.
The molecular basis of the mammalian circadian clock is a negative 
feedback loop involving a small group of canonical clock-work gene products 
(Figure 5.1). The changes in expression of these genes in a group of neurons in the 
suprachiasmatic nucleus (SCN) of the anterior hypothalamus forms a central 
'master clock' that coordinates the endogenous circadian rhythms in other 
peripheral organs. The entrainment cue to the SCN is provided by signals from the 
retina in response to light (Foster, 1998).
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Figure 5.1: Diagram of the molecular clock adapted from
http://www.genome.ad.jp. Bra in -m usc le  a rn t-like  (Bm al) a n d  C irc a d ia n  lo c o m o to r  
o u tp u t  cy c le s  k a p u t (C lo c k ) a re  tra n s c r ib e d  a n d  trans la ted , fo rm  a  h e te ro d im e r  
a n d  a c t iv a te  tran scrip tion  o f  C ry p to c h ro m e  (C ry) a n d  P e riod  (Per) g e n e s  b y  
b in d in g  to  'e -b o x ' consensus se q u e n ce s  in th e ir p rom o te rs . Per a n d  C ry a re  
tra n s c r ib e d  a n d  tra n s la te d : p h o s p h o ry la tio n  o f  Per b y  ca se in  k inase  Is  re g u la te s  
d im e risa tio n  o f  Per-C ry he te ro d im e rs . The Per-C ry h e te ro d im e r en te rs  th e  n uc leu s  
a n d  b in ds  to  its o w n  p ro m o te rs  to  d is ru p t tra n s la tio n a l a c tiv a tio n  b y  th e  B m a l-C lo ck  
h e te ro d im e r. Per2 is th o u g h t to  d rive  expression o f  B m a l th ro u g h  a n  u n kn o w n  site, 
a n d  a  g e n e  c a lle d  R ev-e rb  a lp h a , itse lf a c t iv a te d  b y  B m a l-C lo ck  h e te rod im ers , 
a c ts  as a  n e g a tiv e  repressor o f  B m a l reg u la tio n .
Canonical c ircad ian genes have been found in many different peripheral 
organs and rhythmic c ircad ian expression has been found in every tissue it has 
been investigated in, with the notable  exception of the testes (Yam am oto et al.,
2004). Other tissues have shown expression of canonica l c ircadian genes but it is 
not yet known if the expression is rhythmic. The circadian rhythms of peripheral 
tissues have their own endogenous rhythms tha t can be entrained not only by the 
SCN but also by other cues, for example, feeding times provide a cue to  entrain 
the  c ircad ian rhythm of the liver (Damiola e t al., 2000). C ircadian rhythms are
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thought to influence the timing of most stages in the reproductive process 
(Kennaway, 2005). Canonical circadian genes are known to be expressed 
rhythmically in the non-pregnant rodent uterus (Dolatshad et al., 2006) and oviduct 
(Kennaway et al., 2003) and are known to be expressed (but have not yet been 
shown to be rhythmically cycling) in the pseudo-pregnant rodent uterus and pre­
implantation embryo (Johnson et al., 2002). Circadian genes are expressed at 
certain stages of spermatogenesis, but are not rhythmic in the testes (Yamamoto et 
al., 2004) (Alvarez et al., 2003) (Morse et al., 2003) (Bittman et al., 2003). The non­
pregnant uterus of a mouse in oestrus has an endogenous rhythm of circadian 
genes similar to that of other peripheral organs (Dolatshad et al., 2006). Real-time 
RT-PCR results show a sinusoidal pattern of expression with a 24-hour period. Per2 
and Cry! transcripts peak at ZT 14 and 18 respectively, with Bmal in antiphase 
peaking at ZT0. Because whole uterus cDNAs are used in these experiments, it is not 
clear from these results whether the rhythmic expression of these genes is present in 
just one of the uterine tissues or all of them, and if so whether each tissue has its 
own phase or the phase of each tissue is coordinated so the whole uterus is in 
synchronisation. If they are coordinated, is this by the SCN or is it by another cue 
such as hormonal effects? Chronic oestrogen treatment of ovariectomised mice 
causes a disturbed rhythm of Perl and Per2 in the uterus (Nakamura et al., 2005). 
Instead of the normal sinusoidal pattern, the expression patterns have two peaks in 
24 hours. This modification is not seen in the circadian rhythms of other organs in the 
oestrogen treated mouse, or in non-oestrogen treated uteri, implying that the 
circadian rhythms of the uterus are sensitive to oestrogen. It is not known whether 
this is a specific result of the action of oestrogen through the oestrogen receptor or 
a result of the rapid division of uterine epithelial cells when exposed to oestrogen.
It is not known whether the circadian rhythm present in the uterus has any 
downstream effects on the timing of embryo implantation. Mice with a loss-of- 
function deletion in the Clock gene that causes asynchrony in the expression of
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Bmal, Cryl and Per2 have decreased reproductive fitness, though this appears to 
be due to defects in oestrous cycle and parturition. There is no evidence for any 
defects in fertilisation, mating and implantation (Dolatshad et al„ 2006).
The aim of this section of work was to find out whether rhythmic expression 
of canonical circadian genes exists in separate uterine layers. In addition, as well as 
being of interest in the timing of events in implantation and pregnancy, the 
expression of circadian rhythm genes in tissues is a good test of the quality of the 
RNA obtained from the dispose treatment/mechanical extraction technique, and 
a chance to test the markers identified in chapter 3 in a wider context.
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5.2: Collection of experimental material
Two sets of tissues were obtained from pseudopregnant mice sacrificed in 
duplicate at 7 time points at 4-hour intervals over days 5 and 6 of 
pseudopregnancy (section 2.2.3). Because of the problem described in Chapter 4, 
where insufficient RNA was obtained from samples at each time point by laser 
capture, manually dissected epithelium and stroma/glands samples were 
collected.
For the first set, the first time-point taken was ZTO (06:00) on day 5, then 
samples were taken at 4 hour time points until 06:00 on day 6: designated ZT24. 
After removing the uterine horns, half of one was placed into a sterile 1.5ml 
Eppendorf tube, flash frozen in liquid nitrogen then stored at -80°C. These half horns 
were taken for laser microdissection preparation (see chapter 4). The epithelium 
and stroma from the remaining 1.5 horns were removed after dispose treatment 
and mechanical extraction (section 2.2.4), then placed in a 1.5ml Eppendorf tube 
containing 1 OOjjI Trizol and frozen at -80°C. These samples were taken for RNA 
extraction. Details of the samples taken are logged in Table 5.1, along with 
qualitative assessments of the quantity and purity of tissue obtained.
For the second set of tissues, the time points ZT4, ZT8 and ZT12 were taken at 
10:00, 14:00 and 18:00 respectively. The time points ZT16, ZT20, ZT24 and ZTO were 
taken from mice that had been kept under reverse lighting conditions for the 
previous two weeks to reset their circadian rhythms, so were taken at 10:00, 14:00, 
18:00 and again at 18:00 respectively (2.2.1). The epithelium and stroma from each 
horn was removed after dispase treatment and mechanical extraction (section 
2.2.4), then placed in a 1.5ml Eppendorf tube containing lOOpi Trizol and frozen at - 
80°C. These samples were taken for RNA extraction. Details of the samples taken 
are logged in Table 5.2 along with qualitative assessments of the quantity and 
purity of tissue obtained. During the dissection of the uterus it was noted whether
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corpora lutea (CL) were pregnant on the ovary to confirm pseudopregnancy. A 
total of 14 samples were obtained for the first set and 14 for the second set.
Mouse number 
(and ZT)
1
<0
2
<0
3
<10
4
(10
5
<20
6
<20
7
<24)
8
<20
9
<0
10
<0
11
<8>
12
<0
13
(12)
14
(12)
Quantity of LE 
obtained
2 2 1 1 2 2 2 2 2 2 2 2 1 1
Quantity of 
stroma obtained
2 2 2 2 1 1 1 1 2 2 2 2 2 2
Difficulty of 
separation
0 0 1 0 0 1 1 1 0 0 0 1 0 0
Table 5.7; Notes on dissection and extraction of set 1 pseudopregant mice. 
Qualitative assessments of the quantity of tissue and difficulty of separation of the 
epithelial and stromal layers were made for each extraction. Quantity o f tissue was 
assessed on a scale of 0-2. 0= No material obtained from extraction, 1= Very little 
material obtained from extraction, 2= Reasonable amount of tissue obtained. 
Difficulty of separation was assessed on a scale of 0-1. 0= Easy separation, 1= 
Difficult separation. ZT= Zeitgeber time, LE= luminal epithelium.
Mouse number 
(and ZT)
1
(4>
2
<0
3
<20
4
<24)
5
(12)
6
00
7
(12)
8
<20
9
<0
10
(10
11
(0
12
<24)
13
<0
14
<0
Quantity of LE 
obtained
2 1 2 1 2 2 2 2 2 2 2 1 2 1
Quantity of 
stroma obtained
2 2 2 2 2 1 2 2 2 2 2 1 2 1
Difficulty of 
separation
0 1 0 1 1 0 1 1 0 0 0 1 0 0
Table 5.2: Notes on dissection and extraction of set 2 pseudopregnant mice. 
Qualitative assessments of the quantity of tissue and difficulty of separation of the 
epithelial and stromal layers were made for each extraction. Quantity of tissue was 
assessed on a scale of 0-2. 0= No material obtained from extraction, 1= Very little 
material obtained from extraction, 2= Reasonable amount of tissue obtained. 
Difficulty o f separation was assessed on a scale of 0-1. 0= Easy separation, 1= 
Difficult separation. ZT= Zeitgeber time, L£= luminal epithelium.
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A sample obta ined from a difficult separation of epithelium and stroma is more 
likely to  have contam ination from the other tissue layer because it is more difficult 
to  pull the  layers apart, so an easy separation is likely to  be an indicator of the 
purity of a tissue, To investigate whether ease of separation (and therefore purity of 
tissue) is a property of the time of the tim e on day 5 tha t the sample was taken, 
average difficulty of separation over the 4 samples from each time point was 
ca lcu la ted  and is represented in Figure 5.2.
1 -  
0.75 - 
0.5 - 
0.25 - 
0 -
Figure 5.2: Average difficulty of separation for the four samples taken at each time 
point during day 5 of pseudopregnancy.
Figure 5,2 suggests tha t there is a correlation betw een the tim e of extraction (ZT) 
and the 'stickiness' of the sample. As discussed in section 3.4, the expression of 
adhesion molecules is up-regulated in the endom etrium  as the w indow  of 
im plantation progresses. This is likely to  make m echan ica l separation of the uterine
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layers more difficult and result in more glandular epithelium and stroma in the 
luminal epithelium samples.
Following collection of all samples in Trizol, RNA extraction was performed using a 
phenol/chloroform protocol followed by purification with a Qiagen kit (2.7.1) and 
reverse transcription (2.7.3).
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5.3: Real-Time RT-PCR analysis using Taqman®
Following RNA extraction and reverse transcription, real-time RT-PCR analysis was 
perform ed using a DNA O pticon 2 Real-Time PCR m achine (section 2.7.6). The 
techno logy behind Taqman®, the relative merits of different protocols for real-time 
PCR and how a decision on how which of these to  use was arrived at, is discussed 
in section 2.7,4. The primers for 18s were run on the samples first to  assess the 
am ount of cDNA in each. Samples with an 18s value below  1/10th o f the highest 18s 
value, were excluded from the analysis, as shown in Tables 5.3 to  5.6 (excluded 
samples shown highlighted in grey). This was to  prevent the inclusion of samples 
with very little cDNA tha t are more likely to  give erroneous fluorescence readings 
for the other genes. To check the purity of each  sample, the epithelium samples 
were run with the Tn-C primers/probe set and the stroma samples were run with the 
EP2 primers/probe set, No significant EP2 expression was found in any stromal 
sample. Cts greater than 35 were observed for T enascin -C  in some epithelial 
samples, implying mild stromal contam ination. These samples are ind icated in 
Tables 5.3 and 5.4.
Scrnple 1 2 4 5 6
7
8 9 10 11 12 13 14
ZT 4 4 16 20 20 24 24 0 0 8 8 12 12
l& j& e 8356 1133 3562 10374 3911 39 5895 15476 16850 13555 8924 1249 4054
Trhc? Yes Yes
Table 5.3: 18s a n d  Ten-C  results fo r Set I e p ith e liu m  sa m p le s , sh o w in g  th e  s a m p le  
n um be r, th e  Z e itg e b e r  tim e  (ZT) a t  w h ic h  th e  m ouse  w as s a c rifice d , th e  18s v a lu e  in 
re la tiv e  units a n d  w h e th e r Tn-C w as id e n t if ie d  in th e  s a m p le  using re a l- t im e  RT-PCR. 
S am ples  w ith  a n  18s va lu e  o f  less th a n  1/10 th o f  th e  h ig h e s t va lu e  in th e  se t w e re  n o t  
used  in th e  analysis o f  c a n o n ic a l c irc a d ia n  g e n e  p ro d u c ts  a n d  a re  m a rk e d  in g rey.
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Sample 1 2 3 4 5 6 7 8 9 10 11 12 13 14
ZT 4 8 20 24 12 16 12 20 8 16 4 24 0 0
7&vdue 17 5 155 78 58 224 38 157 200 595? 1439 2186 2762 2386
Tn-d> Yes Yes Yes Yes Yes Yes
Table 5.4: 18s and Ten-C results for Set 2 epithelium samples. S how ing  th e  sa m p le  
n u m b e r, th e  Z e itg e b e r tim e  (ZT) a t  w h ich  th e  m ouse  w as killed, th e  18s va lu e  in 
re la tiv e  units a n d  w h e th e r Tn-C w as id e n t if ie d  in th e  s a m p le  using re a l- tim e  RT-PCR. 
Sam ples w ith  a n  18s va lu e  o f  less th a n  l / l ( y h o f  th e  h ig h e s t va lu e  in th e  se t w e re  n o t  
used  in th e  analysis o f  c a n o n ic a l c irc a d ia n  g e n e  p ro d u c ts  a n d  a re  m a rk e d  in g rey.
Scrnple 1 2 3 4 5 6 7 8 9 10 11 12 13 14
ZT 4 4 16 16 20 20 24 24 0 0 8 8 12 12
/<9svdue 5018 5474 5608 5043 4580 5608 5093 5961 6168 7099 5397 2586 4172 3739
Table 5.5: 18s results for Set I stroma samples. S how ing  th e  sa m p le  n um be r, th e  
Z e itg e b e r  tim e  (ZT) a t  w h ich  th e  m ouse  w as k ille d  a n d  th e  18s va lu e  in re la tiv e  units. 
A ll sam p les  w ere  used  in th e  analysis o f  c a n o n ic a l c irc a d ia n  genes.
Scrnple 1 2 3 4 5 6 7 8 9 10 11 12 14 15
ZT 4 8 20 24 12 16 12 20 8 16 4 24 0 0
Jflsvdue 100 12095 91 7205 1684 47 16? 40 166 226 84 249 352 1772
Table 5.6: 18s results for Set 2 stroma samples. S how ing  th e  sa m p le  n u m b e r, th e  
Z e itg e b e r  tim e  (ZT) a t  w h ich  th e  m ou se  w as k ille d  a n d  th e  18s va lu e  in re la tiv e  units. 
S am ples  w ith  a n  18s va lu e  o f  less th a n  1/10th o f  th e  h ig h e s t va lu e  in th e  se t w e re  n o t  
u sed  in th e  analysis o f  c a n o n ic a l c irc a d ia n  g e n e  p ro d u c ts  a n d  a re  m a rk e d  in g rey.
Samples in set 1 had more consistent levels of cDNA than set 2, This is most likely to  
be due to  low efficiency in the reverse transcription reaction for set 2, or
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degradation of RNA during extraction. Because of this, the majority of the samples 
contributing to the analysis are from set 1.
The remaining samples were run with primer/probe sets for the genes Bmal, 
Clock, Perl, Per2, Cryl and 18s (for sequence details see section 2.7.5). The mean 
value of each set (set 1 epithelium, set 1 stroma, set 2 epithelium and set 2 stroma) 
was calculated for each primer/probe set, including 18s. Each individual result was 
then divided by the mean of its own set, then circadian gene values were 
normalised by dividing by their own 18s values, for example Bmal by 18s. The two 
sets of results for each normalised circadian gene were then combined, and the 
average and standard error of the mean (SEM) were calculated for each time 
point, as described in section 2.7.7 and shown in Figures 5.2 to 5.11.
Figure legend for Figures 5.3 to 5.7
Average expression in the luminal epithelium of genes Bmal (Figure 5.3) Clock 
(Figure 5.4), Cryl (Figure 5.5), Perl (Figure 5.6) and Per2 (Figure 5.7) a t four-hourly 
circadian time points, calculated from real-time RT-PCR results for the gene of 
interest normalised to the expression of 18s ribosomal RNA and plotted with the 
standard error of the mean as y-axis error bars for each time point.
Figure legend for Figures 5.8 to 5.12
Average expression in the stroma/glands of genes Bmal (Figure 5.8) Clock (Figure 
5.9), Cryl (Figure 5.10), Perl (Figure 5.11) and Per2 (Figure 5.12) a t four-hourly 
circadian time points, calculated from real-time RT-PCR results for the gene of 
interest normalised to the expression of 18s ribosomal RNA and plotted with the 
standard error of the mean as y-axis error bars for each time point.
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5.3.2: Results from Taqman® on LE samples
Figure 5.3: Average expression of Bmal in LE over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
2
1.5
0.5
0
208 12 16 240 4
Figure 5.4: Average expression of Clock  in LE over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
0.5
Figure 5.5: Average expression of C ryl in LE over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
2.5
0.5
Figure 5.6: Average expression of Perl in LE over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
2.5
0.5
Figure 5.7: Average expression of Per2 in LE over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
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5.3.2: Results from Taqman® on S&G samples
Figure 5.8: Average expression of Bmal in stroma over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
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Figure 5.9: Average expression of Clock  in stroma over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
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Figure 5.10: Average expression of C ryl in stroma over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
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Figure 5.11: Average expression of Per 7 in stroma over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
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Figure 5.12: Average expression of Per2 in stroma over a 24 hour period on day 5 
of pseudopregnancy, normalised to 18s
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5.4: Discussion of Chapter 5
These results canno t be interpreted as evidence for canon ica l c ircad ian gene 
rhythmic expression in the separate layers of the uterus, but canno t prove tha t the 
layers o f the uterus are arrhythmic, in particular, tw o of the results, for C ry l and 
B m a l in the epithelium (Figure 5.3 and 5.5), are suggestive tha t there is a rhythm in 
this uterine layer but tha t more replicates and m odification of the epithelium 
m echan ica l removal technique are needed. The characteristic pattern of 
expression of c ircad ian genes is a sinusoidal curve with a 24-hour phase, as 
illustrated in Figure 5,13. The values for C ry  and Per genes are generally in anti­
phase with values for B m a l genes in both SCN and peripheral tissues (Oishi e t a l„ 
1998). By contrast, C lo c k  gene expression is thought to  be constant over the 24- 
hour period.
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Figure 5.13: (Taken from  D o la ts h a d  e t  a l„  2006) The mRNA expression profiles of 
Per2, Cryl and Bmal genes in estrous uteri from wild type mice measured by real­
time RT-PCR, w h e re  ZTO = ligh ts  on, a n d  ZT12= ligh ts off.
Amongst the real-time RT-PCR results obta ined in these experiments, the only 
sinusoidal curve characteristic of a 24-hour cycling circadian gene expression
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pattern may be seen in Bmal expression in both LE (Figure 5.3) and stroma (Figure 
5.8) and Cryl in LE (Figure 5.5, where it is in anti-phase to Bmal). Perl and Per2 do 
not have obvious circadian patterns in either LE (Figures 5.6 and 5.7) or stroma 
(Figures 5.11 and 5.12) but their expression may be influenced by oestrogen, as 
discussed below. In order to conclude whether these results are biological or a 
result of the methodology, three possible points can be considered.
The first is that there is not a rhythm in the pseudo-pregnant uterus, despite 
the rhythmicity of the oestrous uterus (Dolatshad et al., 2006). The second possibility 
is that there is a rhythm in the individual layers but not enough replicates have 
been taken to show this. The third possibility is that there is a rhythm in the 
pseudopregnant uterus as a whole, but the mechanical separation and incubation 
for between two and three hours that is an integral part of the extraction protocol 
disturbs this rhythm in some way.
The first possibility is that there is no rhythm in the pseudopregnant uterus. To 
test this hypothesis, firstly real-time RT-PCR would have to  be performed on whole 
uterus samples from the first 5 days of early pregnancy to confirm the presence of a 
circadian rhythm. A circadian rhythm in Bmal, Cryl and Per2 has already been 
confirmed in uteri from mice in oestrous (Dolatshad et al., 2006). If the circadian 
rhythm is disrupted at some point, then the influence of ovarian steroid hormones 
could be investigated. It is possible that changes to the endogenous rhythm of the 
uterus take place during early pregnancy and that the 24-hour rhythm is modified 
by the combined action of progesterone and oestrogen. Chronic oestrogen 
treatment of ovariectomised mice has been shown to cause a disturbed rhythm of 
Perl and Per2 in the uterus (Nakamura et al., 2005). Instead of the normal sinusoidal 
pattern, the expression patterns are biphasic, with a peak at ZT4 and a peak at 
ZT16. This modification is not seen in the circadian rhythms of other organs in the 
oestrogen treated mouse, or in non-oestrogen treated uteri, implying that the 
circadian rhythm of the uterus is specifically sensitive to oestrogen. It is not known
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whether this is a specific result of the action of oestrogen through the oestrogen 
receptor or a result of the rapid division of uterine epithelial cells when exposed to 
oestrogen. None of the canonical circadian genes in this study (Figures 5.3- 5.12) 
show a strongly biphasic expression pattern, although this could be due to a lack of 
sufficient biological replicates (as discussed below) and the patterns of expression 
of Perl (Figure 5.6) and Per2 (Figure 5.7) in luminal epithelium over a 24 hour period 
appear to be more biphasic when compared to the flatter patterns of Bmal (Figure 
5.3) and Cryl (Figure 5.5) in luminal epithelium over the same period. More 
research is needed to determine whether the biphasic pattern of expression is a 
biological phenomenon during early pregnancy, investigation of the action of 
nidatory oestrogen can be achieved through establishment of pseudopregnancy 
then ovariectomy before the nidatory oestrogen release on day 4 of pregnancy.
The second possibility is that there is a rhythm in the individual layers but not 
enough replicates have been taken to show this. Due to the poor quality of the 
cDNAs obtained from many of the samples in the second set, fewer biological 
replicates than the n=4 aimed for were taken for most time-points. Taking more 
biological replicates for each time point would help determine whether there are 
rhythms present but they are being overlooked. It may be that there is a rhythm in 
epithelium but not stroma or vice versa. The expression of Cryl (Figure 5.5, peak at 
ZTs 12 to 20) is antiphase to Bmal (Figure 5.3, peak ZTs at 0 to 4) in the epithelium but 
not the stroma, although the pattern is not as strongly cyclic as that found in the 
whole uterus as shown in Figure 5.13. This is the most convincing observation that 
the results would benefit from further replicates and modifications of the technique.
The third possibility is that there is a rhythm in the pseudopregnant uterus as 
a whole, but the mechanical separation and incubation for between two and 
three hours that is an integral part of the extraction protocol disturbs this rhythm. 
The disturbance of rhythm could be either because the whole transcriptome is 
disturbed when cells are removed and incubated in HBSS with dispose, or because
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the circadian genes specifically are disturbed when the tissue is incubated in this 
case.
The first explanation for disruption of the rhythm (that the whole RNA 
population is unrepresentative) is unlikely. Global changes in gene expression take 
place when a tissue is put under stress, such as heat shock protein expression or 
apoptosis. Degradation by RNases also influences the RNA population present in in 
vitro experiments. It is unlikely that the RNA population is unrepresentative in these 
experiments, as the dispose incubation and mechanical extraction technique has 
been previously used to produce tissues that have mainly been used for 
subsequent recombinant culturing, but have also been used for real-time RT-PCR 
analysis and microarray analysis in which RNA populations appear to be 
representative and give consistent results (discussed in section 2.2.5). RNase 
degradation is unlikely to happen when cells are not lysed and remain intact. It is 
more likely to be a problem in the downstream experiments that lyse the cells to 
extract RNA. RNase-free technique (section 2.4.1) was stringently observed 
throughout downstream experiments.
The second explanation for disruption of the rhythm that it is specifically the 
circadian genes that are disrupted is more likely. When tissues are removed and 
cultured they are separated from their master pacemaker, the SCN. In the past, it 
was thought that the SCN gave individual cells their rhythmicity, but two landmark 
papers (Nagoshi et al., 2004), (Welsh et al., 2004) re-evaluated this: individual cells 
in culture still have their own endogenous rhythms, but the SCN synchronises them 
so the organ they are a part of consists of perfectly synchronised cells. Removal of 
an organ from its SCN results in a slow de-synchronisation of the circadian rhythms 
of individual cells so that the organ as a whole becomes asynchronous even 
though individual cells are still cycling. However, the de-synchronisation of cells in 
culture occurs over a period of two to seven days (Yamazaki et al., 2000); too long 
a period for a disruption that would have to take effect over 2-3 hours in these
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experiments. The lapse into asynchrony of cultured cell has been shown to be 
reversed within an hour with a 'serum shock', which resets cells by a rapid induction 
of Perl and Per2 (Balsalobre et al., 1998). In vitro studies have tried to elucidate the 
nature of the substance in serum that acts as a mediator between a Zeitgeber 
such as light or feeding times and the synchronisation of cells. cAMP, protein kinase 
C, glucocorticoid hormones, calcium ions (Ca2+) have been shown to be some of 
the components of serum that directly induce expression of Perl in vitro (Balsalobre 
et al., 2000). These studies focus on identifying substances that can induce 
circadian gene expression in vitro, but it may be possible that a lack of these 
factors can disrupt the expression of Perl and other circadian genes. Sudden 
disruption of a circadian rhythm though tissue explanting has not been 
investigated, but tissue explants from mice with recently light-shifted circadian 
rhythms (a jet-lag style scenario) are asynchronous. It is also possible that the 
incubation medium may have had some effect on immediate gene expression: in 
this study, tissue explants were cultured in calcium- and magnesium-free Hank's 
Buffered Salt Solution (HBSS), whereas in other tissue explant experiments (Yamazaki 
et al., 2000) Dulbecco's Modified Eagle's Medium (containing calcium and 
magnesium) was used. As described above, calcium ions can induce Perl 
expression so a sudden change in the levels of calcium may be enough to disrupt 
its expression.
Since incubation with dispose after dissection is vital to prepare the 
epithelium and stroma for mechanical extraction, it is impossible to remove this 
step altogether/although experimenting with different incubation media may result 
in finding one that disrupts the tissue less. The only way to completely circumvent 
the problem of incubating the tissue with dispose before extraction is to extract 
tissues using laser microdissection, and this has its own problems associated with it, 
as discussed in Chapter 6.
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Chapter 6: Discussion
Summary
6.1: Recap of aims of Thesis and problems encountered during the work 
6.2: Comparisons with previous studies 
6.3: Future directions
6.1: Recap of aims of Thesis and problems encountered during the work
The theme of these experiments was the investigation of changes in gene 
expression of tissues of the murine uterus around the time of implantation with a 
view to characterising molecular markers for each of the tissues. The work centred 
on a technique for separating the luminal epithelium from the rest of the uterine 
tissue using a mild enzymatic (dispose) digestion followed by mechanical 
extraction (Bigsby et al., 1986). This technique has been used successfully in several 
previous studies with down-stream techniques including co-culturing of the 
epithelium and stroma and RNA extraction followed by RT-PCR or northern 
hybridisation. Papers using this technique are discussed in Section 2.2.5.
In Chapter 3: Tissue type markers for the pseudopregnant mouse uterus 
luminal epithelium and stroma from day 4 and 5 pseudopregnant mice were 
obtained using the dispose method. These tissues were evaluated by histology. 
Through viewing histological sections of tissues isolated using the dispose 
technique, it was concluded that luminal epithelium samples obtained were 
predominantly luminal epithelium only, but with possible glandular and stromal 
contamination if taken from day 5 pseudopregnant mice. Stromal samples had 
patches of glandular epithelium throughout but little luminal epithelium
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contamination. Neither luminal epithelium or stroma/glands samples appeared to 
contain any myometrium or residual tissue.
The initial aim of this work was to characterise molecular markers for the 
different tissues types in the uterine stroma, in order to verify the tissues present in 
manually dissected uterine samples. Realistically, manually dissected samples from 
the mouse uterus are not going to be pure tissues. If they are going to be used 
subsequently in applications such as microarrays then testing the tissues using real­
time RT-PCR at least gives an idea of the levels of each tissue present in the 
samples. Markers for tissues in the peri-implantation uterus (days 4 and 5) were 
tabulated after a literature search. Possible markers that were specific for 
pseudopregnant uterine luminal epithelium (E P 2  and Osf-2), glands (LIF) and stroma 
(Tn-c and EPS) were identified. A set of paired luminal epithelium and 
stroma/glands tissues was obtained using the dispose technique and tested for the 
presence of these markers using real-time RT-PCR with Taqman® probes. Osf-2 was 
present at higher levels in the stroma and glands samples than it was in the luminal 
epithelium samples, and it was concluded that Osf-2 was not suitable as a luminal 
epithelium marker and was possibly expressed in either stroma, glands or 
myometrium due to the high expression in whole uterus extracts. E P 2  was present in 
luminal epithelium samples, but at very low levels in stroma/glands samples so was 
evaluated as a good marker for luminal epithelium tissues. Tn-c displayed the 
opposite pattern to E P2  and was assessed as a good stromal marker. E P3  was 
expressed at relatively low levels in luminal epithelium samples and relatively high 
levels in stroma/glands samples. Since it was not possible to obtain pure glandular 
epithelium tissues through manual dissection, LIF could not be verified as a 
glandular maker without the use of laser microdissection, as discussed in Chapter 4.
Searching for markers that are specifically expressed in LE, glands or stroma 
during the peri-implantation period revealed that the majority of genes that have 
been investigated during this time localise to more than one cell type, or change
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their localisation influenced by progesterone, oestrogen and the presence of the 
implanting blastocyst, such as Cox-2 (Chakraborty et al., 1996). The genes that 
have consistent expression are either ones such as Tn-c that are a structural 
component of the uterus, with very little change in expression during the oestrous 
cycle and early pregnancy (Noda et al., 2000), or those such as LIF that are 
induced in a narrow time window and switched off just as quickly (Bhatt et al., 
1991). Although two markers were picked to test for both luminal epithelium and 
stromal specificity, it proved more difficult to find specific markers for glandular 
epithelium, and only LIF was identified as a possible marker. This is likely to be 
because the luminal and glandular epithelium are structurally very similar, 
originating from the anterior Mullerian duct during development (Mericskay et al., 
2004), and many genes are up-regulated in both compared to the stroma.
Manually dissected epithelial and stromal samples were shown to contain 
both glandular epithelium and occasionally pieces of each other. These samples 
could not be used for a definitive verification of the expression of the putative 
markers. In Chapter 4: Markers Specific For Uterine Sub- Component Tissues, luminal 
epithelium, glandular and stromal tissues were taken from peri-implantation mice 
using laser microdissection, and the markers evaluated in Chapter 3 were 
confirmed as tissue specific using real-time RT-PCR. The tissues were also hybridised 
to microarray chips and analysed to compare the global expression of genes in 
each of the three tissue types and search for possible new markers. Laser 
microdissection confirmed the specificity of E P z  EP3, Tn-c and LIF as specific 
markers.
A microarray study comparing global gene expression patterns in each of 
the three tissues of interest yielded a list of genes that would benefit from further 
investigation. The initial aim was to gather samples from several time points on day 
4 of pseudopregnancy so further experiments into canonical circadian rhythm 
gene expression could be performed. Unfortunately the low yield of laser
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itiicrodissection tissue meant that the time-point samples had to be combined to 
pool enough for the microarray, and the tissue for the circadian study was 
subsequently obtained by manual dissection. The experimental design of the 
microarray meant that analysing the results was difficult. The reference cDNA used 
consisted of a pool of luminal epithelium samples from several time points over the 
peri-implantation period. Although this meant that individual tissue samples could 
not be compared to whole uterine expression, useful data were obtained by 
comparing stromal or glandular tissue expression to LE, and LE expression at two 
different time points over the peri-implantation period.
Several verification methods were used to check that the data generated 
by the microarray was useable, but conflicting results were obtained. Control gene 
readings were highly variable, general fluorescence levels were low and none of 
the tissue-specific markers could be found in the relevant data sets. Despite this, 
many of the genes in the lists generated by the microarray had been confirmed as 
involved in implantation by previous studies. The implication of these conflicting 
results is that there is useful information in the microarray, but the experiment would 
benefit from being repeated and the gene lists generated tested using real-time 
RT-PCR. Unfortunately, the integrity of RNA obtained from laser microdissection may 
be affected by the freeze-thawing and chemical treatment necessary to obtain 
the samples, and this may in turn affect the results of downstream studies such as 
microarrays.
The low yield from the laser microdissection samples meant that the initial 
idea of testing pure samples of uterine tissues at specific time points on day 4 and 5 
of pregnancy could not go ahead. Instead, In Chapter 5; Investigation of 
expression of canonical circadian genes in uterine tissue, luminal epithelium and 
stroma samples were taken at regular time points from day 5 pseudopregnant 
mice, then evaluated for cycling of canonical circadian gene transcripts using 
real-time RT-PCR. Epithelium samples were also tested with Tn-c to indicate any
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samples that might have stromal contamination, but those that were found to 
have mild stromal contamination did not correlate with unusual real-time RT-PCR 
values for canonical circadian genes. The tissues could not be shown to possess 
rhythmic expression of canonical circadian genes. This may be a result 
representative of the layers of the uterus due to disruption of the circadian rhythm 
in early pregnancy, but could also be an artefact from disruption of the circadian 
rhythm during removal and dispose treatment of the tissues. More studies would be 
necessary to determine this and ideas are discussed further in Chapter 5.
These results may lead to questioning of the relevance of manual dissection 
of uterine tissues now that laser capture is becoming more widely available. 
Despite its obvious advantages, laser dissection is labour intensive and uses 
specialist equipment. Large-scale studies would be difficult to base around laser 
microdissection and collection of tissues. By contrast, manual dissection is quick, 
does not require any specialist equipment, and produces intact tissues for cell 
culture studies. If used in the right context, it is preferable to laser microdissection, 
for example. However laser dissection is preferable for many studies, such as the 
accurate quantifying of transcripts in very specific regions of the uterus.
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6.2: Comparisons with previous studies
The peri-implantation uterus has been studied intensely, with the aim that 
elucidation of transcriptional changes during this time may be able to shed light on 
reproductive disorders in humans (Sharkey and Smith, 2003), or suggest starting 
points for research into novel forms of contraception (Catalano et al., 2005). Until 
the recent advent of microarray studies, progress has been slow due to a reliance 
on single-gene studies of null mutants with known reproductive defects. 
Microarrays have sped up the process of searching for new genes involved in 
implantation as they can generate lists of potentially interesting genes from one 
experiment. Despite this, they often produce contradictory results, but verification 
of generated data and repetition of studies is increasing confidence in these 
results. Many of these studies and their overlap with this work are discussed in 
Chapter 4.
The issue of the spatial complexity of the uterus during implantation has 
been ignored in array studies until the recent interest in the technology of laser 
microdissection. One study (Niklaus and Pollard, 2006), used laser microdissection to 
compare the transcriptomes of luminal and glandular epithelium from pregnant 
mice around the time of blastocyst implantation and luminal and glandular 
epithelium in a delayed model of implantation. The results showed that receptive 
and non-receptive glandular and luminal epithelium have very different 
transcriptomes, with 153 genes being significantly up-regulated in the receptive 
luminal epithelium and 118 in the receptive glandular epithelium. In the delayed 
implantation model, 130 genes were shown to be significantly up-regulated in the 
luminal epithelium and 152 in the glandular epithelium. The overlap between the 
receptive and non-receptive sets was just one gene: Srrml (Serine/arginine 
repetitive matrix 1). The study went on to verify the data using real-time RT-PCR and 
in situ hybridisation. Interestingly, this study also used previously characterised
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markers as positive control genes for real-time RT-PCR, Immune responsive gene I 
(Irg IX Histamine decarboxylase (HDC) and Calbindin 28k (C lbl)  were used as 
positive controls for genes up-regulated in the LE, whereas lnterleukin-6 signal 
transducer (Il6st) was used for the GE. Niklaus et al also note that there are more 
luminal epithelium-specific transcripts to investigate than gland-specific transcripts. 
There are differences in experimental design between this study and Niklaus et al., 
mainly that pseudopregnant mice are used in this study whereas pregnant mice 
are used in Niklaus et al. Using Osf-2 as an example (Chapter 3), the expression 
pattern of a gene in a pregnant mouse is often very different to a pseudopregnant 
mouse at the same stage, due to the effects of communication between the 
luminal epithelium of the uterus and the implanting blastocyst. Consequently, there 
is not much overlap between the genes found to be up-regulated in LE and GE in 
this study, and those identified in the Niklaus et al. study. There are several instances 
of different genes from the same family being identified in both studies. Claudin 7 in 
Niklaus et al. and Claudin 4 in this study are both found to be up-regulated in 
luminal epithelium. Niklaus et al. also identifies several genes previously known to 
be involved in implantation as being up-regulated in the LE, such as Histamine 
decarboxylase. Like this microarray study, the Niklaus et al. list of genes up- 
regulated in LE and GE does not contain tissue-specific marker genes EP2 (LE) and 
LIF (GE). These genes regularly evade identification in microarray studies. The 
reason for this is unknown, but further studies may offer some insight.
The microarray studies discussed in section 1.3.2 use the mouse as a model 
organism. The mouse is a popular choice for microarray studies (as discussed in 
Chapter 1) because of the similarity of its uterus to the human uterus and the 
greater availability of tissue samples. For obvious reasons, implantation 
transcriptome changes are not studied in humans and microarray studies focus on 
the change from pre-receptive to receptive or receptive to post-receptive states 
of the menstrual cycle, which are comparable to the state of pseudopregnancy in
183
the mouse. Despite this, several microarray studies have been performed on 
human tissue samples (White and Salamonsen, 2005), including a laser 
microdissection study comparing the transcriptomes of proliferative phase luminal 
epithelium and stroma (Yanaihara et al., 2005). The overlap between human and 
mouse studies is similar to the overlap within the contingent of mouse studies (see 
Chapter 4 discussion for examples of genes identified in this microarray study that 
are also identified in human studies). A full review of human receptivity microarrays 
is beyond the scope of this discussion, but mouse microarray studies have a 
valuable part to play in the elucidation of the mammalian (and more specifically 
the human) implantation process, as there is much overlap between the genetic 
control of receptivity and implantation, and the scope for experimentation is much 
larger.
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6.3: Future directions
The results of these studies are rich in springboards for potential future work. The 
characterisation of molecular markers for uterine tissue types is useful for verifying 
the composition of manually dissected uterine samples for subsequent work, and 
has already been used for that purpose in a microarray study (Campbell et al., 
2006). A layer of the uterus neglected in this work is the myometrium. The 
myometrium is a relatively static tissue in early pregnancy but becomes more 
important as pregnancy progresses and the uterus expands to accommodate the 
growing foetuses, then aids the process of parturition. It is difficult to obtain 
myometrium thorough manual dissection, but laser capture would allow isolation of 
samples of pure myometrium.
The lists of genes generated by the microarray study can be tested on laser 
microdissected tissue samples to verify that their expression is tissue specific (Hong 
et al., 2004), or used as probes in in situ hybridisation studies. The question of 
whether canonical circadian gene expression in the uterus is arrhythmic can also 
be addressed by testing whole uterus samples from time points over early 
pregnancy, using laser microdissection to obtain samples of tissue and testing 
changes in the incubation medium for manually dissected samples.
The changes that take place in the transcriptomes of the mammalian 
uterus during receptivity and implantation are still not fully characterised, but a 
number of new techniques are contributing to the current knowledge with every 
new study published. The ultimate aim of elucidating the mechanisms of 
implantation is to be able to treat reproductive problems and develop new 
contraceptive technologies that could possibly be of use in the future.
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